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Foreword
This Workshop is the second of two that the International Laboratory for Research
on Animal Diseases (ILRAD) convened to assist in its research planning for the
quinquennium 1994–1998. The first Workshop, `Recent Developments in the Re-
search and Control of Theileria annulata’, was held in September 1990.
ILRAD has a global mandate for the improvement of livestock production through
improved disease control. The focus of its research since its inception in 1973 has
been on tsetse-fly-transmitted trypanosomiasis and on theileriosis caused by Theil-
eria parva. At the time ILRAD was established, a method of immunization against
T. parva had been developed based on infection of animals with live parasites and
simultaneous treatment with tetracylines to control the severity of infection. To
develop a new non-living vaccine, it was necessary to obtain a detailed understanding
of the important protective immune responses of cattle and the parasite antigens that
provoked them. This became a major focus of ILRAD’s research. ILRAD has also
focused on improving the infection-and-treatment method of immunization by ad-
dressing the problems posed by the antigenic diversity of T. parva stocks and strains
found in the field and by characterizing immunizing stocks for use in different
countries. To define the tick-borne disease environments in which infection-and-
treatment immunization is being used, it has also been necessary to develop more
sensitive and specific assays for the diagnosis of tick-borne diseases. In the longer
term, the development of a subunit vaccine for T. parva will have to be considered in
parallel with similar developments for other tick-borne disease pathogens because
these diseases are considered together for control purposes. The progress made in
research on T. parva at ILRAD, particularly in defining the nature of the immune
responses, has been of direct relevance to research on other tick-borne diseases. The
establishment of a vaccine development area within the Theileriosis Program, inves-
tigating the induction of protection using different vectoring and adjuvant systems in
cattle, provides another important opportunity for future work on other tick-borne
diseases in collaboration with laboratories elsewhere.
It is against this background that ILRAD wished to discuss the importance of
anaplasmosis, babesiosis and cowdriosis, the methods of control being used for the
diseases and the problems encountered with these control methods, recent findings
in the epidemiology and molecular biology of these diseases and developments
towards new vaccines. These discussions will help ILRAD identify where its current
research program may contribute to research on these diseases and, should funding
and mandate allow, the establishment of collaborations that will contribute towards
the improvement in control of other tick-borne diseases using non-living, easily
delivered vaccines.
In response to a recommendation from this Workshop on collaboration in the
development of standardized diagnostic tests, representatives from the Centre for
Tropical Veterinary Medicine (Edinburgh), ILRAD, the Tick Fever Research Centre
(Brisbane), University of Florida and Washington State University met to discuss the
various tests being developed for anaplasmosis and babesiosis. A collaboration and
sharing of reagents was arranged to identify the most effective reagents for incorpo-
ration in both antigen- and antibody-capture enzyme-linked immunosorbent assays
(ELISAs). A promising test described at the Workshop was a competitive ELISA for
Cowdria ruminantium based upon a 32-kilodalton (kDa) antigen. That promise has
since been undermined by widespread cross-reactivity with other rickettsia. It is
hoped that the widely recognized need for diagnostic tests and the collaboration
described above will result in the rapid development of such tests.
Since the Workshop, ILRAD’s Board of Directors and the Technical Advisory
Committee of the Consultative Group on International Agricultural Research
(CGIAR), which sponsors ILRAD, have approved modification of the institute’s
research objectives to include the development of novel vaccines for other tick-borne
diseases. This change in objective will be undertaken on a collaborative basis with
laboratories already working on identifying potentially protective antigens. ILRAD’s
vaccine development and bovine immunology expertise and laboratory resources will
be its contribution to these collaborations.
I am particularly grateful to Mr. Peter Werehire for his assistance in preparing these
proceedings. I would like to thank Mr. Kepher Nguli for helping to organize and run
the workshop. I also thank my ILRAD colleagues for acting as rapporteurs and
chairmen and for reading and commenting on manuscripts. Ms. Susan Nduta retyped
many of the manuscripts and the rapporteurs’ summaries. Mr. William Umbima and
the ILRAD library staff checked the references. The maps of South America and West
Africa were prepared by Mr. Russ Kruska and Mr. Mohammed Baya, of ILRAD’s
Socioeconomics Program. The cover illustrations were prepared by Mr. David
Elsworth and Figure 2 in Prof. A. Ilemobade’s paper was re-drawn by Mr. Joel
Mwaura, both of ILRAD’s Graphic Arts Unit. The photomicrograph of Cowdria
ruminantium reproduced on the cover is from a colour slide provided by Dr. Linda
Logan-Henfrey. I thank CRC Press Inc., Baton Rouge, USA, for permission to
reproduce Figure 2 in the paper by Dr. Sonia Montenegro-James.
Thomas T. Dolan
International Laboratory for
Research on Animal Diseases
Nairobi, November 1992
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Opening address
A.R. Gray
Director General
International Laboratory for Research on Animal Diseases
P.O. Box 30709
Nairobi, Kenya
It is my pleasant duty to welcome you, put this workshop on `Recent Developments
in the Control of Anaplasmosis, Babesiosis and Cowdriosis’ into context, stress what
ILRAD needs to get from it and then hand over to the chairman of the first session
to get the meeting moving.
I am very pleased to welcome you all this morning. Almost every one of the invited
participants has made it to the opening session, in many cases after lengthy journeys. I
think a  majority of you have  been  to ILRAD before and `welcome back’ seems
appropriate. I am also very pleased to see some first-time visitors and we will be doing
our best to help you find your way around and to ensure you enjoy your visit to Kenya.
ILRAD is supported by the Consultative Group on International Agricultural
Research to develop improved methods for the control of livestock diseases that
adversely affect agricultural productivity in developing countries. Most of you know
that the Laboratory has concentrated to date on the African tsetse-transmitted try-
panosomiasis problem and on East Coast fever, or theileriosis transmitted by ticks
and caused by Theileria parva. Most of you also know that ILRAD works on a
five-year planning, budgeting and review cycle, and that is what brings us together
here this week.
Left to ourselves, we are probably quite capable of drawing up plans for the period
1994–1998 for the continuation of our current research programs on trypanosomiasis
and theileriosis, and possibly getting them funded. But we are well aware that it will
be necessary to improve both our understanding and the control of a number of
additional tick-borne diseases, including anaplasmosis, babesiosis and cowdriosis, to
get the maximum benefit from any future improvement in the control of East Coast
fever. We need to know what progress other laboratories are making towards the
control of these three diseases. This is not to say that we are planning to start work
on anaplasmosis, babesiosis or cowdriosis but we need to review what is going on in
these areas when we make the case for continuation of work on theileriosis. This we
explained when we wrote earlier inviting your participation this week, and this is
where we need your help.
The group here this morning includes leading figures in research and control of
anaplasmosis, babesiosis and cowdriosis and some specialists who have worked on
field aspects of these diseases in Africa. If you are not familiar with research progress
in these areas, I do not know who is! At this point I would therefore like to restate
the purpose of the workshop, which is:
`To obtain up-to-date information on the global distribution, control methods and
economic importance of anaplasmosis, babesiosis and cowdriosis; insights into
current research on the biology, new diagnostics and vaccine development; and to
examine what new biological control materials and diagnostics might become
available commercially in the near future.’
The workshop will provide an opportunity to identify where ILRAD might com-
pliment current research and identify neglected areas that might become primary
research foci in the future. The workshop has been organized around a number of
themes and rapporteurs have been appointed to summarize the status of knowledge
and anticipated discussion in each area. The rapporteurs will summarize the gist of
presentations, and note significant points arising in discussion and particularly any
gaps in knowledge or recommendation for further work.
I hope the session chairman will help the group to stay focussed on the various
objectives and I look forward to having your help in this important planning task. I
am pleased to declare the workshop opened and to hand over to the Chairman, Bob
Dalgliesh, to get the first session which is to review the status of these three diseases
under way.
OPENING ADDRESS
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DISEASE
DISTRIBUTION, ECONOMIC
IMPORTANCE AND CONTROL
Distribution, economic importance and control
measures for Babesia and Anaplasma
A.J. de Vos
Queensland Department of Primary Industries
Tick Fever Research Centre
280 Grindle Road
Wacol, Brisbane
Queensland 4076, Australia
INTRODUCTION
Bovine babesiosis and anaplasmosis form part of a complex of diseases sharing the
feature of being predominantly transmitted by ticks. Worldwide, babesiosis and
anaplasmosis must count amongst the most important of all tick-borne diseases
(TBDs). They are impediments to the development of livestock industries (McCosker,
1981). A total of 111 species have been described from the genus Babesia and at least
seven of these are known to affect cattle (Levine, 1988). Three species, Babesia bovis,
B. bigemina and B. divergens, are recognized as being of economic significance in
cattle. In the genus Anaplasma, only Anaplasma marginale infection is important in
cattle. Diseases caused by these four organisms form the basis of this paper but,
because of its lesser significance, B. divergens will be mentioned briefly.
PARASITES AND DISTRIBUTION
The vectors and distribution of Babesia species and A. marginale are summarized in
Table 1. Babesia bovis, B. bigemina and A. marginale are present in many countries
between  40 N  and  32 S  (McCosker, 1981). Boophilus microplus is the most
important and widespread vector but its distribution in Africa is limited, even though
much of the continent is climatically favourable for its survival. What stops it from
spreading is the overlapping distribution of Boophilus decoloratus, a closely related
tick that favours the drier and colder parts of the potential range of Boophilus
microplus. The two tick species interbreed but produce sterile progeny which creates
a hybrid zone through which Boophilus microplus penetrates with difficulty, except
in high rainfall areas (Sutherst, 1987).
Babesia bigemina is transmitted by the same tick species as B. bovis and therefore
has much the same distribution except in Africa, where it is more widespread because
of the ability of Boophilus decoloratus and Rhipicephalus evertsi to act as vectors
(Friedhoff, 1988).
Anaplasma marginale is transmitted biologically by at least 20 tick species.
Mechanical transmission by biting arthropods also occurs and is considered to be
the major method of transmission in the southeastern USA (Kuttler, 1979). In
Argentina, the occurrence of A. marginale well beyond the limit of tick distribution
is  also  ascribed  to mechanical transmission (Spath et al., 1990). However, in
Australia mechanical transmission of A. marginale apparently plays no major role
in the epidemiology of anaplasmosis (Callow, 1984).
Babesia divergens is transmitted almost exclusively by Ixodes ricinus in northern
Europe (Friedhoff, 1988). It has undoubtedly been exported to other parts of the
world, including Africa, Australia and North America where different Ixodes species
occur but, so far, there has been no evidence of it becoming established in these other
environments.
ECONOMIC IMPORTANCE
Up to 500 million cattle are exposed to babesiosis and anaplasmosis the world over
but this figure is not a true reflection of the number at risk to disease. The majority
of native Bos indicus and Sanga type cattle in endemic regions are probably exposed
to B. bovis, B. bigemina and A. marginale infections but do not develop overt
disease. This is partly due to the existence of a state of enzootic stability whereby
the cattle become naturally infected at an early age, when there is significant
TABLE 1. The vectors and distribution of Babesia species and Anaplasma marginale
of cattle.
Species Vector Distribution
Babesia bovis Boophilus microplus Latin America
Boophilus annulatus Southern Europe
Boophilus geigyi Africa
Asia
Australia
Babesia bigemina Boophilus microplus As for Babesia
Boophilus decoloratus bovis, more wide-
Boophilus annulatus spread in Africa
Boophilus giegyi
Rhipicephalus evertsi
Babesia divergens Ixodes ricinus Northern Europe
Ixodes persulcatus
Anaplasma marginale Boophilus spp. As for Babesia
Rhipicephalus spp. bigemina, more
Hyalomma spp. widespread in
Dermacentor spp. Africa and South
Tabanidae America, also in
Stomoxys spp. North America
Psorophora spp.
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passively acquired and innate immunity, and are immune to challenge later in life.
Although the infections can have a serious effect on previously unexposed adult
cattle, these breeds are generally more resistant than Bos taurus breeds (Callow,
1984), presumably because of a long association between host and parasite.
Exposure of improved Bos taurus cattle can, however, have disastrous conse-
quences, especially under the following conditions:
(a) When  susceptible,  high-risk cattle  such  as  bulls and pregnant cows are
imported into endemic areas, mortality rates in excess of 50% are not uncommon
(McCosker, 1981). In a recent shipment of about 1,200 New Zealand cattle to
Indonesia, a mortality rate in excess of 70% was recorded (R.C. Payne, unpublished
data). It has been estimated that about 70,000 susceptible breeding cattle are being
imported into enzootic areas of the world each year (P.D. Chudleigh, unpublished
data).
(b) When cattle are exposed following the spread of ticks into previously
uninfested areas. An extreme example of this was the loss of one million cattle in
Zimbabwe due to tick-borne and other diseases following disruption of dipping
during the 1970s (Lawrence et al., 1980).
(c) When infection is introduced into a disease-free vector population. There
are few countries or areas where the vectors of Babesia and Anaplasma are
present but not the organisms. One such country, New Caledonia, has been
endemic for Boophilus microplus for many years but only recently became
infected with Babesia following the introduction of Australian cattle carrying
these parasites.
(d) When enzootic stability fails to develop due to low tick transmission rates
caused by, amongst others, ecological factors such as drought or use of acari-
cides. In Australia, the naturally low transmission rate of B. bovis also contributes
to most outbreaks occurring in cattle bred in endemic areas (Callow and Dalgli-
esh, 1980).
The economic impact of babesiosis and anaplasmosis can be expressed in terms
of mortality, loss of production (including liveweight gain, milk production and
draught potential), the cost of control and, in some cases, restrictions placed on the
movement of animals (Norval et al., 1991). As in the case of other areas of pest
management, there are few reliable estimates of economic losses resulting from
babesiosis and anaplasmosis. The problem is further complicated by the occurrence
of more than one tick-borne disease in most areas and the need to control ticks per
se.
The relative importance of B. bovis, B. bigemina and A. marginale differs in
different parts of the world. In North and South America and southern Africa, A.
marginale is the most important by virtue of its wider distribution and high
virulence. In Australia it has the same distribution as Babesia and is only moder-
ately virulent, accounting for no more than 10% of recorded outbreaks of tick-borne
diseases. When present, B. bovis is usually an important cause of disease. In
Australia, for instance, it accounts for 80% of all outbreaks of tick-borne diseases.
Babesia bigemina is generally less virulent and therefore less important except in
areas where it is the only Babesia spp. present. In Australia, it is the cause of only
about 10% of confirmed babesiosis outbreaks.
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CONTROL
In most countries where babesiosis and anaplasmosis are endemic, disease control
rather than eradication is the only realistic option. Eradication is unlikely to be
feasible except in ecologically isolated areas and in advanced countries with the
necessary resources. This is particularly true in the case of anaplasmosis with its
non-bovine reservoirs and variety of vector species.
Active control of babesiosis and anaplasmosis is achieved by three main meth-
ods: immunization, chemoprophylaxis and vector control. Ideally, the three meth-
ods should be integrated to make the most cost-effective use of each and also to
exploit breed resistance and the development and maintenance of enzootic stability
(Lawrence and de Vos, 1990).
Live Babesia bovis and Babesia bigemina vaccines
Live vaccines prepared from blood of infected cattle have been used since the
beginning of the century to protect cattle against babesiosis. In the early carrier-donor
systems, blood from recovered cattle served as vaccine. Today, improved production
techniques provide more refined and effective vaccines. Commercially available
vaccines in Australia and elsewhere are still based on the blood of infected, splenec-
tomized calves (Callow, 1984), but current work will determine the production
potential of in vitro culture systems for both B. bovis and B. bigemina (Jorgensen et
al., 1992). Available vaccines are generally effective and safe, provided care is taken
to ensure viability at the time of use and use is restricted to low-risk classes of cattle
(young animals). These precautions are essentially the same as those for other live
vaccines.
As with any vaccine production facility, a satisfactory code of manufacturing
practice applies to the production of babesiosis vaccines. This code must ensure
adequate quality control, absence of contaminants and delivery of safe, efficacious
products. The maintenance of these standards requires facilities, funding and infra-
structure unavailable in most countries in need of effective vaccines. Therefore,
controlled production systems are bound to develop which satisfy the needs of entire
regions rather than individual countries. It was with this in mind that FAO identified
a government laboratory in Malawi for support in developing a production facility to
service the needs of southern African countries. Production statistics from existing
laboratories generally reflect demand rather than production potential. Thus, in
Australia, where the demand for B. bovis vaccine has been relatively constant at
0.7–0.8 million doses each year, the current production potential with existing
facilities is at least twice this figure. Chilled vaccine is popular in some countries,
including Australia, but has not been widely accepted elsewhere because of short-
comings, including short shelf-life, difficult quality control and risk of vaccine-
induced reactions in adult cattle (Dalgliesh, 1992).
The risk of vaccine-induced reactions in adult cattle has been reduced with the
development and use of attenuated strains. Attenuation of B. bovis by serial passage
in splenectomized calves is well documented (Callow, 1984) and may result from
selective enrichment of avirulent parasite sub-populations (Carson et al., 1990).
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Babesia bigemina parasites with low, stable virulence have been obtained by exploit-
ing observations of early workers that parasites from chronic infections are less
virulent than acute phase parasites. Thus, relapse parasites collected following
splenectomy of carrier animals are now used to prepare a B. bigemina vaccine
(Callow, 1984; Pipano and Hadani, 1984). Long-term maintenance in culture con-
taining horse serum and the use of sublethal doses of irradiation have also been used
in attempts to reduce the virulence of B. bovis and B. bigemina (Dalgliesh, 1992).
Even with relatively avirulent strains, there is a risk of reactions when adult cattle of
susceptible breeds have to be immunized. Attempts to reduce this risk include the
prophylactic use of drugs in what is sometimes referred to as chemoimmunization.
The most notable success in this field has been the use of oxytetracycline given at or
soon after vaccination to modify Babesia reactions (Pipano et al., 1987; W.K.
Jorgensen, unpublished data). Some success has also been achieved by immunizing
cattle with non-living, culture-derived antigens before inoculation with a live B. bovis
vaccine (Pipano et al., 1984).
Antigenic variation occurs within and between strains of B. bovis and B. bigemina
(Dalgliesh, 1992) but it does not appear to affect the level or duration of protection
afforded by live vaccines. A single inoculation usually confers lasting immunity
against heterologous challenge, even in different countries. Thus, Australian strains
were protective against experimental challenge in South America, South Africa and
Sri Lanka (Dalgliesh et al., 1990) and have successfully protected thousands of
susceptible cattle imported into Southeast Asian and South American countries.
Even though living vaccines against babesiosis are generally highly effective,
failures to protect cattle do occur. This happened in Australia in 1968 and 1976 due
to loss of immunogenicity of particular B. bovis vaccine strains passaged repeatedly
in splenectomized calves (Callow and Dalgliesh, 1980). Since 1977, passaging of the
vaccine strain has been restricted by regular reversion to stabilate with a low passage
number. This approach kept the failure rate at a low level for ten years. Since 1988,
however, the number of failures has again increased, especially in well-managed Bos
taurus cattle (Bock et al., 1991). There was no correlation between vaccine failures
and the time after immunization. Controlled testing of the vaccine strain against a
virulent heterologous isolate at regular intervals since 1980 indicated its protective
effect had not changed. However, the vaccine strain was poorly protective against
three recent isolates from forms which had reported vaccine failures (Bock et al.,
1991). These results and field observations indicating regional spread of parasites
causing failures suggest that the latest failures stem from changes in field populations,
not the vaccine strain.
Genetic exchange and recombination take place in Plasmodium falciparum and
may also occur in Babesia (Walliker, 1989). Both species therefore appear to be
populations of interbreeding organisms in which new genotypes are continually
generated. This possibility led Walliker (1989) to predict that widespread use of a
vaccine based on a single form of a given antigen may result in rapid selection of
parasites expressing alternative antigen forms. Recent experience in Australia seems
to indicate that this selection will take place even when antigenically complex live
vaccines are used. If this theory is correct it may mean that the useful life of a live
vaccine strain of B. bovis will depend on the degree of exposure of field populations
to immunized animals, and will be ten years or less if exposure is frequent.
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Live Babesia divergens vaccines
A standardized B. divergens vaccine is prepared in Sweden from the blood of infected,
splenectomized calves in much the same way as the B. bovis vaccine in Australia. In
Germany, blood of infected gerbils (Meriones unguicalatus) has also been used in
small-scale immunization trials and has the advantage of being free of bovine cells
(Dalgliesh, 1992). Strains used in the Swedish and German vaccines are not attenu-
ated but the trend has been to immunize calves before they are 12 months old, when
natural resistance is evident (Christensson and Thorburn, 1987). As reviewed by
Dalgliesh (1992), efforts to attenuate B. divergens by rapid passage in splenectomized
calves, irradiation and passage in abnormal hosts (gerbils) have all been unsuccessful
but a reduction in virulence was seen following 18 months in culture.
Live Anaplasma vaccines
Anaplasma centrale is a relatively benign organism which confers partial protection
against challenge with virulent A. marginale. It was isolated in South Africa in 1911
(Potgieter, 1979) and has been used for years to immunize cattle in many countries.
The level of protection afforded by A. centrale is generally adequate against moderate
challenge in Australia (Callow and Dalgliesh, 1989) but deficient against virulent
challenge in Latin America and elsewhere (Palmer, 1989). A vaccine based on an A.
marginale strain attenuated by irradiation and passaged through deer and sheep
(Palmer, 1989) has also been used successfully to immunize cattle. This vaccine is
commercially available in Latin America and California (Corrier et al., 1985) and
affords solid protection against virulent challenge.
Significant differences exist between some isolates of A. marginale as shown by
differential reactivity with isolate-restricted monoclonal antibodies and limited cross-
protective immunity (McGuire et al., 1984; Palmer, 1989). The ability of A. marginale
to generate antigenic variants appears to have been confirmed recently with the
demonstration of cyclical multiplication of organisms during persistent infection of
immunocompetent hosts (Kieser et al., 1990). Interestingly, there has been no field
evidence of changing levels of protection following immunization with A. centrale,
even though its use as a vaccine has been commonplace in South Africa since 1911
and in Australia since 1974.
Non-living vaccines
Non-living vaccines would overcome difficulties inherent in the production, trans-
portation and use of live vaccines. Most attempts to develop non-living Babesia and
Anaplasma vaccines ended while still in the experimental stage but there have been
some notable successes. Probably the best example is the commercially available
Anaplasma vaccine based on a lyophilized preparation of organisms administered
with an adjuvant. Yearly boosters of this vaccine are recommended and the level of
protection afforded is dependent upon the nature of the challenge isolate (Palmer,
1989). The potential for this vaccine to induce isoerythrolysis in the new-born is
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well-known and efforts have been made to minimize the risk by, amongst others,
improved methods of antigen purification (Palmer, 1989).
Soluble B. bovis antigen prepared from culture supernatant and given with an
adjuvant has also been used to immunize cattle. As reviewed by Montenegro-James
et al. (1989), immunized cattle undergo milder reactions than susceptible controls
when challenged with heterologous strains and protection is noticeable for up to 13
months. As a result, production and distribution of the vaccine in Venezuela is due to
commence for immunization of susceptible, imported stock. In parallel studies in
Australia, the level of protection afforded by culture-derived B. bovis antigen was not
considered adequate to make a viable proposition.
Subunit vaccines
Progress made in recent years towards defined subunit vaccines against Babesia and
Anaplasma is described elsewhere in these proceedings. However, the evidence
provided earlier for the evolution of antigenically different B. bovis field isolates in
the face of regular use of a live vaccine in Australia is worthy of note. The vaccine
strain used comprised several sub-populations with variable biological and genomic
characteristics (Carson et al., 1990; Timms et al., 1990).
Chemotherapy/chemoprophylaxis
Several groups of compounds have been used in the chemical control of babesiosis
(Kuttler, 1988). Of these, only imidocarb dipropionate, diminazene aceturate and
tetracycline antibiotics remain freely available in most endemic countries. Both
imidocarb and oxytetracycline are effective for the control of anaplasmosis as well.
Chemoprophylaxis is not a viable long-term alternative to effective immunization,
but imidocarb and diminazene have been used to protect cattle for several months
against babesiosis and low dose administration of tetracycline in the feed has been
suggested as a means of controlling anaplasmosis in the USA.
The long prophylactic effect of imidocarb against B. bovis and B. bigemina has
been used to protect newly introduced cattle in the hope that the animals will become
exposed to natural infections and develop immunity while still partially protected by
the drug. This procedure has been used with some success in instances where vaccines
are not readily available but has major limitations. The transmission rate by ticks must
be very high to ensure infection during the period of protection and the sheer numbers
of ticks required are likely to affect the cattle. Furthermore, immunity conferred in
this way may not always be adequate to protect cattle against future challenge (de
Vos et al., 1986).
Vector control
Vector control was used successfully to control and eventually eradicate Babesia from
the USA. In Africa, where babesiosis and anaplasmosis form part of very important
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complexes of ticks and tick-borne diseases, the principle means of control has also
been based on intensive, usually government regulated, tick-control programs. How-
ever, evidence is mounting which indicates that tick control as a sole means of disease
prevention is not a  viable long-term option, mainly due to the development of
acaricide resistance and economic constraints.
Integrated control
No single method is likely adequately to control the complex problem of these and
other tick-borne diseases in Africa and elsewhere (Norval et al., 1991; Young et al.,
1988). However, there are now clear grounds for considering new, integrated
approaches which encompass:
(a) selection of tick-resistant cattle,
(b) exploitation of enzootic stability,
(c) use of effective vaccines when enzootic stability is not evident, and
(d) use of acaricides only when economically justified in relation to the direct
effects of ticks on livestock production.
CONCLUSIONS
Most of the several approaches used to control disease caused by Babesia and
Anaplasma have involved induction and maintenance of immunity to challenge.
Control strategies planned for the foreseeable future must continue to include some
form of immunization, but none of the currently available vaccines is ideal. The effort
invested in the  research and development of better alternatives is considerable.
However, lessons learnt in Australia with live vaccines and the experience of our
colleagues working on malaria show that we need to improve our understanding in
two important areas if we are ever to construct the ideal Babesia vaccine. The same
may also be true for an Anaplasma vaccine. Firstly, we must better understand factors
which cause variant characteristics to arise in parasite populations, and develop ways
for predicting and measuring these changes. The possible role of genetic exchange
among field populations and parasites used in vaccines should be considered. Sec-
ondly, the expression of protective immunity to Babesia and Anaplasma infections
by the host is still poorly understood and we lack means of measuring it. If malaria
research can be used as a guide, the search for improved Babesia and Anaplasma
vaccines is bound to fail if it is based solely on sound (molecular) biological principles
without understanding the mechanisms of immune-expression against the organ-
isms.
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INTRODUCTION
Heartwater is a rickettsial disease of ruminants caused by Cowdria ruminantium
and transmitted by ticks of the genus Amblyomma. The most important vectors of
heartwater to livestock are the tropical bont tick Amblyomma variegatum and the
southern Africa bont tick A. hebraeum. Other vectors that frequently parasitize
livestock are A. asterion, A. cohaerens, A. gemma, A. lepidum and A. pomposum.
Heartwater occurs in sub-Saharan Africa and has been introduced with A. vari-
egatum to several islands in the Indian and Atlantic oceans and to a number of
islands in the Caribbean. The presence of heartwater and A. variegatum in the
Caribbean constitutes a threat to livestock production in the tropical and sub-tropi-
cal areas of the American mainland (Barré et al., 1987). Heartwater is considered
to be the most important tick-borne disease of cattle in southern Africa (Howell et
al., 1981) and in eastern Africa it is ranked second in importance to East Coast
fever; its economic importance in cattle in the remainder of sub-Saharan Africa is
recognized but not well documented. Unlike the other major tick-borne diseases of
cattle (anaplasmosis, babesiosis and theileriosis), heartwater is also of considerable
economic importance in sheep and goats and it can cause mortality in several wild
ruminant species (Oberem and Bezuidenhout, 1987a). Heartwater has traditionally
been controlled by the dipping of cattle and sometimes sheep and goats (i.e., vector
control), and an infection-and-treatment method of immunization has been avail-
able in South Africa since the 1940s. Endemic stability for heartwater probably
occurs in most situations in which indigenous livestock are maintained without tick
control in infected areas.
From the turn of the century until the 1960s almost all the research on heartwater
was carried out in South Africa, mainly at the Veterinary Research Institute, Onder-
stepoort. This situation started to change as the importance of the disease became
more widely recognized in Africa, and when the spread of A. variegatum in the
Caribbean was noted. The research effort gained momentum in the 1980s, with the
development of an in vitro culture system for C. ruminantium (Bezuidenhout et al.,
1985) and the application of new research methods based on molecular biology.
Research on heartwater and its vectors is now carried out by several groups in Africa
and elsewhere. These include:
• The University of Florida, which has a Southern Africa Development Coordination
Conference (SADCC) regional project based in Zimbabwe.
• Washington State University, which has a project in Kenya.
• The Veterinary Research Institute at Onderstepoort in South Africa.
• Institut d’Elevage et de Médecine Vétérinaire des Pays Tropicaux of France, which
conducts research on the Caribbean island of Guadeloupe.
• The Heartwater Research Network, Faculty of Veterinary Medicine, University of
Utrecht in The Netherlands.
• The Food and Agriculture Organization of the United Nations at the regional
project, `Production of Anaplasma, Babesia and heartwater vaccines for East and
Central Africa’, in Lilongwe, Malawi.
• Universidade Eduardo Mondlane in Maputo, Mozambique.
The single most important development in heartwater research in the past decade
has undoubtedly been the in vitro culture of C. ruminantium, which has now been
refined by Yunker et al. (1988) and Byrom and Yunker (1990) so that large quantities
of the organism can be produced routinely. This source of C. ruminantium has
facilitated the development of the first reliable diagnostic tests that can be used to
detect the organism or antibodies to it in living hosts and the organism in the tick
vector. These tests are now being used in field studies on the epidemiology and
economics of heartwater, which should provide a basis for improving the control or
management of the disease in the future. The culture system also provides a source
of C. ruminantium for immunological studies, which may lead to the production of
improved vaccines. Such vaccines could be based on culture-derived organisms or
on specific antigens produced by recombinant-DNA technology. Jongejan (1991) has
already reported protective immunity to heartwater after vaccination with an in
vitro-attenuated stock of C. ruminantium. Further research on vaccine development
is being undertaken by the University of Florida/USAID/SADCC Heartwater
Research Project in Zimbabwe.
Recent research on the biology and ecology of Amblyomma ticks is also contrib-
uting to the understanding of the epidemiology of heartwater and has led to a new
innovative control method for A. hebraeum and A. variegatum. Attached males of
these species emit an aggregation-attachment pheromone (AAP), which is used by
unfed nymphs and adults in host location and host selection (Norval et al., 1989a,
1989b). The effect of the pheromone is to focus heartwater infection in certain host
groups such as cattle and buffalo. The ticks that feed on these hosts, which remain
long-term carriers (Andrew and Norval, 1989), become highly infected (Norval et
al., 1990) and play an important role in the maintenance of endemic stability. The
chemical components of the AAP have been identified (Schoni et al., 1984; Apps et
al., 1988; Lusby et al., 1991).
DISTRIBUTION
The distribution of heartwater corresponds closely with that of its African Amblyomma
vectors (Provost and Bezuidenhout, 1987). Distribution maps of the vectors have been
DISEASE DISTRIBUTION, ECONOMIC IMPORTANCE AND CONTROL
14
compiled by Walker and Olwage (1987). The most widely distributed vector in Africa
is A. variegatum, which occurs throughout western Africa from the Sahel southwards,
in areas of northeastern Africa including southern Sudan, most of Ethiopia and
northwestern Somalia, in most of central and eastern Africa, and in southern Africa as
far south as the Zambezi River system and central Mozambique. In the highland areas
of northern Angola, A. variegatum gives way to A. pomposum and in southern Africa
it is replaced by A. hebraeum. There is evidence that A. variegatum and A. hebraeum
are mutually exclusive due to inter-specific competition resulting from inter-specific
responses to the female-produced sex pheromone and the male-produced AAP (Re-
chav et al., 1982; Norval, 1983a). Amblyomma cohaerens, A. gemma and A. lepidum
occur fairly widely in eastern and northeastern Africa. Amblyomma asterion occurs in
the Congo basin, in coastal areas of Angola and on the off-shore islands of Sao Tome
and Principe.
Outside the African continent, A. variegatum is established in Yemen, on the Indian
Ocean  islands of Madagascar,  Grande Comore,  Reunion  and  Mauritius,  on  the
Atlantic Ocean islands of Cape Verde, and on the Caribbean islands of Guadeloupe,
Marie Galante, Martinique, Antigua, St. Lucia, St. Kitts, Nevis, St. Maarten/St.
Martin, La Desirade, Monserrat and Dominica. It has also been recorded from or has
been temporarily established on several other islands in the Antillean chain—An-
guilla, Barbados, Puerto Rico, Saba, St. Eustatius, St. Vincent, the US Virgin Islands
and Vieques.
Three other African Amblyomma species, A. marmoreum, A. sparsum and A.
tholloni, are known to transmit heartwater, but are not considered to be important
vectors to livestock as they are parasites of specific wild hosts. Amblyomma mar-
moreum, a tortoise tick, may be an exception in parts of South Africa where its
immature stages frequently parasitize domestic animals (Petney and Horak, 1988).
Two American Amblyomma species, A. maculatum and A. cajennense, have been
shown to be vectors of heartwater under experimental conditions (Uilenberg, 1982a,
1983a) but it is not known if the species would be able to perpetuate infection under
field conditions. Field vectors must be capable of onward transmission from asymp-
tomatic carriers; to date, the capacity to transmit from carriers has been demonstrated
only for nymphs of A. hebraeum (Andrew and Norval, 1989) and A. variegatum
(Jongejan et al., 1988). Amblyomma maculatum occurs in coastal areas around the
Gulf of Mexico and A. cajennense in Central America, Cuba and much of South
America as far south as Uruguay. If either or both of these species are found to be
potential field vectors, large areas of the American mainland could be at risk to
heartwater introduced by the importation of carriers. As yet such an introduction has
not occurred  despite the importation  of wild ruminants from Africa (potential
carriers) into some infested areas, particularly in the southern United States.
The most serious threat of heartwater to the American mainland is undoubtedly
the presence of A. variegatum and C. ruminantium in the Caribbean (Barré et al.,
1987). The tick is continuing to spread in the Caribbean, infesting about one new
island each year (Alderink and McCauley, 1988). Should it be introduced to the
mainland, A. variegatum has the potential to become established and spread over a
large area in the southern United States, Central America and a large part of eastern
South America. Sutherst and Maywald (1985) have shown, using the climate-match-
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ing model CLIMEX, that these areas are climatically suitable for the survival of A.
variegatum.
ECONOMIC IMPORTANCE
The distribution of the disease and its tick vectors places upper limits on the number
of animals currently at risk to heartwater. Using FAO/WHO/OIE (1990) estimates,
Africa has a maximum of about 175 million head of cattle that are either in countries
where heartwater has been confirmed (Provost and Bezuidenhout, 1987) and/or
where vectors occur and the disease is likely to be present (Walker and Olwage, 1987).
This figure includes cattle on the Indian and Atlantic ocean islands where the disease
is established. Caribbean islands on which A. variegatum is established mostly have
small numbers of cattle, ranging from 7,000 head on St. Lucia and Nevis to 74,000
head on Guadeloupe (FAO/WHO/OIE, 1990). Small cattle populations do not mean
that the cattle are economically unimportant to either the individual owner or the state
economy. The economic impact of the disease on these animals at risk can be
separated into two categories: disease-related mortality and non-lethal losses. Losses
in each category include:
Mortality
• of susceptible animals moved to endemic areas,
• caused by heartwater epidemics when vectors spread,
• in endemically unstable situations,
• when tick control fails, and
• when susceptible animals are raised in endemic areas.
Non-lethal losses
• production losses caused by sub-clinical (carrier state) infections,
• losses due to the costs of control of heartwater and its vectors and the treatment of
clinical cases,
• lost production potential caused by the inability to upgrade local livestock by
cross-breeding with exotic breeds imported into a heartwater endemic area, and
• production losses caused by infestations of vectors.
The circumstances in which heartwater causes mortality in domestic livestock are
now well defined. The following are examples of such losses.
Cattle, sheep and goats are moved from heartwater-free to endemic areas. This
has occurred when high-yielding exotic breeds have been introduced to upgrade or
replace local stock (Uilenberg, 1982b). In Botswana this occurs when cattle are
moved from heartwater-free areas in the drier western part of the country to endemic
areas in the east (Windsor, 1987). In Zimbabwe it occurs when cattle are moved from
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the heartwater-free highveld to the lowveld (Norval and Lawrence, 1979). In South
Africa losses have occurred when animals have been moved locally to better grazing
(Neitz, 1967). Losses have been reported in Mali when livestock have been trekked
from the Sahel to markets in areas where A. variegatum is common (Logan et al.,
1988).
Heartwater vectors and infection spread to new areas. This is well illustrated by
the spread of A. hebraeum and heartwater into the Eastern Cape Province of South
Africa in the nineteenth century, which caused devastating livestock losses to British
settler farmers (Lounsbury, 1899). More recently very large losses of cattle, sheep
and goats  due  to  heartwater occurred when the  distribution of A. hebraeum in
Zimbabwe expanded when dipping was disrupted during the pre-independence war
(Norval, 1979; Lawrence et al., 1980).
Vector populations are suppressed by tick control measures or drought and
endemic stability is lost. The adverse effects of intensive dipping and periodic
droughts on endemic stability for heartwater have long been recognized in South
Africa (Howell et al., 1981; Bezuidenhout and Bigalke, 1987) but quantitative data
on losses have not been published. In Zimbabwe, Norval and Lawrence (1979)
reported that over an eight-year period one commercial ranch in an endemic area
that practised intensive dipping lost 933 out of 116,038, or almost 1%, calves to
heartwater.
Intensive tick control fails or is relaxed. Intensive tick control may fail for a variety
of reasons, ranging from acaricide resistance in tick populations to political or
economic instability or poor management (Lawrence et al., 1980; Norval, 1983b) or
it may be deliberately relaxed, for example following ECF immunization (Uilenberg
et al., 1978; Uilenberg, 1984; Radley, 1984). In all these circumstances heartwater
can be a major cause of mortality in livestock.
Heartwater-susceptible breeds of livestock are raised in endemic areas. Certain
livestock  breeds, for example Merino sheep and Angora goats, are  particularly
susceptible to heartwater and suffer significant losses, even when they are raised in
endemic areas (Thomas and Mansvelt, 1957; Gruss, 1987). In endemic areas in the
Eastern Cape Province of South Africa, heartwater mortality rates in Angora goats
may be up to 30% per annum (Norval, 1974). Van de Pypekamp and Prozesky (1987)
reviewed literature which claimed that Merino sheep have heartwater mortality rates
of 5–95%.
Although the circumstances in which mortality occurs are well defined, the actual
numbers of deaths caused by heartwater have never been studied or recorded in a
systematic or structured manner. The estimates of mortality are largely anecdotal,
such as those listed by Camus and Barré (1988) and others mentioned above. Some
deaths due to heartwater are recorded in the annual reports of veterinary departments
and others can be found in the  detailed records kept by a small proportion of
commercial farmers, but most appear to go unreported. Two important factors
contribute to this: firstly, the difficulty of obtaining a definitive diagnosis of heartwa-
ter which until the present has only been possible by examination of brain smears
and, secondly, heartwater is not a notifiable or specified disease in any country and
so farmers and veterinarians are under no obligation to report cases. Despite the lack
of reliable estimates, the available information provides a clear indication that
heartwater-related deaths are a significant cost to livestock owners.
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There are no data concerning non-lethal production losses caused by heartwater.
Losses due to the sub-clinical (carrier state) forms of the disease could include slower
rates of liveweight gain, delayed or missed conceptions, higher rate of abortions,
lower birth weights, and reduced milk yields. Other non-lethal losses are the costs of
controlling heartwater and its vectors and in treating clinical cases. Reliable estimates
of these costs are difficult to obtain. A small survey of large-scale ranchers in
Zimbabwe’s southeast lowveld region showed that farmers pay from US$1 to 17 per
head per year to dip cattle to protect them from heartwater (Meltzer, 1990). Not only
are these costs significant in local currency terms, but since the acaricides and drugs
used for treatment have to be imported, they can represent a notable expenditure of
foreign currency. In Africa, foreign currency is a scarce resource, and the costs of
controlling and treating heartwater represent a distinct opportunity cost in terms of
alternative uses for that foreign currency. Thus, the `shadow price’ or `true cost to
society’ of importing acaricides and drugs to control heartwater can be considerably
greater than just the `shelf price’ of these items.
The lost production potential caused by the inability to import live animals to
conduct cross-breeding programs to upgrade the production of indigenous breeds is
another opportunity cost of unknown magnitude caused by heartwater. This loss is
particularly important in terms of milk production. The indigenous Zebu and Sanga
breeds generally produce about 400–800 kg of milk per lactation versus the
2,000–5,000 kg produced by exotic taurine purebreds and cross-breds (Oliver, 1971;
Webster and Wilson, 1980; Wilson, 1968). The removal of constraints imposed by
heartwater and other tick-borne diseases could allow increased milk production, with
the subsequent improvement in human nutritional status.
Non-lethal production losses in cattle caused by infestations of A. hebraeum and
A. variegatum are more adequately quantified than those caused by the disease itself.
Norval et al. (1989c) and Pegram et al. (1989) have demonstrated that each adult
female that completes feeding causes a loss in liveweight gain of 10 g for A. hebraeum
and 41–60 g for A. variegatum.
The disease-related mortality and non-lethal production losses may be tempered
by the fact that susceptibility could be altered by age, sex, breed and nutritional status.
It is generally accepted that there is a reverse age-related innate resistance to
heartwater, with calves being resistant for up to three to four weeks of age (Uilenberg,
1983b; van de Pypekamp and Prozesky, 1987). The case for a sex- or breed-related
difference  in susceptibility is  less  clear. Van der Merwe  (1987) claimed that a
heartwater infection-and-treatment immunization program showed clear differences
in mortality due to sex and breed. Unfortunately, van der Merwe’s results were not
statistically analysed, and the number of deaths reported were exceedingly small (24
out of 2,743 animals immunized). Uilenberg (1983b) felt that there is a breed-related
difference in susceptibility, but that ` . . . inherited resistance has nothing to do with
Zebu influence’. Uilenberg (1983b) further maintained that the humpless breeds
which are raised in heartwater endemic regions, such as the N’Dama and Dahomey,
are `highly resistant’. He provided no data that supported such a claim. No literature
could be found describing the interaction between nutritional status and the impact
of heartwater. Finally, it is noteworthy that, overall, heartwater appears to be a more
serious problem in southern Africa where the vector is A. hebraeum than in the rest
of sub-Saharan Africa and the infected islands where A. variegatum is the main or
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only vector. There is evidence that the vector species does influence the epidemiology
of heartwater. In Sudan, Karrar (1968) reported that heartwater was less of a problem
in  areas  infested  with A.  variegatum than  in those infested with other vectors.
Similarly, in Zimbabwe, Norval (1983a) noted an apparent absence of clinical
heartwater in the northwest where the vector is A. variegatum and a severe problem
in the south where the vector is A. hebraeum. A positive correlation between species
of vector and the impact of the disease could explain why Uilenberg (1983b) observed
that the indigenous N’Dama and Dahomey breeds from West Africa, where A.
variegatum is more predominant, are more resistant than breeds from southern Africa.
The reasons why heartwater causes more losses when associated with one vector
species than another are not known and require investigation.
CONTROL
Vector control
Controlling tick-borne diseases through the use of acaricides to control their tick
vectors has been practised in eastern and southern Africa since the turn of the century.
While this control method has prevented Amblyomma ticks and heartwater from
becoming established in the highveld of Zimbabwe (Norval and Lawrence, 1979;
R.A.I. Norval, B.D. Perry, M.I. Meltzer, R. Kruska and T.H. Booth, in preparation)
and achieved localized heartwater eradication in parts of South Africa (Stampa, 1969)
and Kenya (A.S. Young, personal communication), it is fraught with difficulties and
does not provide a long-term solution to heartwater problems. Listed below are the
major problems associated with the control of heartwater by vector control.
• The costs of acaricides (particularly the foreign exchange component) and their
application are becoming too high to be met in several affected countries.
• National tick control programs suffer organizational problems and are vulnerable
to political or economic instability.
• Acquired resistance to acaricides in one or more tick species can adversely affect
control programs.
• Intensive tick control can create endemic instability for heartwater.
• Control of heartwater by intensive tick control may adversely affect endemic
stability for other tick-borne diseases such as babesiosis (this is potentially a
problem associated with Amblyomma eradication in the Caribbean).
• Tick control has little effect on Amblyomma abundance where alternate hosts for
the adult stage are present; this is because the aggregation-attachment pheromone
(AAP) emitted by attached males causes unfed nymphs and adults to attach in
preference to the untreated hosts.
• Dipping or spraying using acaricides pollutes the environment and may result in
residues in meat and milk.
A significant advance in the control of A. hebraeum and A. variegatum has been
the utilization of the AAP, naturally emitted by the attached males, to attract unfed
nymphs and adults to a source of pesticide (Norval et al., 1989a, 1989b, 1991).
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Synthetic pheromone components and an acaricide can be incorporated into slow-re-
leasing plastic `tick decoys’, which can be attached to the hosts (Sonenshine and
Hamilton, 1989). This slow-release tick decoy system has the following advantages
over traditional dipping or spraying.
• It uses less acaricide per head treated and should therefore be less costly and less
of an environmental hazard.
• It is long-lasting and removes the need for frequent mustering of animals for
dipping or spraying.
• Control is directed specifically at Amblyomma ticks and so should not affect the
epidemiology of tick-borne diseases other than heartwater.
• The use of the AAP to attract unfed ticks makes effective control of A. hebraeum
and A. variegatum feasible, even in the presence of alternate hosts.
Chemotherapy
The first chemotherapeutic agent found to be effective against heartwater was the
sulfonamide drug `Uleron’ (Neitz, 1939). Subsequently other drugs, in particular
tetracyclines, have been found to be effective (Weiss et al., 1952; van Amstel and
Oberem, 1987). Two major problems appear to be preventing the widespread adoption
of chemotherapy as a control strategy. First, there often are difficulties in the early
diagnosis of the disease when chemotherapy is most likely to be effective (van Amstel
and Oberem, 1987). The second problem is the relatively high cost of drugs such as
the  tetracyclines, in both local and foreign currency terms. To demonstrate the
magnitude of potential costs, it has been estimated that administering long-acting
oxytetracycline as part of the infection-and-treatment immunization method for East
Coast fever will cost US$1.40 per animal (A.W. Mukhebi, personal communication).
Other cost estimates, reviewed by Mukhebi et al. (1990), range from US$2.50–4.00
per head. Uilenberg (1983b) noted that even using long-acting oxytetracycline to treat
heartwater may require two or more treatments, which would substantially increase
the cost estimates given above.
Chemoprophylaxis
Purnell et al. (1989) reported that susceptible cattle introduced to an endemic
heartwater area and given three injections of long-acting oxytetracycline on days 7,
14 and 21 after introduction did not develop clinical disease. Again, a major constraint
to the widespread adoption of this methodology is the cost. A variation of adminis-
tering injections at set intervals is to use slow-release drug implants, such as the
doxycycline implant. The latter has been reported to `look promising’ when used in
Angora goats raised in heartwater endemic areas (B. Fivaz, personal communication).
A cost-benefit analysis of such implant technology has yet to be published.
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Infection-and-treatment method of immunization
The first practical and effective method of immunization was introduced by Neitz
and Alexander (1941) who exploited the innate age-related resistance of calves to
immunize them with virulent C. ruminantium. The infection-and-treatment method
of immunization was developed when Uleron became available as a chemotherapeu-
tic agent (Neitz, 1940). The method has since been refined and tetracyclines have
replaced Uleron (van der Merwe, 1987). Infections are produced by intravenous
inoculation of whole blood from reacting animals (sheep) or stabilate made from ticks
fed on reacting animals (Bezuidenhout, 1981). After inoculation the temperatures of
individual animals must be monitored so that treatment can be initiated at or soon
after the start of the febrile reaction. Block treatment of herds or flocks is not
generally recommended as the incubation period is extremely variable (du Plessis
and Malan, 1987). Treatment prior to the febrile reaction may prevent the develop-
ment of immunity and treatment too late in the reaction can result in death. For best
results this method of immunization obviously needs to be carried out under strict
veterinary supervision.
The need for veterinary supervision obviously increases the cost of application,
which limits the number of farmers successfully adopting the technique. The infec-
tion-and-treatment method of immunization is used on a large scale only in South
Africa, where approximately 175,000 doses of heartwater `vaccine’ are sold annually
(Oberem and Bezuidenhout, 1987b). Some other disadvantages of the method are:
• Infected blood or stabilate must be stored on dry ice.
• Infection must be administered intravenously.
• The need to monitor febrile reactions in individual animals limits the number that
can be immunized at any one time.
• Deaths frequently occur if procedures are not adhered to strictly.
• Use of whole blood introduces a risk of transmitting other pathogens.
• The procedure, which includes the use of tetracyclines, is costly.
• Some problems exist with cross-immunity between immunizing and field stocks
of C. ruminantium (du Plessis et al., 1989).
Attenuated cell culture vaccines
The development of an attenuated vaccine for heartwater, to replace the infection-
and-treatment method of immunization, would represent a significant advance in
practical terms. The recent report by Jongejan (1991) on the protection induced by
an in vitro attenuated stock of C. ruminantium is therefore very encouraging.
Further research on immunization by this attenuated stock is obviously required;
the attenuation of other stocks should also be investigated.
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Recombinant vaccines
The ultimate goal of the University of Florida’s Heartwater Research Project is to
develop a live recombinant vaccinia virus vaccine. The strategy and progress will be
discussed in the next section. The reason for the emphasis on recombinant vaccinia
virus vaccines is one of economics. The World Health Organization-sponsored
smallpox eradication campaign in the 1970s clearly demonstrated that vaccinia virus
vaccines can be produced with some very basic tools and materials, freeze dried and
distributed to the most remote regions (Fenner et al., 1988). Using production costs
from the WHO campaign, it has been estimated that a recombinant vaccinia virus
vaccine against heartwater could be produced for as little as US 10 cents per dose
(Meltzer, 1990). The ability to freeze-dry vaccinia virus means that there will be no
logistical problems associated with establishing a continuous cold or frozen chain
from the site of production to the on-farm site of inoculation. Thus, it is feasible to
consider that a vaccine against heartwater could be produced and distributed in a
developing country without excessive start-up costs.
DISCUSSION
Overall two approaches to the control of heartwater and its vectors are emerging:
eradication in the Caribbean and management in Africa.
Barré and Garris (1990) are of the opinion that A. variegatum can be eradicated
from individual islands in the Caribbean if all livestock and dogs are treated system-
atically with a suitable acaricide over a given period of time. The two major problems
foreseen are ensuring that the acaricide is applied on a regular basis to all potential
hosts and the costs of such applications. Slow-releasing tick decoys that are attached
to hosts present a possible solution to these problems. The tick pheromone emitted
by the decoys will ensure that the unfed ticks are attracted to acaricide-treated hosts;
this would not otherwise occur because of the absence of pheromone-emitting male
ticks from these animals.
The extent of Amblyomma distribution in Africa and the frequent association of
Amblyomma ticks with wild hosts means that the eradication of heartwater from this
continent is simply not feasible. Localized eradication may be possible under some
circumstances but, as discussed earlier, it carries considerable long-term risks. The
alternative to eradication is the management of heartwater in the environments in
which it occurs. In the past the management of heartwater in Africa has been either
largely empirical or unplanned.
The first step towards improving the management of heartwater is to collect
information on the epidemiology and economic impact of the disease. Currently,
by using information on the sizes of tick infestations, the value of the resultant
losses in productivity and the costs of tick control, it is possible to estimate a
damage threshold for either tick species, above which tick control is economically
justified. With the development of an IFA test (Semu et al., 1992), an indirect
ELISA (Jongejan et al., 1991) and a DNA probe (Waghela et al., 1991), it should
now be possible to conduct surveys to determine the prevalence of heartwater and
to carry out controlled experiments to measure the effects of the carrier state on
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productivity. With this type of information, and more data on Cowdria infection
rates in vector populations, it should also be possible to estimate disease transmis-
sion thresholds, necessary for the maintenance of endemic stability. Disease trans-
mission thresholds and damage thresholds will form the basis for epidemiological
and economic models, with which the effects of a variety of potential control
strategies can be simulated. The most appropriate of these strategies for given
environments can then be field tested and, if proved effective, can be implemented
on a large scale. As improved heartwater vaccines based on either attenuated stocks
or specific immunizing antigens produced by recombinant-DNA technology be-
come available, they can be integrated into plans for the systematic management
of the disease. Similarly, new methods of vector control will provide cost-effective
alternatives to dipping as a means of minimizing the production losses associated
with the tick vectors of heartwater. An added dimension to the control of heartwater
in the future will be the integration of these control methods into overall tick and
tick-borne disease control strategies and into the herd-health management systems
of farmers.
To achieve the goals outlined above we consider the development of all aspects of
heartwater research, including vector ecology and control, epidemiology and socioe-
conomics, as well as vaccine development, to be essential. If any of these research
areas are ignored or omitted, achieving the ultimate objective of improving the
well-being of rural farmers could be considerably delayed.
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INTRODUCTION
Most of Central and South America lies in the region of warm climates found between
latitudes 30° N and 30° S (N-S 30°) of the equator. The N-S 30 region produces almost
half of the world’s livestock, yet it accounts for only 30% of the world meat output
(Lombardo, 1976). The continent of South America includes 12 countries with a total
area of 17,707,081 km2. Approximately 216 million of the estimated 600 million cattle
in the N-S 30° region are found in South America alone (McDowell, 1972).
Although Latin America has twice as many cattle as the United States, the region
produces less than half as much beef (McDowell, 1972). The productivity ratio is 1:4,
meaning Latin America feeds four times as many cattle as the US in order to produce
one tonne of beef (McDowell, 1972). This ratio must be reduced to effectively expand
food supplies and improve farm income.
Ticks and tick-borne diseases have long been incriminated as major obstacles to
efficient livestock production. In South America, vast areas of grazing land, although
inadequate for cultivation and occupied by indigenous breeds, could yield greater
quantities of animal protein were it not for constraints imposed by tick-borne diseases
on the importation of improved European breeds (Smith, 1977). At present, average
rates of dairy and beef production in this region are only 10–25% of acceptable values
found in the northern latitudes (McDowell, 1972). Pressed by the need for economic
improvement, most Latin American countries have attempted to increase the efficiency
of commercial cattle operations by importing more productive breeds from countries
with temperate climates. However, imported cattle are highly susceptible to tick-borne
diseases and fare poorly when introduced into endemic areas.
Anaplasmosis and babesiosis may cause morbidity and mortality in susceptible
cattle introduced into tick-infested areas of Mexico and Central and South America
(Pino, 1981). Methods presently available for the control of these diseases rely
almost entirely on the use of chemotherapeutic drugs or acaricides for the control
of ticks (Smith, 1977). Undoubtedly, to implement effective control measures,
renewed efforts are needed, particularly in acquiring a comprehensive under-
standing of tick biology and disease relationships.
DISTRIBUTION AND ECONOMIC IMPORTANCE
OF ANAPLASMOSIS AND BABESIOSIS IN SOUTH AMERICA
Bovine anaplasmosis and babesiosis are widespread in most Latin American coun-
tries. The highest prevalence is found in humid, tropical and subtropical regions
FIGURE 1. Map of South America showing the eight countries from which anaplasmosis and
babesiosis are described.
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(Smith, 1977). In general, anaplasmosis is more prevalent than babesiosis. Babesia
bigemina appears to be the most prevalent Babesia species, although B. bovis seems
to be more pathogenic (Lopez, 1977). Of the estimated 250 million cattle in Central
and South America, approximately 175 million (70%) are in tick-infested regions
between latitudes 33° North and 35° South of the equator (Lopez, 1977). Climatic
conditions in those areas favour development of the one-host tick Boophilus micro-
plus, the most important vector of bovine babesiosis in the region. Field studies
conducted in Uruguay have demonstrated an annual output of up to six generations
of B. microplus in certain areas (Nari et al., 1979a). The distribution of ticks is
restricted to high altitude, low temperature regions, especially the Andes mountain
range and southern South America (Nari et al., 1979a). In many areas of Central and
South America and the Caribbean, B. bigemina and B. bovis are enzootically stable.
The high rate of transmission of these haemoparasites results in most cattle becoming
infected at a young age (Young, 1988).
Argentina. The area at risk of anaplasmosis encompasses a population of 22
million cattle in the northern region of Argentina (32° S) (Spath et al., 1990).
Babesiosis is restricted to areas where B. microplus is present (up to 30° S),
representing 82 million hectares with a cattle population of 12 million head in
Northeast and Northwest Argentina (Spath et al., 1990). Boophilus microplus is
found throughout the year in northeastern Argentina, with a peak incidence occur-
ring at the end of the dry season. Other ticks found are Amblyoma cajennense, A.
neumanni and A. parvum (Guglielmone et al., 1990). In this region more than 80%
of the cattle become seropositive to Babesia spp. at nine months of age (Gugliel-
mone et al., 1990). Babesiosis outbreaks are most frequently due to B. bovis
(Guglielmone et al., 1990). The Nelore breed (Bos indicus) presents lower infection
rates with A. marginale and Babesia spp. than do the Criollo and Hereford breeds
(Aguirre et al., 1988). Also, Nelore cattle are known to exhibit the lowest level of
B. microplus infestation (Aguirre et al., 1988).
Uruguay. The geographic location (30–35° S) and temperate climate favours
development of B. microplus in the northern part of the country. However, only
2.5–3.0 tick generations are observed each year (Nari et al., 1979a). Approximately
six million cattle are found in this region. Previous studies have also reported ticks
to reside in ecological zones at the extreme south of Uruguay (34° S) (Nari et al.,
1979a). The southern region is only marginal for tick survival as development is
limited by the low winter temperatures. The prevalence of haemoparasites on farms
located at various latitudes throughout the region has been studied (Nari et al., 1979a).
At 31.2° S, positive seroreactors for B. bovis and A. marginale have been found in
87% and 90.4% of the farms, respectively. At 32° S, 61.2, 69.2 and 61.5% of farms
were positive for B. bovis, B. bigemina, and A. marginale, respectively. In more
southern latitudes (e.g. 33.5° S), no farms were positive for either Babesia species
whereas 50% had seroreactors to A. marginale (Nari et al., 1979b).
The cattle population in the south is affected by conditions of enzootic instability
and the animals are routinely premunized (Nari et al., 1979b). The negative impact
of haemoparasites on cattle performance has been shown by Nari et al. (1979a). The
authors observed that 14-month-old A. marginale carriers had less weight gains
(47.6%) as compared with uninfected animals after a 75-day observation period. This
effect was attributable to A. marginale. After 140 days, carriers of Babesia spp.
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demonstrated decreased weight gain (26.1%) as compared with uninfected cattle.
Livestock in Uruguay are composed exclusively of Bos taurus breeds. Cattle are
regularly exported to neighbouring Brazil and Paraguay (Nari et al., 1979b).
Paraguay. A recent serological survey reported that A. marginale, B. bigemina
and B. bovis are widespread in the eastern region of Paraguay, and in much of the
South and Central Chaco with rates of 92, 79 and 71%, respectively (Nari et al.,
1979b). An enzootically stable situation exists with regard to the three parasites
over much of the country (Payne and Osorio, 1990). The livestock industry of
Paraguay is based on beef production with only 3% of the six million cattle being
utilized in the dairy sector. Cattle breeds are mainly Criollo (Bos taurus of Spanish
descent) and Hereford-Zebu cross-breeds. Boophilus microplus is the predominant
cattle tick in Paraguay with a widespread, year-long presence in cattle-rearing
regions (Payne and Osorio, 1990).
Bolivia. A high prevalence of antibodies to B. bovis and A. marginale (97 and 93%,
respectively) has been found in dairy cattle in the tropical, eastern region of the
country (Santa Cruz) (Nicholls et al., 1980). Imported Bos taurus suffer heavy losses
when introduced into this endemic area (Nicholls et al., 1980).
Brazil. Brazil occupies an area of 8.5 million km2 in eastern South America and
has a cattle population of approximately 100 million. The country consists of three
large agricultural regions: Amazon Region is composed of four states, three territories
and is characterized by the Amazon rain forest with a warm, humid climate; Northeast
Region constitutes nine states with a characteristically semi-arid climate; and Mid-
South Region encompasses ten states and is characterized by both tropical and
temperate climates.
Most cases of cattle `tristeza’ (anaplasmosis and babesiosis) occur in the southern
region where most breeds are of European origin (Bos taurus). The prevalence of B.
bovis in Rio Grande do Sul ranges from 46.6 to 96.1% (average 80.3%) for B.
bigemina and 34.4 to 93.3% (average 76.2%) for B. bovis (Leite, 1988). In Minas
Gerais, A. marginale prevalence has been reported to be 87.6% for Zebu cattle, 87.8%
for Criollo animals, and 91.7% for Holstein cattle (Ribeiro and Reis, 1981). Babe-
siosis had an average prevalence of 82.5 and 79% for B. bovis and B. bigemina,
respectively (Patarroyo et al., 1987). In Mato Grosso do Sul, babesiosis (82.2%) is
more prevalent than anaplasmosis (40.3%) (Madruga et al., 1983).
Colombia. Located in the northwestern part of South America, Colombia has an
area of 1.14 million km2, of which 44 million hectares are suitable for grazing. By
1979, the cattle population was 27.1 million, the majority being for beef production.
Cattle represent 87% of the country’s livestock and contributes 38.7% of all agricul-
tural output (Vizcaino, 1981). The Colombian Andes form three parallel mountain
ranges that divide the country longitudinally into three major climatic zones: a hot
lowland zone with an altitude below 800 m; an intermediate zone between 800 to
2,100 m; and a high zone above 2,100 m with an average annual temperature of 13
°C. The distribution of anaplasmosis and babesiosis is influenced by climate. No
disease or ticks have been reported at altitudes above 2,200 m (Corrier et al., 1976).
Tropical and subtropical climates cover nearly 90% of the territory, providing favour-
able conditions for haemoparasites and their tick vectors. Twenty-three million head
(85%) consisting of Criollo, Zebu and cross-bred beef cattle reside in endemic areas.
Dairy cattle (approximately four million animals) of Bos taurus breeds (Holstein,
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Brown Swiss) are found in tick-free, high altitude areas and in the subtropical
intermediate zone. Serious losses have been reported in dairy farms where susceptible
calves are exposed to ticks (Corrier et al., 1978). The highest serological prevalence
has been reported on the Caribbean coast followed by the Eastern Plains (Llanos
Orientales) and the Andean region (Vizcaino, 1981). The most prevalent parasite is
A. marginale, followed by B. bigemina and B. bovis. Except for the Caribbean coast
where a situation of enzootic stability exists throughout the zone, epidemics are
known to occur in other regions (Vizcaino, 1981; Gonzalez et al., 1978). Further
information regarding the epidemiologic characteristics of haemoparasites in Colom-
bia is presented in Table 1.
It has long been considered that enzootic stability (abundant ticks and a high rate
of parasite transmission which results in most cattle becoming infected at an early
age) is desirable and economically acceptable because it precludes disease outbreaks
and mortality (Dalgliesh et al., 1990). However,  studies (Mullenax,  1986;  E.F.
Gonzalez, O. Vizcaino and A. Betancourt, unpublished data) with Zebu-cross cattle
and dairy cattle in stable areas of the Eastern Plains and Cauca Valley have challenged
that notion. Chronic carriers of blood parasites exhibit decreased productivity as
manifested by delayed conception, retarded growth, weight loss or reduced weight
gains, reduced milk production, depreciated hides and lower market value (Table 2).
Although it is difficult to separate production losses caused by the combined effects
of anaplasmosis and babesiosis from those caused by climate, nutritional stress, ecto-
and gastrointestinal parasites and other diseases, the negative impact of haemoparasi-
tic diseases exists even under conditions of enzootic stability. An estimate of the
economic losses caused by haemoparasitic diseases in the Americas is presented in
Table 3.
Venezuela. Located in northern South America, Venezuela consists of a total area
of 912,050 km2. A large portion of the territory is part of the Orinoco River basin.
The country can be divided into three regions: Coast and mountains, Orinoco plains
and Guyana region. Only the first two regions are relevant for livestock production.
The cattle population is 10.53 million; 38.4% (4.05 million) are for dairy and 61.6%
(6.48 million) for beef production. In the first region, the Colombian Oriental
mountain range merges into two separate ranges named Perija and Merida. These
surround Maracaibo Lake and the Gulf of Maracaibo. To the east and parallel to the
littoral lie the Caribbean mountain range. In this region the climate varies from
tropical to temperate to cool according to the altitude. Most dairy farms are located
in this region with 85% of milk produced in the states of Zulia, Lara, Falcón, Táchira,
Mérida and Trujillo (Toro et al., 1992). The most common breeds are Bos taurus
(Holstein, Brown Swiss) and Criollo crosses (Carora breed) or Brahman (Siboney
breed). An important contingent of pure-bred Holstein cattle are imported annually
from the USA, New Zealand and Canada (Toro et al., 1992).
Beef farms are concentrated in the Venezuelan plains located south and southeast
of the Mérida and Caribbean mountain ranges west of the Orinoco River. This area
consists of savannah grasslands where cattle operations are extensive in nature with
open  range-type management.  Predominant  cattle breeds are Zebu,  Criollo and
Zebu-Criollo crosses. The principal beef-producing states are Apure, Barinas, Por-
tuguesa, Cojedes, Guárico, Anzoátegui and Monagas (Toro et al., 1992). Sero-
epidemiological surveys conducted in  dairy farms of the midwestern region  of
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TABLE 1. Epidemiological characteristics of haemoparasites in important cattle regions of Colombia (1979).
Hectares
Herd (mill.) (mill) Seroprevalence Patency (%) Mortality Epid
Region Breed Type explot. A. marginale B. bigemina B. bovis A. marginale B. bigemina B. bovis T. vivax % Status
CARIBBEAN 10.9 4.7
North Coast Zebu Beef 83–93 57 —
Criollo Beef
Baranquilla Cross-bred Beef 57.4 50 38.1 92.3 7.6 7.6 23 2.2–7.7 Stable
Valledupar 77.8 67.1 63.1 l00 15.4 7.6 15.4
(23.2)*
LLANOS ORIENT. 3.4 71–74 62–64 67.3
Piedemonte Z/Cr/Cb Beef 62.4 40.1 41.6 63.6 9 9 27.2 Stable
Sabana (24.2)* Unstable
ANDEAN 3.47 Dairy 45 46.6 26.0 3.7–18 Unstable
Bos taurus
Valle del Cauca 6.81 Double 73 62.5 65.4
Z/Cr/Cb Beef 88.1 87.4 44.4
La Dorada 67 (39)* 51.7
Manizales 34.2 27.8 26.9 72.7 9 9 0
Bucaramanga 69 50.8 53.2 70 10 10 10
(15.7)*
* Tailed A. marginale
Adapted from Vizcaino, O. 1981. ICA-IICA Bull. No. 25l.
T. vivax = Trypanosoma vivax
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Venezuela have found more cattle seropositive to B. bigemina (78.2%) than to B. bovis
(38.8%). The prevalence of antibodies to anaplasmosis was reported to be 57.7% with
an overall A. marginale infection rate of 21.1% (James et al., 1985). Venezuela offers
a wide range of epidemiological conditions because highly susceptible pure-bred
cattle are imported regularly. The diversity of management practices, geographic
characteristics, farm size, etc. produces a milieu that provides varying degrees of
enzootic stability for these infections (Montenegro-James et al., 1989). Seropreva-
lence studies carried out in major cattle regions of Venezuela indicated that the
average prevalence for B. bovis was 33.1%, ranging from 6.3 to 79.4%, with the mean
B. bigemina prevalence of 47.1% (range 2.2 to 89.5%) (Montenegro-James et al.,
1989). The average prevalence for A. marginale was 51.3% with a range of 22.2 to
88.1% (Toro et al., 1992). Seventeen farms that were involved in the sero-
epidemiological studies demonstrated relatively low seroprevalence rates of bovine
babesiosis (range 2.2 to 14.0%) for farms with systematic tick dipping and various
degrees of cattle confinement, compared to 96% prevalence when sporadic dipping
and grazing were practised (Figure 2) (Montenegro-James et al., 1989). In Zulia State
and the various Andean states where dairy farms predominate, the highest prevalence
was found for A. marginale followed by B. bigemina and B. bovis, whereas in
beef-producing regions (Plains) the prevalence was similar for each of the three
parasites (Figure 3).
FIGURE 2. Serological prevalence of bovine babesiosis in 17 dairy farms (various locations
throughout Venezuela) managed under varying conditions for parasite and tick control.
Reprinted with permission from Veterinary Protozoan and Hemoparasite Vaccines, CRC
Press, Inc. (Montenegro-James et al., 1989).
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Guyana. Babesia infections in cattle are widely distributed with a high prevalence
found in all ecologically defined regions of the country, i.e. coast, forest and savanna.
The seroprevalence for B. bigemina has been reported at 80.1% (range 73.1 to 100%),
whereas the prevalence for B. bovis was 61.4% (range 45.2 to 88.2%) (Applewhaite
et al., 1981).
CONTROL MEASURES FOR ANAPLASMOSIS
AND BABESIOSIS IN SOUTH AMERICA
Control measures employed in most South American countries for anaplasmosis and
babesiosis essentially rely on chemotherapy, use of acaricides to control B. microplus
and, to a lesser degree, on immunization methods. In general these measures are
expensive, time-consuming and in many cases of limited success.
Chemotherapy. For babesiosis, diamidine derivatives (Berenil®, Ganaseg®, Pi-
robenz®)  are frequently used. Imidocarb  dipropionate  (Imizol®)  is  also recom-
mended for chemoprophylaxis (Anon, 1988). For anaplasmosis, the drugs of choice
are long-acting tetracyclines and imidocarb, although the latter has not always proven
effective (Adams and Todovoric, 1974). Because of the need for higher dosages and
longer treatment regimens for anaplasmosis, the use of drugs is generally limited to
control outbreaks and not to sterilize carriers.
Tick Control. Initially, ambitious aims towards eradication of ticks induced several
countries to engage in expensive and unsuccessful national campaigns for tick
control. Mexico, Cuba, Costa Rica, Colombia, Uruguay and Argentina developed
such programs. Problems with cost, acaricide resistance, infrastructure and mainte-
nance were important deterrents. Currently in most countries, the approach has been
TABLE 2. Summary of losses in a 100-head herd due to stable enzootic anaplasmosis
and babesiosis—Colombian llanos (Mullenax, 1986).
$
Calves and calfhood losses 275.05
Milk production losses 100.80
Failure of weight gain in fattening steers 36.15
Failure of weight gain in fattening females 6.89
Failure of weight gain in stockers and feeders 55.35
Death loss in bulls 93.50
Total/100-head herd with typical population distribution 567.74
Total estimated per-animal loss in a 100-head herd 5.68/head
Total estimated per-head treatment cost 1.87
Total per-head cost of loss and treatment distributed
over total population 7.55/head
Valle del Cauca 1975 (Gonzalez et al., unpublished data).
Losses in dairy cows (chronic carriers of anaplasmosis and babesiosis).
Average—605 l milk/year than non-affected dairies.
Higher incidence of infertility and abortions.
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FIGURE 3. The prevalence of antibodies to Anaplasma marginale and Babesia bovis in cattle in different regions in Venezuela.
M
onte
n
egro
-Jam
e
s
,T
IC
K
-B
O
R
N
E
D
ISE
A
SE
S
IN
SO
U
T
H
A
M
E
R
IC
A37
Zulia Andes Centro Occid. Llanos
0
20
40
60
80
Total
Dairy       2.2 x 10                              5.3 x 10                       4.6 x 10                     5.8 x 10
Beef        4.8 x 10                              3.0 x 10                       2.9 x 10                     4.0 x 10    
5 5 5
5 5 5 6
%
 P
e
v
a
le
n
c
e
B. bovis
B. bigemina
A. marginale
6
one of discretional suppression in which the livestock owner makes a decision to
reduce tick populations. The most common acaricides are organophosphorous com-
pounds, formamidine and pyrethroids (A. Guglielmone, personal communication).
Immunization. Based on the success achieved in Australia with the use of A.
centrale and attenuated B. bovis and B. bigemina as vaccines against anaplasmosis
and babesiosis, adaptation of these methods was attempted in the 1970s in Bolivia,
Venezuela, Colombia, Uruguay and Argentina. The latter two countries were true
pioneers in the use of premunization techniques. The initial work of Prof. Jose
Ligneres in Buenos Aires at the beginning of the century was followed by that of Prof.
Miguel C.  Rubino  in  Uruguay (Muskus and Leon, 1965). Possibly the  lack of
adequate technology, infrastructure and the availability of material have accounted
for the limited effectiveness of those methods (Callow, 1974). Premunization utilizing
local isolates has produced severe reactions that necessitate chemotherapy and
veterinary surveillance in order to control disease (Todovoric and Tellez, 1975;
Todovoric et al., 1978; Corrier et al., 1980). In Brazil premunization is employed
without official control or veterinary supervision. Limited amounts of attenuated B.
bovis and B. bigemina vaccines are produced in a few veterinary research institutions
(J. Patarroyo, personal communication).
In Venezuela premunization was officially applied in all imported cattle by the
Institute of Climatization and Premunization until the 1950s (Muskus and Leon,
1965). Recently, an inactivated culture-derived B. bovis-B. bigemina vaccine has been
produced at the Veterinary Research Institute in Maracay and used to vaccinate
approximately 15,000 cattle  with  satisfactory results  (Montenegro-James, 1989;
TABLE 3. Estimate of economic losses associated with anaplasmosis and babesiosis
in the Americas.
Average
Country/ Cattle No. Pathogen(s) Total cost and cost/
Region (millions) Enzootic Status ($ million/yr) head/yr Reference
Anaplasma marginale
USA 118.0 enzootic-nonenzootic 100 0.85 McCallon, 1973
California 4.0 non-enzootic 5.2–11.0 1.33 Goodger et al., 1979
Texas 12.8 non-enzootic 9.0 0.70 Alderink and Dietrich, 1983
Anaplasma and Babesia
Mexico 35.0 enzootic-nonenzootic 287 8.2 Mullenax, 1986
Colombia 27.1 enzootic-nonenzootic
(Llanos) 22.0 stable enzootic 133 3.2 Mullenax, 1986
Brazil 99.5 enzootic-nonenzootic — —
R. do Sul 9.89 enzootic-nonenzootic 99 9.9 Madruga, 1984
Argentina 12.0 enzootic-nonenzootic 120 Spath et al., 1990
(North)
Venezuela 10.0 enzootic-nonenzootic 23.3* Toro-Benitez, 1985
Central America 58.0 enzootic-nonenzootic 850 3.12 Lombardo, 1976
South America 215.6 enzootic-nonenzootic 1365–1638 5–6 Anon, 1987
*Mortality only
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Montenegro-James et al. 1992a). More recently, an inactivated A. marginale vaccine
consisting of isolated initial bodies, either administered alone (Montenegro-James et
al., 1991) or simultaneously with the Babesia vaccine, has been evaluated. Promising
results have been obtained in both laboratory and field trials (Montenegro-James et
al., 1992b).
Uruguay has utilized an attenuated B. bovis and B. bigemina vaccine derived from
local isolates and A. centrale (from Israel) for anaplasmosis since 1941. Premunition
procedures are adequately supervised. Cattle exported to Paraguay and Brazil are
regularly vaccinated. However, Payne et al. (1990) have reported the failure of A.
centrale to protect cattle against A. marginale challenge. The same authors also
indicated that although the Babesia vaccine is generally satisfactory, up to 38% of
vaccinated cattle may require treatment.
In Argentina, limited use of live attenuated Babesia vaccines and A. centrale has
proved satisfactory (Anziani et al., 1987; Guglielmone, 1980). A recent cost-benefit
analysis indicated that there is a considerable demand in Argentina for an effective
vaccine(s) against anaplasmosis and babesiosis (Spath et al., 1990).
REFERENCES
ADAMS, L.G. and TODOVORIC, R.A. 1974. The chemotherapeutic efficacy of imidocarb
dihydrochloride on concurrent bovine anaplasmosis and babesiosis. II. The effects of
multiple treatments. Tropical Animal Health and Production 6: 79–84.
AGUIRRE, D.H., BERMUDEZ, A.C., MANGOLD, A.J. and GUGLIELMONE, A.A. 1988.
Natural infection with A. marginale in Hereford, Criollo and Nelore cattle in Tucumán,
Argentina. Revista Latinoamericana de Microbiologia 30 (1): 37–42.
ALDERINK, F. and DIETRICH, R. 1983. Economic and epidemiological implications of
anaplasmosis in Texas beef cattle herds. Texas Agricultural Experimental Station Bulletin
No. 1426, 15 pp.
ANON. 1987. Consulta de expertos sobre erradicacion de la garrapata con referencia especial
a las Americas y el Caribe. FAO, Mexico, 22–26 de Junio de 1987.
ANON. 1988. Acción y toxicidad de los formacos utilizados contra la Babesia bigemina.
Veterinaria (Montevideo, Uruguay) 24 (98): 15–24.
ANZIANI, O.S., TARABLA, H.D., FORD, C.A. and GALLETO, C. 1987. Vaccination with
Anaplasma centrale: response after an experimental challenge with Anaplasma marginale.
Tropical Animal Health and Production 19: 83–87.
APPLEWHAITE, L.M., CRAIG, T.M. and WAGNER, G.G. 1981. Serological prevalence of
bovine babesiosis in Guyana. Tropical Animal Health and Production 13: 13–18.
CALLOW, L.L. 1974. Epizootiology, diagnosis and control of babesiosis and anaplasmosis.
Relevance of Australian findings in developing countries. Bulletin de l’Office Interna-
tional des Epizooties 81: 825–835.
CORRIER, D.E.,  CORTES,  J.M.,  THOMPSON,  K.C.,  RIAÑO,  H.,  BECERRA,  E. and
RODRIQUEZ, R. 1978. A field survey of bovine anaplasmosis, babesiosis and tick vector
prevalence in the eastern plains of Colombia. Tropical Animal Health and Production 10:
91–92.
CORRIER, D.E., GONZALEZ, E.F. and BETANCOURT, A. 1976. Current information on
the epidemiology of bovine anaplasmosis and babesiosis in Colombia. In: Wilde, J.K.H.,
ed. Tick-borne Diseases and their Vectors. Proceedings of an International Conference,
Edinburg, 1976. Scotland: University of Edinburgh, pp. 114–120.
Montenegro-James, TICK-BORNE DISEASES IN SOUTH AMERICA
39
CORRIER, D.E., VIZCAINO, O., CARSON, C.A., RISTIC, M. KUTTLER, K.L., TRE-
VINO, G.S. and LEE, A.J. 1980. Comparison of three methods of immunization against
bovine anaplasmosis. An examination of post-vaccinal effects. American Journal of
Veterinary Research 41: 1062–1065.
DALGLIESH, R.J., JORGENSEN, W.K. and de VOS, A.J. 1990. Australian frozen vaccines
for the control of babesiosis and anaplasmosis in cattle. A review. Tropical Animal Health
and Production 22: 44–52.
GONZALEZ, E.F., VIZCAINO, O. and BETANCOURT, A. 1978. Epidemiologia de la
anaplasmosis y babesiosis bovina en el valle geográfico del Rio Cauca. Revista Instituto
Colombiano Agropecuaria 12: 349–356.
GOODGER, W.J., CARPENTER, T. and RIEMANN, H. 1979. Estimation of economic loss
associated with anaplasmosis in California beef cattle. Journal of American Veterinary
Medical Association 174: 1333–1336.
GUGLIELMONE, A. 1980. La prevencion de babesiosis y anaplasmosis en Argentina y
Australia. Revista de Medicina Veterinaria (Buenos Aires) 61: 275–277.
GUGLIELMONE, A., MANGOLD, A.J., AGUIRRE, D.H. and GAIDO, A.B. 1990. Ecologi-
cal aspects of four species of ticks found on cattle in Salta, Northwest Argentina.
Veterinary Parasitology 35: 93–101.
JAMES, M.A., CORONADO, A., LOPEZ, W., MELENDEZ, R. and RISTIC, M. 1985.
Seroepidemiology of bovine anaplasmosis and babesiosis in Venezuela. Tropical Animal
Health and Production 17: 9–18.
LEITE, A. 1988. Prevalencia sorologica de Babesia bigemina e Babesia bovis em 33
propriedades na zona sul do Rio Grande do Sul. Universidade Federal de Pelotas. Pelotas
R.G.S., Brazil (M.S. thesis).
LOMBARDO, R.A. 1976. Socioeconomic importance of the tick problem in the Americas.
PAHO Scientific Publication No. 326: 79–89.
LOPEZ, G. 1977. Necesidades futuras en investigación sobre garrapatas en Colombia.
Revista Veterinaria Venezolana 42: 95–105.
MADRUGA, C.R. 1984. Tristeza parasitaria—Babesiose e Anaplasmose. EMBRAPA, Centro
Nacional de Pesquisa em Gado de Corte, Sanidad Animal, Circular Tecnica No. 15, pp.
18–27.
MADRUGA,  C.,  AYCARDI, B.  and  PUTT, N. 1983. Epidemiologia da anaplasmose e
babesiose em bovinos da regiao do cerrado do estado do Mato Grosso do Sul. I. Prevalen-
cia. Arquivo Brasileiro de Medicina Veterinaria e Zootecnia 35: 631–640.
McCALLON, B.R. 1973. Prevalence and economic aspects of anaplasmosis. In: Proceedings
of the 6th National Anaplasmosis Conference. Las Vegas, Nevada, pp. 1–3.
McDOWELL, P.E. 1972. The role of livestock in the warm climates. In: McDowell, R.E., ed.
Improvement of Livestock Production in Warm Climates. San Francisco: W.H. Freeman,
pp. 3–20.
MONTENEGRO-JAMES, S. 1989. Immunoprophylactic control of bovine babesiosis: role
of exoantigens of Babesia. Transactions of the Royal Society of Tropical Medicine and
Hygiene 83 (Supplement): 85–94.
MONTENEGRO-JAMES, S., JAMES, M.A., BENITEZ, T.M., LEON, E., BAEK, B.K. and
GUILLEN, A.T. 1991. Efficacy of purified Anaplasma marginale initial bodies as a
vaccine against anaplasmosis. Parasitology Research 77: 93–101.
MONTENEGRO-JAMES, S., KAKOMA, I. and RISTIC, M. 1989. Culture-derived Babesia
exoantigens as immunogens. In: Wright, I.G., ed. Veterinary Protozoan and Hemoparasite
Vaccines. Boca Raton, Florida: CRC Press, Inc., pp. 61–98.
MONTENEGRO-JAMES, S., TORO, M., LEON, E. and  GUILLEN, A.T.  1992a.  Field
evaluation of an exoantigen-containing Babesia vaccine in Venezuela. Memorias Instituto
Oswaldo Cruz, in press.
DISEASE DISTRIBUTION, ECONOMIC IMPORTANCE AND CONTROL
40
MONTENEGRO-JAMES, S., TORO, M., LEON, E., GUILLEN, A.T., LOPEZ, R. and
LOPEZ, W. 1992b. Immunization with an inactivated polyvalent vaccine against anaplas-
mosis and babesiosis. Annals of the New York Academy of Sciences 653: 112–121.
MULLENAX, C.H. 1986. Estimated production and dollar losses due to stable enzootic
anaplasmosis and babesiosis in the Colombian Llanos (1981–1984). Proceedings of
Annual Meeting of Anaplasma Research Workers. Baton Rouge, Los Angels: Louisiana
State University Press, pp. 2–16.
MUSKUS, C. and LEON, C.E. 1965. El control de la piroplasmosis en Venezuela. Aclima-
tación, alimentación y premunización de los animales importados. Revista Veterinaria
Venezolana 18: 277–302.
NARI, A., CARDOZO, H., BERDIE, J., CANABEZ, F. and BAWDEN, R. 1979a. Estudio
preliminar sobre la ecologia de B. microplus en Uruguay. Veterinaria (Montevideo,
Uruguay) 15: 25–31.
NARI, A., SOLARI, M.A. and CARDOZO, H. 1979b. Hemovacuna para el control de Babesia
spp. y Anaplasma marginale en el Uruguay. CIVET, Miguel C. Rubino, Montevideo,
Uruguay. Veterinaria 16: 137–148.
NICHOLLS, M.J., IBATA, G. and RODAS, F.V. 1980. Prevalence of antibodies to Babesia
bovis and Anaplasma marginale in dairy cattle in Bolivia. Tropical Animal Health and
Production 12: 48–49.
PATARROYO, J., RIBEIRO, M.F.B., SANTOS, J.L. and FARIA, J.E. 1987. Epidemiologia
das babesioses bovinas no estado de Minas Gerais e prevalencia de anticorpos fluorescen-
tes na zona da Mata, MG. Arquivo Brasileiro de Medicina Veterinaria e Zootecnia 39:
423–429.
PAYNE, R.C. and OSORIO, O. 1990. Tick-borne diseases of cattle in Paraguay. I. Sero-
epidemiological studies on anaplasmosis and babesiosis. Tropical Animal Health and
Production 22: 53–60.
PAYNE, R.C., OSORIO, O. and YBAÑES, A. 1990. Tick-borne diseases of cattle in Paraguay.
II. Immunization against anaplasmosis and babesiosis. Tropical Animal Health and Pro-
duction 22: 101–108.
PINO, J.A. 1981. The neglected diseases of livestock. In: Ristic, M. and Kreier, J.P., eds.
Babesiosis. New York: Academic Press, pp. 545–554.
RIBEIRO, M. and REIS, R. 1981. Prevalencia da anaplasmose em quatro regioes do estado
de Minas Gerais. Arquivos da Escola de Veterinaria Universidade Federal de Minas
Gerais 33: 57–62.
SMITH, R.D. 1977. Current world research on ticks and tick-borne diseases of food-produc-
ing animals. Interciencia 2: 335–344.
SPATH, E., MANGOLD, A.J. and GUGLIELMONE, A.A. 1990. Estimation of the potential
demand for a bovine babesiosis and anaplasmosis vaccine in Argentina. Veterinary Parasi-
tology 36: 131–140.
TODOVORIC, R.A. and TELLEZ, C.H. 1975. The premunization of adult cattle against
babesiosis and anaplasmosis in Colombia, South America. Tropical Animal Health and
Production 7: 125–131.
TODOVORIC, R.C., GONZALEZ, E. and LOPEZ, G. 1978. Immunization against anaplas-
mosis and babesiosis. Part II. Evaluation of cryopreserved vaccines using different doses
and routes of inoculation. Tropenmedizin und Parasitologie 29: 210–214.
TORO-BENITEZ, M. 1985. Nueva perspectiva en la prevencion de la babesiosis bovina,
production y evaluacion de una vacuna inactivada. FONAIAP Divulga, Suplemento, Vol.
2 (No. 19) Septiembre-Diciembre, 4pp.
TORO, M., LEON, E., GUILLEN, A.T., LOPEZ, R. and MONTENEGRO-JAMES, S. 1992.
Epidemiologia de la anaplasmosis y babesiosis bovina en Venezuela. Veterinaria Tropical,
in press.
Montenegro-James, TICK-BORNE DISEASES IN SOUTH AMERICA
41
VIZCAINO, O. 1981. Impacto económico de los hemoparásitos y sus vectores en ganado de
leche. I. Simposio Colombiano sobre trastornos de la reproducción en ganado lechero.
Revista Instituto Colombiano Agropecuario 251: 37–51.
YOUNG, A.S. 1988. Epidemiology of Babesiosis. In: Ristic, M., ed. Babesiosis of Domestic
Animals and Man. Boca Raton, Florida: CRC Press, pp. 81–98.
DISEASE DISTRIBUTION, ECONOMIC IMPORTANCE AND CONTROL
42
Anaplasmosis, babesiosis and cowdriosis
in the West African sub-region: distribution,
economic importance and control measures
A.A. Ilemobade
Department of Animal Production
School of Agriculture and Agricultural Technology
Federal University of Technology
P.M.B. 704
Akure, Nigeria
INTRODUCTION
The West African sub-region consists of Nigeria, Ghana, Cote D’Ivoire, Benin
Republic, Togo, Cameroon, Liberia, Sierra Leone, Guinea, Senegal, Niger, Chad,
Mali, The Gambia, Burkina Faso, Equitorial Guinea and Mauritania. The region
covers the following vegetational zones: Sahel, Sudan, Northern and Southern Guinea
savanna zones, derived savanna, rain forest and mangrove forest. Anaplasmosis,
babesiosis and cowdriosis (heartwater) constitute the major tick-borne diseases of
domestic ruminants in the region where they are endemic. These diseases cause
considerable economic losses through death, decreased meat and milk production,
unthriftness, decreased draught power together with the cost of control measures.
They are also a major constraint to improved breed and livestock development. This
presentation will draw, to some extent, on recent studies carried out under the
EEC-sponsored ticks and tick-borne diseases project executed by the Ahmadu Bello
University, Zaria, and the Royal University of Utrecht, the Netherlands.
DISTRIBUTION
Anaplasmosis
Two species of the genus Anaplasma, A. marginale and A. centrale, have been
recorded as occurring in Africa, although doubts have been expressed about A.
centrale occurring as a distinct species from A. marginale. Anaplasmosis occurs in
the  whole of  the West African sub-region. Ticks  and  biting  flies  occur  widely
throughout the whole region, but it is difficult to determine the relative importance
of ticks or flies in the transmission and maintenance of the diseases. It is reasonable
to assume, based on reports of the disease’s occurrence elsewhere, that both ticks and
biting flies are likely to be involved.
Serological studies carried out under the EEC-sponsored ticks and tick-borne
diseases project in different ecological zones in Nigeria showed that the prevalence
of antibodies against A. marginale in cattle in the main ecological zones was 0–40%,
irrespective of whether it was during the wet or the rainy season (Table 1) and that
the prevalence of A. marginale was also generally low using thin blood smears.
Babesiosis
Two species of Babesia, B. bigemina and B. bovis, are reported to occur in cattle in
the sub-region (Leeflang and Ilemobade, 1977). The major tick genera found in the
sub-region are Boophilus, Amblyomma, Hyalomma and Rhipicephalus. Only
boophilid ticks are known to transmit Babesia species in this region. The three
boophilid species reported in Nigeria and which have been reported to occur in some
parts of the sub-region are Boophilus decoloratus, Boophilus geigyi and Boophilus
annulatus (Mohammed, 1974). Boophilus decoloratus is more abundant in the Sudan
and Northern and Southern Guinea savanna zones than the other two species.
Boophilus geigyi seems to be as abundant as Boophilus decoloratus in the wet forest
zones, a reason why Dipeolu (1975) argued that it may be the main transmitter of B.
bovis. It has, however, proved difficult to establish the tick responsible for
transmitting B. bovis in the sub-region. The widespread distribution of B. bovis in the
FIGURE 1. The West African sub-region.
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brain smears of slaughtered cattle in Nigeria, and the scanty population of Boophilus
annulatus and Boophilus geigyi in the areas of highest cattle concentration, however,
suggest that the identification of the vector for B. bovis in Nigeria needs further
investigation. It may well be that Boophilus decoloratus is involved.
Cowdriosis
Cowdriosis (heartwater) is widespread in the sub-region except for the very dry
ecological zones like Sahel, where Amblyomma spp. ticks are very rare. It has been
established that the disease is transmitted exclusively by ticks of the genus Am-
blyomma and, since these ticks are probably the most widespread in the sub- region,
it is not surprising that heartwater is also widespread.
ECONOMIC IMPORTANCE
Tick-borne diseases are major limiting factors to successful animal production in the
sub-region. They are the cause, in cattle, of high morbidity and mortality, decreased
meat and milk production, and loss of draught power and manure. They are also an
impediment to the upgrading of indigenous breeds of cattle, sheep and goats and to
the introduction of more productive, exotic breeds.
TABLE 1. Prevalence of antibodies against Anaplasma marginale in cattle in Nigeria,
using IFAT on samples from ranches in the main ecological zones.
Season Dry season Wet season Wet season
(1985/86) (1986) (1987)
Age (years) <3 ≥3 <3 ≥3 <3 ≥3
Sudan zone
Gidan Jaja 11% (18) 17% (47) 5% (20) 37% (38) 6% (32) 29% (51)
Bunkure 12% (34) 27% (48) 4% (19) 51% (35) 19% (27) 31% (65)
Gombole/Gajuba 15% (41) 26% (38) 15% (20) 20% (49) — —
Northern Guinea
Savanna zone
Shika 0% (11) 7.5% (67) 50% (30) 46.5% (71) 26.5% (34) 42% (53)
Vom 12% (26) 40% (52) 45% (31) 8.6% (35) 16% (19) 21% (42)
Southern Guinea
Savanna zone
Mokwa 0% (32) 0% (69) 0% (30) 0% (76) 5.7% (35) 0% (65)
Raav — — 0% (29) 0% (28) 0% (28) 0% (35)
Forest zone
Akunnu — — 0% (11) 0% (39) 0% (40) 0% (30)
Fashola 14% (14) 6.9% (87) 6.6% (30) 2.8% (35) 6.6% (30) 1.7% (56)
Mountain zone
Obudu 22% (63) 9.4% (32) 7.9% (27) 2.7 (36) — —
Mambilla — 4.6% (87) 3.8% (26) 0% (38) — —
Actual figures in brackets.
Source: EEC-sponsored ABU/RUU ticks and tick-borne diseases project.
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TABLE 2. Prevalence of antibodies against Babesia bigemina in cattle in Nigeria
using IFAT on samples from ranches in the main ecological zones.
Season Dry season Wet season Wet season
(1985/86) (1986) (1987)
Age (years) <3 ³ 3 <3 ³ 3 <3 ³ 3
Sudan savanna
Gidan Jaja 50%(26) 80%(70) 3.4%(18) 3.3%(42) 3%(33) 7.6%(52)
Bunkure 18.9%(37) 25%(60) 0%(24) 2.1%(48) 28.5%(28) 25.8%(62)
Gombole/Gujuba 33.3%(51)
Northern Guinea
Vom 43%(30) 67.6%(65) 30%(30) 45%(42) 18.7%(16) 14%(49)
Shika 6%(15) 40%(80) 72.4%(29) 62.5(80) 35%(34 16.9%(63)
Southern Guinea
Raav — — 0%(12) 0%(28) 3.5%(28) 0%(35)
Mokwa 12.5%(32) 33%(69) 6.6%(32) 5.2%(76) 0%(32) 3%(65)
Forest Zone
Akunnu — — 18.1%(11) 30.7%(39) 15%(40) 46.6%(30)
Fashola 14.2%(14) 32.2%(87) 7.1%(28) 57.1%(35) 6.6%(30) 12.5%(56)
Source: EEC-sponsored ABUU/RUU ticks and tick-borne diseases project.
FIGURE 2. Map of Nigeria showing eight vegetation zones.
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CONTROL MEASURES
There are three major approaches to the control of tick-borne diseases of livestock in
the West African sub-region.
Vector control ensures that the incidence of the disease is kept within manageable
limits. The two commonly used methods are hand de-ticking and the application of
acaricides. The escalating costs of labour and acaricides make the use of acaricides
a less attractive option. Fortunately the problem of acaricide resistance in ticks has
not, as far as can be established, arisen and if costs can be managed, this method is
likely to remain a practical control measure for the foreseeable future.
Chemotherapy, when used under veterinary supervision, allows, in conjunction
with acaricidal control, for some measure of pre-immunity or immunity to be
established against the diseases. Drugs can be used during the period of initial
exposure in a method known as chemo-immunization. However the method can be
expensive and relies on challenge occurring during the period of drug cover which
may create problems under a pastoral system. Chemotherapy of sick animals is fairly
widely used.
Immunization using live blood vaccines has been used only under experimental
conditions.
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INTRODUCTION
Southeast Asia is a large and not clearly defined area of the world and for the purposes
of this paper `Southeast Asia’ describes the 12 countries listed in Table 1. The single
host cattle tick, Boophilus microplus, has been identified in all these countries and
the haemoparasites Babesia bovis, B. bigemina and Anaplasma marginale it transmits
are endemic in the cattle populations (Brockelman, 1990). Other ticks of the genera
Boophilus and Rhipicephalus may also transmit one or more of the haemoparasites
to cattle complicating the epidemiology (Brockelman, 1990).
Few detailed studies have been made of the distribution, economic importance and
control of babesiosis and anaplasmosis in any Southeast Asian country. The Australian
Centre for International Agricultural Research (ACIAR) established a project in Sri
Lanka on `Control of tick-borne diseases of ruminants in Sri Lanka with particular
reference to babesiosis and anaplasmosis’. The Queensland Department of Primary
Industries (QDPI) was the commissioned organization and after a favourable review
at completion in 1990, the project’s achievements were assessed by an independent
economist. Sri Lanka can be considered a model for Asia because it encompasses a
variety of cultures, topography and climate and the observations made during the
course of this project may serve as examples of what could occur in the other countries.
DISTRIBUTION OF BABESIOSIS
AND ANAPLASMOSIS IN SOUTHEAST ASIA
The predominantly Bos indicus indigenous cattle in Southeast Asia coexist in relative
harmony with the haemoparasites and their vector with little evidence of clinical
babesiosis and anaplasmosis (Dalgliesh et al., 1990). Livestock improvement pro-
grams in the region during the last decade have resulted in a steady increase in high
yielding Bos taurus cattle introduced from cool temperate climates. The combined
stresses of shipment, change of management, introduction to a hot, humid climate and
exposure to a variety of diseases for the first time have resulted in spectacular losses
amongst these European breed cattle. Tick-borne diseases, including babesiosis and
anaplasmosis, are significant contributors to these losses (Dalgliesh et al., 1990). The
countries underlined in Table 1 have purchased vaccine against babesiosis and anaplas-
mosis, requested assistance in the diagnosis of the diseases or have requested the
transfer of technology to produce the vaccines themselves. These countries consider
babesiosis and anaplasmosis to be a major threat to local and imported susceptible
cattle.
Distribution in Sri Lanka
The first objective of the ACIAR project in Sri Lanka consisted of a serological survey
of cattle in widely separated localities to identify the approximate distribution of B.
bovis and Anaplasma. Antibodies were detected in all localities tested and indicated
that climatic difference had no substantial effect on the distribution (Jorgensen et al.,
1992). A second objective of the project was to assess the risk of disease outbreaks
occurring in the locations tested. Risk assessment for B. bovis can be based on the
seroprevalence of antibodies in groups of cattle over nine months of age (Mahoney
and Ross, 1972). At this age immunity conferred by colostral antibodies and calfhood
resistance to both Babesia and Anaplasma has waned and cattle without antibodies
by this age are potentially at risk to the diseases. The seroprevalence for B. bovis in
all Sri Lankan localities below 1,200 metres, where the cattle are predominantly Bos
indicus, was consistently in excess of 90%. Cattle located above 1,200 metres in the
hill country showed a seroprevalence ranging from 13 to 100%. The comparatively
low proportion of cattle with antibodies to B. bovis in certain locations in the hill
country suggested a high susceptibility to infection and clinical disease. The risk is
compounded by the fact that this group comprises Bos taurus breeds, genetically the
most susceptible to Babesia infections (Jorgensen et al., 1992).
The low seroprevalence for B. bovis in some of the localities above 1,200 metres
was due to the management practice, common to many Sri Lankan hill country farms
of maintaining calves indoors away from tick-infested pastures until nine months of
age. Deaths due to babesiosis in recently released cattle have been reported in recent
years on many of the properties in the hill country (Jorgensen et al., 1992). The
seroprevalence for Anaplasma varied considerably (18–90%) amongst localities and
TABLE 1. Countries of Southeast Asia where Boophilus microplus ticks have been
identified*.
Brunei Indonesia Phillipines
Burma Malaysia Sri Lanka
China Pakistan Taiwan
India Papua New Guinea Thailand
*Hoogstraal, 1956; D.H. Kemp, personal communication.
Countries underlined recognize babesiosis and anaplasmosis as threats to imported
cattle.
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did not correlate with climatic zones. Seroprevalence varied greatly even at two
localities very close together (Jorgensen et al., 1992) and further investigation of
Anaplasma transmission is required.
CONTROL IN SOUTHEAST ASIA
Clinical cases of babesiosis and anaplasmosis are seldom diagnosed in indigenous
Bos indicus in Southeast Asia (Brockelman, 1990). However, spectacular losses do
occur such as when unvaccinated New Zealand cattle were imported into Indonesia
where the haemoparasites are endemic (R.C. Payne, unpublished data).
Control of babesiosis and anaplasmosis in Sri Lanka
In addition to defining the seroprevalence, a further objective of the ACIAR project
was the development of a production facility for live babesiosis and anaplasmosis
vaccine. The serological surveys had shown that the cattle most at risk were suscep-
tible Bos taurus breeds maintained in the cooler hill country which is relatively free
of other diseases such as foot and mouth and brucellosis. The Sri Lankan authorities
had earlier recognized the risk of the diseases and introduced the carrier/donor
vaccination system in the late 1940s to reduce losses when Bos taurus cattle were
first imported to upgrade milk production. The carrier donor system relies on
chronically infected animals to supply infected blood for vaccination of susceptible
cattle. Problems that were encountered with this form of vaccination were similar to
those which occurred in Australia. These included extremely variable infection rates
with the cattle not always being protected, unpredictability of reactions and the
transfer of other field strains and blood parasites to cattle being vaccinated. Increasing
numbers of Bos taurus animals imported in the 1970s and 80s highlighted the
deficiencies of the carrier donor system. The proposed vaccine production facility in
Sri Lanka would use similar procedures to those developed in Queensland. Use of
infected blood from splenectomized donor calves in this production method ensures
infectivity of the vaccine, minimizes transfer of pathogenic organisms and minimizes
vaccine reactions by using attenuated strains (Callow and Dalgliesh, 1980).
Initially the Sri Lankan authorities wished to attenuate a local strain of B. bovis
rather than release the Australian vaccine strain. Suitable laboratory facilities for
tick-free calf accommodation were identified and attenuation of a local B. bovis
isolate by serial syringe passage in splenectomized calves was initiated and continued
for more than 30 passages (Weilgama et al., 1989). The virulence and protection of
the Sri Lankan and Australian B. bovis vaccine strains were compared in 37 suscep-
tible Bos taurus bulls imported from Victoria, Australia. Animals vaccinated with the
Australian B. bovis vaccine strain experienced mild reactions while those vaccinated
with the Sri Lankan strain experienced unacceptably severe reactions (Weilgama et
al., 1989). Both strains protected well against subsequent field challenge when the
animals were distributed to centres in the mid and hill country.
Cattle vaccinated with attenuated strains of B. bovis and B. bigemina can have
significant cross protection against subsequent challenge by vector-transmitted heterolo-
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gous field strains. The Australian B. bovis and B. bigemina vaccine strains have now
been shown to successfully protect susceptible Bos taurus cattle against challenge by
pathogenic strains in Bolivia, South Africa (Dalgliesh et al., 1990) and Malawi (J.
Lawrence and J. Malika, personal communication). There is also evidence that the
Australian vaccine strains protect against field strains in Malaysia, Thailand and
Trinidad (A.J. de Vos and co-workers, 1990, unpublished observations). The chilled
vaccine now produced in Sri Lanka is made using the Australian B. bovis vaccine strain
(K). Like the Australian product, it has a shelf life of six days if stored at 4 °C. This
short shelf life does not allow testing for pathogenic organisms after production nor
does it allow easy dissemination to remote areas prior to the expiry date. Further
development has resulted in the production of a new frozen vaccine stored in liquid
nitrogen that can be kept for at least five years. The new product is manufactured as a
dilutable concentrate that allows comprehensive testing for infectivity, efficacy and
confirmation of the absence of pathogenic organisms (Jorgensen et al., 1989; Dalgliesh
et al., 1990). The advantages of the new frozen vaccine are reviewed in detail by
Dalgliesh et al. (1990).
Drug therapy in Sri Lanka
Acute babesiosis and anaplasmosis may be controlled by treatment. However, vacci-
nation is the only viable long-term strategy for the protection of susceptible cattle. The
only readily available drug for treatment of acute babesiosis in Sri Lanka is diminazene
aceturate (Berenil, Hoechst). Oxytetracycline (Terramycin, Pfizer) is available for
treatment of anaplasmosis. Another drug, imidocarb dipropionate (Imizol, Pitman
Moore), an effective treatment for both babesiosis and anaplasmosis, may become
available; however its cost relative to diminazene makes widespread use unlikely in
Sri Lanka. Imidocarb has a prophylactic effect for babesiosis for six weeks at a dose
rate of 2 ml/100 kg, but it is not satisfactory for long-term use due to toxic effects with
prolonged use (A.J. de Vos and W.K. Jorgensen, unpublished observations).
Most female breeding cattle shipped to Sri Lanka and other countries of Southeast
Asia are pregnant (B. Barker, personal communication). In the experience of the staff
at the Tick Fever Research Centre (TFRC), there is much greater risk of abortion for
cows in the third trimester of pregnancy if they develop acute babesiosis. Severe
reactions may occur even with attenuated vaccine strains and further research is under
way at TFRC to develop a vaccination protocol that minimizes risk for pregnant cows
(Jorgensen et al., 1992). Until a suitable protocol for vaccination of pregnant animals
is available, the prophylactic use of imidocarb until calving may be a viable option
for protecting susceptible cows entering Southeast Asian countries. After calving it
is recommended that the animals be vaccinated no sooner than eight weeks after the
last imidocarb treatment and maintained tick free until vaccination takes effect.
ECONOMIC IMPORTANCE IN SOUTHEAST ASIA
Brockelman (1990) reviewed the economic importance of babesiosis and
anaplasmosis in Southeast Asia and observed that, of an estimated 337 million
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cattle in Asian countries, perhaps 2–20% are affected by the diseases. In Sri
Lanka and other Asian countries, the cattle most in danger from babesiosis and
anaplasmosis are those that represent the greatest economic investment such as
high quality breeding stock imported to increase milk and meat production
(Brockelman, 1990; Dalgliesh et al., 1990; Jorgensen et al., 1992). The major
exporters of bovine breeding stock to Southeast Asian countries are USA, Can-
ada, Australia and New Zealand (B. Barker, personal communication). Babesia
bovis and B. bigemina are not present in USA, Canada, New Zealand and four of
the seven Australian states. Anaplasma marginale occurs in USA and Australia
but not all cattle are protected by previous infections or vaccination. Clearly,
many cattle exported from these countries will be susceptible to babesiosis or
anaplasmosis unless vaccinated. The Australian component of the live cattle trade
to Southeast Asia is shown in Table 2. Assuming an imported value of US$800
for a breeding cow and more for bulls, these figures represent a considerable
investment for the importing country. Should the animals die, the economic loss
is not only the purchase price but the potential contribution of that animal to the
genetic improvement of the national herd.
Economic importance in Sri Lanka
The economic importance of babesiosis and anaplasmosis to a Southeast Asian
country may again be demonstrated using Sri Lanka as an example. ACIAR commis-
sioned an independent economist to assess the value of the benefits that had been
developed during the QDPI project on tick-borne diseases of ruminants (Chudleigh,
1991). Since the Veterinary Research Institute in Sri Lanka adopted a new system of
vaccine production using splenectomized donor calves, they can provide a vaccine
which is more effective and less dangerous to the recipient animal than the carrier
donor-derived vaccine previously used. The new frozen vaccine developed during the
project makes the best use of this production system, cryopreserving it as a dilutable
concentrate which can be stored for at least five years (Dalgliesh et al., 1990). The
most important benefit of the project to Sri Lanka will be that valuable, imported
TABLE 2. Live cattle exports from Australia to Southeast Asia.
Purpose of cattle
Destination Breeding Fattening Slaughter Total
Malaysia 443 11,887 9,846 22,176
Brunei — 103 6,712 6,712
Thailand 2,648 — — 2,648
Phillipines — 578 19,118 20,544
Indonesia 5,692 1,200 — 6,892
Data from Australian Meat and Livestock Corporation showing the means for the period
1988–1990.
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cattle will be more fully protected by the new vaccine (Chudleigh, 1991). Approxi-
mately 100 Bos taurus animals will be imported into Sri Lanka annually as part of a
genetic upgrading scheme (Chudleigh, 1991). An estimated 25% mortality could be
expected amongst susceptible animals entering an area endemic for babesiosis and
anaplasmosis. Chudleigh (1991) calculated that a saving of US$18,000 per annum
could be directly attributed to provision of safe effective babesiosis and anaplasmosis
vaccines. Other less definable benefits to Sri Lanka include reduced mortality and
increased productivity amongst the F1 generation of breeding stock in the enzooti-
cally unstable hill country. These first generation cattle have an estimated value of
five times that of the indigenous Bos indicus breeds (Chudleigh, 1991). The primary
function of the six large government farms holding these cattle is supplying most of
the island’s milk. However, they also sell excess animals to other farms and small
holders at nominal prices, further increasing productivity. Prior to the vaccination
programs assisted by the ACIAR project, Chudleigh (1991) calculated the annual cost
of mortality on these farms from babesiosis and anaplasmosis to be US$40,000 per
annum. Morbidity effects due to babesiosis and anaplasmosis are more difficult to
determine. Affected animals can develop severe anaemia and liver damage usually
losing weight and condition. Acute disease can affect milk production and a basal
body temperature rise above 40.5 °C during severe reactions can cause abortion in
late pregnancy and temporary loss of fertility in bulls.
As the proportion of vaccinated cattle in the hill country increases, the number of
field cases will decrease, minimizing expensive chemotherapy. Treatments for babe-
siosis and anaplasmosis in Sri Lanka cost 1.1 and 4 US cents respectively. The
government, however, subsidizes drug costs (Chudleigh, 1991). Chudleigh (1991)
estimates that US$220 was spent annually on the treatment of babesiosis and anaplas-
mosis on government farms prior to use of a safe, effective vaccine. Manufacturing
babesiosis and anaplasmosis vaccines in Sri Lanka minimizes labour costs, making
the cost per dose more affordable to small land owners. Although their weekly income
may be only US$7, they are now able to take advantage of buying higher yielding
Bos taurus cross-breed animals without fear of them dying from babesiosis and
anaplasmosis.
CONCLUSION
In Southeast Asia indigenous Bos indicus cattle are usually located in babesiosis and
anaplasmosis endemic areas where they are infected early in life and become resistant
to the disease. The cattle at greatest risk are susceptible Bos taurus breeds imported
to improve meat and milk production. The best protection available at present is a
single vaccination with living vaccines against the haemoparasites from which
susceptible cattle acquire a long-lasting immunity.
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INTRODUCTION
Sensitive and specific assays for detection of microbial pathogens provide critical tools
for identification of sick animals requiring prompt, appropriate therapy and for disease
prevention by regulation of animal movement. In addition, defined assays are required
for understanding epidemiology including the parameters that influence herd immu-
nity. Although diagnosis of acute Anaplasma and Babesia infections in cattle based on
clinical signs and identification of intraerythrocytic organisms has been used for most
of this century, epidemiological research has been constrained by the lack of diagnostic
assays suitable for large numbers of carrier cattle and arthropod vectors. Development
of improved diagnostic assays provides new opportunities for haemoparasitic disease
research. In this brief review, I will focus on recent developments and current needs
in diagnostic assays for Anaplasma marginale, Babesia bigemina and B. bovis.
DIRECT ORGANISM DETECTION
Acute infection in cattle. Direct detection of intraerythrocytic organisms provides
identification of animals with active infection and eliminates variables that confound
serological diagnosis such as colostral antibodies, post-vaccination antibodies, or
antibodies in animals spontaneously or chemotherapeutically cleared of infection.
Wright-Giemsa stained blood smears from cattle with clinical signs remains the most
commonly used method to confirm diagnosis of anaplasmosis or babesiosis. For B.
bigemina, the onset of fever in acute infection is coincident with the presence of
intraerythrocytic parasites, easily microscopically detectable at very low levels due to
characteristic parasite morphology. In contrast, B. bovis may cause clinical disease
with severe neurological signs followed by death with few detectable parasitized
erythrocytes in peripheral blood. The sequestration of B. bovis parasitized erythrocytes
in cerebral capillaries is readily identifiable in histological sections but not currently
easily diagnosed in vivo. Onset of clinical anaplasmosis is associated with relatively
high A. marginale rickettsaemias, greatly exceeding the minimum microscopically
detectable level of approximately 0.05–0.1% infected erythrocytes. The simplicity of
microscopic examination of stained blood smears and the utility for diagnosis of
multiple haemoparasites has ensured their frequent use in most of the world. In the
United States, A. marginale remains the only significant haemoparasitic disease of
cattle, consequently microscopic examination of blood smears has become an infre-
quently utilized technique with the concomitant loss of expertize in staining and
examination. An antigen capture enzyme-linked immunosorbent assay (ELISA) has
been recently developed (Trueblood et al., 1991) that detects A. marginale in blood
from acutely infected cattle. This rapid assay detects infection prior to the onset of
severe anaemia, allowing early tetracycline therapy required for effective treatment of
acute anaplasmosis. Significantly, the assay does not detect cattle with <2% rickettsae-
mia ensuring that only acutely infected cattle likely to require antibiotic treatment are
identified (Trueblood et al., 1991). Reactivity has been shown with all US strains of
A. marginale tested to date. Whether this test for acute infection and for postmortem
detection (using heart blood) will find common use among veterinarians and diagnostic
laboratories remains to be seen. This type of antigen detection format may be useful
for diagnosis of low level B. bovis parasitemia in cerebral babesiosis.
Chronic infection in cattle. Direct detection of persistently infected carrier cattle
has been limited to either inoculation of suspect blood into susceptible (usually
splenectomized) calves and test feeding of ticks with subsequent microscopic exami-
nation or tick transmission to susceptible cattle. The inability to examine large
numbers of carriers and the lack of quantitation has severely limited the number of
studies that can be done on the epidemiological significance of carrier cattle. The
recent advent of nucleic acid probes for A. marginale, B. bigemina and B. bovis has
provided the most sensitive and specific assays available for quantitation of infection.
The published sensitivity and specificity for available probes are listed in Table 1.
Use of nucleic acid probes has allowed improved definition of persistent infection in
carriers. For example, probing of blood from chronic (>3 year) carrier cattle revealed
cyclic variation in the A. marginale rickettsaemia level (Eriks et al., 1989; Kieser et
al., 1990). These results indicated that the rickettsaemia in individual chronic carriers
varies temporally from <0.000025% to >0.0025% and that direct detection of all
carriers at a given time will require an assay sensitivity of <0.000025%. Significantly,
these observations have spawned several new areas of investigation: i) influence of
cyclic rickettsaemia on tick transmission; ii) mechanism of cyclic rickettsaemia with
a focus on antigenic variation; and iii) use of polymerase chain reaction (PCR) to
enhance sensitivity to allow uniform detection of all carriers. Optimization of sensi-
tivity by PCR has become a routine technique and can be expected to be used with
currently known or newly identified DNA sequences within the near future.
Infection of arthropods. Anaplasma marginale, B. bigemina and B. bovis infections
of arthropod vectors have been detected using microscopic examination of hae-
molymph and tissue sections combined with transmission studies. More recently,
nucleic acid probes have been used to detect and quantitate haemoparasites in vector
ticks. Specifically, DNA probes have been used to identify A. marginale in Dermacen-
tor andersoni, D. variabilis and D. occidentalis (Goff et al., 1988) and B. bigemina
in Boophilus microplus (Hodgson et al., 1989, 1992). The sensitive detection of
infection (as compared to microscopic examination), ability to quantitate levels of
infection and the ability to assay large numbers of ticks provide new opportunities
for epidemiological research. In addition DNA probes allow specific identification
of small numbers of organisms in specific tick tissues (Stich et al., 1990). Current
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research being done based on existing probes includes: i) characterization of devel-
opment of infective stages in the salivary gland (Blouin et al., 1990); ii) influence of
host parasitaemia level on tick infection and transmission; and ii) identification of
small numbers of organisms following purification of infective stages from salivary
glands (Blouin et al., 1990; Hodgson et al., 1989).
Fluorescein-labelled antibodies have been used to definitively identify organisms
in tick tissue, however, to date, little research has been published on stage specific
haemoparasite antigens. Identification of haemoparasite molecules required for in-
vasion of host erythrocytes (Blouin et al., 1990) would be of significant interest for
both pathogenesis studies and vaccine development. The ability to purify and quan-
titate infective stage organisms (Hodgson et al., 1992) should lead to new research
in this area.
SEROLOGICAL DETECTION
The currently utilized serological assays for detection of A. marginale-, B. bigemina-
or B. bovis-infected cattle have been reviewed previously (Kieser et al., 1990). In
TABLE 1. Current nucleic acid probes for Anaplasma and Babesia.
Sensitivity
Organism DNA Parasitemia Specificity Reference
A. marginale 0.5 pg 0.00025% A. marginale Barbet et al., 1987; Eriks et al., 1989;
Goff et al., 1988; Kieser et al., 1990
A. centrale
A. marginale 100 pg <0.001% A. marginale Aboyte-Torres and Buening, 1990;
Aboyte-Torres et al., 1989
A. centrale?
A. centrale 0.3 ng ND A. centrale Visser and Ambrosio 1987, 1989
0.6 ng ND A. marginale
A. centrale 64 ng ND A. centrale Visser and Ambrosio 1987, 1989
ND ND A. marginale
A. centrale 1.25 pg ND A. centrale Visser and Ambrosio 1987, 1989
A. ovis 10 ng 0.0035% A. ovis Shompole et al., 1989
100 ng ND A. marginale
B. bigemina 10 pg ND* B. bigemina Buening et al., 1990
B. bovis 100 pg ND B. bovis McLaughlin et al., 1986
10 ng ND B. bigemina
B. bovis 100 pg ND B. bovis Jasmer et al., 1990
1 ng ND B. bigemina
B. bovis 100 pg† ND B. bovis Jasmer et al., 1990
B. bovis 12 pg ND‡ B. bovis Holman et al., 1989
ND = Not determined.
*Detected <150 parasitized erythrocytes/µl.†Sensitiv ity was reduced to 1ng for DNA from the Australia-L strain.‡Positive detection of blood with approximately 1 parasitized erythrocyte/10 1000×micro-
scope fields.
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summary, these assays are constrained by an unacceptably high number of false
positives particularly in regions with multiple haemoparasitic infections and false
negatives particularly in carriers. Current research is aimed at improvement of these
assays by selection of species-specific, strain-common antigens which can then be
produced by recombinant DNA expression. The principal advantage to recombinant
DNA expression or use of synthetic antigens is that batch-batch variation in antigen
production can be avoided. For each haemoparasite, polypeptides have been identi-
fied that meet the following criteria: highly antigenic following natural infection
including long-term persistent infection in carriers; haemoparasite species specific;
and conserved among different strains and isolates of the haemoparasite species
(Table 2). Serum from long-term A. marginale carrier cattle consistently had high
titres (>104) of antibody to the 86 kDa MSP-3 polypeptide (McGuire et al., 1991;
Palmer et al., 1986). MSP-3 has conserved epitopes among strains isolated from
widely geographically separated regions and shown to antigenically vary in other
polypeptides (McGuire et al., 1991; Palmer et al., 1986). Serological detection of A.
marginale carriers avoids the problem of cyclic rickettsaemia due to the constancy
of antibody titre (McGuire et al., 1991). Recombinant DNA clones expressing MSP-3
have been identified and sequenced. Strategies to obtain diagnostic antigen free of
cross-reactive bacterial host antigens include synthetic peptides based on the trans-
lated sequence, recombinant expression as an inducible fusion protein with sub-
sequent affinity purification and cleavage of the fusion protein and recombinant
baculovirus expression in insect cell culture. Ideally cattle immunized with subunit
antigens should not react with the diagnostic antigen. This would allow discrimina-
tion between immunized cattle and infected cattle, a significant advantage over
current killed organism vaccines and serologic assays. Cattle immunized with A.
marginale MSP-1 are unreactive with MSP-3 (unpublished data). In theory, chal-
lenged but protected cattle would remain seronegative or be only transiently seropo-
sitive to the diagnostic antigen. This hypothesis has not been tested due to the failure
of subunit vaccines to provide consistent protection against infection upon haemo-
parasite challenge. The B. bovis 11C5 reactive polypeptide has been tested as a
recombinant expressed polypeptide fragment (approximately 40 kDa) in an ELISA
format and shown to be specific and sensitive (Bose et al., 1990). Although promising,
the use of this same antigen for subunit immunization may constrain its use as a
diagnostic antigen if the same epitopes are included in both antigens. Additional B.
bovis and B. bigemina polypeptides meeting criteria for application as diagnostic
antigens have been identified but have not yet been extensively tested (see Table 2).
CONCLUSIONS
The  availability of new  reagents for identification of Anaplasma and Babesia
provides new research opportunities, especially in epidemiology. The ability to
identify and quantitate infection in carriers and arthropod vectors will allow
determination of the variables, including acaricide use and vaccination, that affect
development of individual animal and herd immunity. An improved understanding
of herd immunity should lead to improved control over anaplasmosis and babesiosis
in enzootic areas throughout the world.
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TABLE 2. Anaplasma and Babesia polypeptides for diagnostic antigens.
Organism Polypeptide Specificity Strain conservation Reference
A. marginale MSP-3 A. marginale All tested (US, Zimbabwe) McGuire et al., 1991; Palmer et al., 1986;
A. centrale? Shkap et al., 1991; Tebele et al., 1991
B. bigemina p58 B. bigemina All tested (US, Kenya) McElwain et al., 1987, 1988
B. bigemina p72 B. bigemina All tested (US, Kenya) McElwain et al., 1987, 1988
B. bovis ca. 40 kDa* B. bovis Australia (limited testing) Bose et al., 1990
B. bovis Bv42 B. bovis Strain (or regional strain) Goff et al., 1988, 1989; Hines et al., 1989;
specific McElwain et al., 1988; Palmer et al., 1991
B. bovis Bv120 B. bovis Limited testing Goff et al., 1988; Hines et al., 1989;
McElwain et al., 1988
*Recombinant reactive with MAb 11C5 expressed in pGEX-1
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SUMMARY
Serological assays for detecting antibodies to Cowdria ruminantium were, until
recently, of limited value because of the lack of sufficient quantities of good diagnos-
tic antigen. The breakthrough in culturing large numbers of the organism in endothe-
lial cell culture has drastically changed this situation. So far, two types of serological
assays have been developed using Cowdria antigens harvested from these cell
cultures. The indirect fluorescent antibody (IFA) test based on fluorescing extracel-
lular elementary bodies of Cowdria which is being used in several laboratories. A
competitive enzyme-linked immunosorbent assay has been developed more recently
based on recognition by monoclonal antibodies of an immunodominant 32-kilodal-
ton Cowdria protein from endothelial cell culture extracts. By using these serological
assays a more accurate assessment of the prevalence and present distribution of
heartwater in Sub-Saharan Africa and the Caribbean can be obtained.
INTRODUCTION
Heartwater, caused by the tick-borne rickettsia Cowdria ruminantium, occurs in
domestic and wild ruminants in sub-Saharan Africa (Uilenberg, 1983). The disease
is undoubtedly the most important tick-borne disease of small ruminants in Africa.
Indigenous cattle populations in endemic areas appear to have a high degree of innate
resistance to the disease, but for imported breeds including Zebu, heartwater repre-
sents the major tick-borne disease problem outside East Coast fever areas (Provost
and Bezuidenhout, 1987). The existence of heartwater on the Caribbean islands of
Guadeloupe, Marie-Galante and Antigua and the presence of Amblyomma variegatum
on most of the islands in this region constitute a serious threat to livestock on the
American mainland (Barré et al., 1987).
For an accurate assessment of the present distribution of the disease in Africa and
in the Caribbean, a reliable serodiagnostic assay is of prime importance. Serological
assays for detecting antibodies to C. ruminantium were, until recently, of limited
value because of the lack of sufficient quantities of an effective antigen. Several tests
have been developed based on antigen preparations obtained from infected host
tissues. Cowdria antigens have also been produced using short-lived, granulocytic
neutrophil cell cultures and most recently in endothelial cell cultures.
Host tissues as a source of Cowdria antigens
The first serological test for heartwater was a capillary flocculation test developed
by Ilemobade and Blotkamp (1976). This test used an antigen extracted by acetone
from brain material of infected goats or cattle. Antibodies were first detected one to
two weeks after antibiotic treatment and remained at detectable levels for periods
varying between one and four weeks. The short period of antibody detection limited
the practical value of the test.
Complement fixation tests have been developed by du Plessis (1982) and Musisi
and Hussein (1985). The latter authors used sucrose-acetone extraction of infected
calf brain and blood and detected low titres of complement fixing antibodies in
experimentally infected animals. However, these tests have not shown the required
sensitivity and specificity.
Indirect fluorescent antibody test
The first IFA test was developed by du Plessis (1981) using infected peritoneal mouse
macrophages as the source of Cowdria antigen. This test is based on the Kümm strain
which is highly pathogenic for mice (du Plessis and Kümm, 1971). The test has shown
its usefulness in serological monitoring of experimental animals in South Africa (du
Plessis and Malan, 1987). For instance, the persistence of antibodies for three to seven
months,  with peak titres  of 1:5,120,  could  be demonstrated  in cattle  following
infection with the Ball 3 strain. Further, colostrum-derived antibodies to Cowdria
were detected in sera from calves up to four weeks old. In lambs maternal antibodies
were detected between 8 and 12 weeks after colostrum intake (du Plessis, 1984). In
mice peak titres of 1:10,240 were detected and low titres persisted for 18 months. In
sheep titres peaked at 1:20,480 and remained detectable for as long as 39 months,
although at titres as low as 1:80. The persistence of antibody in these experimental
animals for such long periods without reinfection suggests a long-term carrier state,
assuming that no reinfection occurred. The test has not been widely used outside
South Africa, except for Guadeloupe (Camus, 1987), mainly due to the difficulty in
producing sufficient numbers of infected macrophages.
Enzyme-linked immunosorbent assays
Enzyme-linked immunosorbent assays (ELISA) using Cowdria antigens isolated
from sheep brain or A. hebraeum ticks by wheat germ lectin affinity chromatography
(Viljoen et al., 1985; Neitz et al., 1986b, 1986c) or Percoll density gradient centrifu-
gation (Neitz et al., 1986a) have also been reported. Viljoen et al. (1987) have
DIAGNOSIS
68
reviewed the theoretical aspects of the ELISA and its use in the detection of C.
ruminantium antigens and antibodies in various heartwater-infected hosts. The main
obstacles to large-scale use of these assays have been the purification of sufficient
amounts of antigen from infected sheep or tick tissues.
Neutrophil cultures as a source of Cowdria antigens
Logan (1987) described an IFA test based on the discovery that Cowdria developed
in neutrophilic granulocyte cultures (Logan et al., 1987). A slightly modified test
using these cultures as antigen was adopted in Utrecht, where it was shown to be
suitable for several different Cowdria isolates (Jongejan et al., 1989). However, not
all isolates of Cowdria developed equally well in neutrophil cultures and some failed
to do so. The Cowdria-infected neutrophils ranged from 1 to 30% and were highest
after 24 to 72 hours. Thereafter the cultures degenerated quickly. Infected neutrophil
cultures were used as antigen in a similar IFA test as described earlier by workers in
Utrecht (Jongejan et al., 1989) but the test differed to some extent from the original
methods described by Logan (1987). Jongejan et al. (1989) found that it was
important to reduce non-specific fluorescence, especially when using goat antisera
on caprine neutrophil cultures, by pre-incubation with acid glycin buffer as described
for the serodiagnosis of anaplasmosis (Montenegro-James et al., 1985). Counter-
staining with Evans Blue further reduced the non-specific fluorescence. Serological
cross-reactions between five stocks of Cowdria were determined using goat antisera
obtained six weeks after infection. All animals had been treated and given a homolo-
gous challenge two weeks before the sera were tested. In general, antibody titres
detected using heterologous antigens in the test were much lower than on homologous
antigens, demonstrating the presence of serotypes within the genus Cowdria. The
same isolates were also different from each other with respect to their cross-immunity
status in goats (Jongejan et al., 1988, 1991c). However, it was not determined whether
immunologically identical stocks of Cowdria belong consistently to the same sero-
type. The existence of serotypes within the genus Cowdria has reduced the usefulness
of this IFA test based on infected neutrophils. For large-scale production of Cowdria
antigens,  infected endothelial  cell cultures have  been  shown to  be far  superior
(Bezuidenhout, 1987).
Infected endothelial cell cultures as a source of Cowdria antigen
The successful long-term in vitro propagation of Cowdria, first achieved in South
Africa (Bezuidenhout et al., 1985; Bezuidenhout, 1987), has been an important
breakthrough. In Utrecht we have modified these original methods by using non-ir-
radiated bovine endothelial cells isolated from umbilical cord arteries (Van de Wiel
et al., 1989). The details of isolation, maintenance of endothelial cell cultures and the
behaviour of Cowdria within these cultures have been described in detail elsewhere
(Jongejan, 1991). Researchers in Zimbabwe have reported several other improve-
ments in the culture conditions for Cowdria (Byron and Yunker, 1990; Byron et al.,
1991). An IFA test based on fluorescing extracellular elementary bodies of Cowdria
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has been developed using Cowdria antigens harvested from endothelial cell cultures
(Yunker et al., 1988; Martinez et al., 1990). Both studies showed that the extracellular
elementary bodies of Cowdria fluoresced brightly, whereas intracellular colonies of
reticulate bodies fluoresced only faintly. Therefore, to determine the titre, the fluo-
rescence emitted by the elementary bodies is recorded rather than searching for
intracellular fluorescing bodies. This means that culture supernatant containing a
large number of elementary bodies can be centrifuged at 10,000 g and the pellet
spotted onto glass slides without any contaminating host cells. A large number of
antigen slides can thus be prepared from one infected endothelial cell culture.
Comparison of IFA tests
Martinez and his colleagues (1990) have compared three antigens for the serodiag-
nosis of heartwater by IFA. Antigens were obtained from infected bovine endothelial
cells (E5 cell line), peritoneal macrophages infected with the Kümm isolate, and
primary cultures of infected caprine macrophages. The use of endothelial cell cultures
as a source of Cowdria antigen proved superior in all respects. The antigen could be
produced in large quantities at low cost, in contrast to the other two types of antigen
described. The fluorescence was easy and quick to assess compared to the laborious
reading of neutrophil or macrophage  antigens, which often contain only a  low
percentage of small rickettsial colonies.
The demonstration of serotypes of C. ruminantium using the IFA test on infected
neutrophils stressed the need for a Cowdria-specific test detecting all serotypes
(Jongejan et al., 1988). The problem of serotypes has also been addressed by Martinez
et al. (1990) while evaluating the IFA based on endothelial cell culture antigen. The
Welgevonden isolate from South Africa, an isolate from Senegal and the Gardel
isolate from Guadeloupe showed lower heterologous titres compared to homologous
titres. Further, a number of Zimbabwean isolates have also been compared using the
IFA test and it was found that all the isolates were essentially of the same serotype
(Yunker, 1990).
Monoclonal antibody-mediated competitive ELISA
Unpurified Cowdria antigens harvested from infected endothelial cultures did not
give satisfactory results in the indirect ELISA due to the high background obtained
with pre-immune sera (M.J.C. Thielemans and F. Jongejan, unpublished observa-
tions). These non-specific reactions associated with crude antigen could be avoided
by using the specificity of monoclonal antibodies (Hewitt et al., 1982). For instance,
a competitive ELISA mediated by a monoclonal antibody has also been used for the
serodiagnosis of Ehrlichia risticii, the causal agent of equine monocytic ehrlichiosis
(Shankarappa et al., 1989).
It was demonstrated recently that Cowdria contains an immunodominant and
antigenically conserved protein of 32,000 daltons (Jongejan and Thielemans, 1989).
Monoclonal antibodies (MAb) directed against this dominant protein, designated
Cr32, were subsequently raised. These MAb were used to determine the localization
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of the Cr32 protein and to develop a competitive ELISA for the detection of
circulating antibodies. A panel of five MAb were raised against Cowdria. Four MAb
were directed against epitopes on a 32-kilodalton Cowdria protein as demonstrated
by Western blotting; two (4F10B4 and 1E3H10) were of the IgG3 isotype and the
two others (3D8H1 and 1E5H8) of the IgG2b isotype. A fifth MAb (4B2F3H12) of
the IgM isotype recognized a 40-kDa Cowdria protein. All four anti-Cr32 MAb were
reactive in an IFA test based on extracellular elementary bodies. The anti-40 kDa
MAb was negative in this test. MAb 4F10B4 showed the strongest signal in Western
blots using three different stocks of Cowdria.
To determine whether the Cr32 protein has surface exposed antigenic determi-
nants, immuno-gold labelling of Cowdria in vitro using 4F10B4 was carried out
according to methods originally designed by Faulk and Taylor (1971) and adapted
for in vitro labelling of Chlamydia elementary bodies by Kuo and Chi (1987). A
suspension of Cowdria elementary bodies was allowed to react with MAb 4F10B4
and subsequently labelled with colloidal gold conjugated to anti-mouse IgG. The
material was processed for transmission electron microscopy (Ito and Rikihisa,
1981). It was shown that Cr32 has surface-exposed antigenic determinants (Jongejan
et al., 1991b) expected on the basis of its immunodominant recognition.
Using MAb 4F10B4, a competitive ELISA was developed which detected Cow-
dria-specific antibodies in goat, sheep and cattle sera (Jongejan et al., 1991b). In this
test antibodies in animal sera compete with MAb for binding sites on the Cr32 protein
present in a crude sonicated Cowdria extract obtained from infected endothelial cell
cultures. For instance, competition between anti-Cr32 antibodies in bovine sera and
MAb results in a lower extinction since the rabbit-anti-mouse second antibody does
not recognize bovine antibodies.
The competitive ELISA detected antibodies in 55 out of 70 (79%) goats experi-
mentally infected with one of eight different Cowdria stocks. Fourteen out of the 15
sera which were negative in the competitive ELISA were also negative in the IFA
test. Nevertheless, all 15 sera recognized some epitopes of the Cr32 Cowdria protein
as judged from their reaction with this protein in Western blots of infected endothelial
cell culture extract. Overall, there was 89% agreement between the competitive
ELISA and the IFA test considering all 70 goats. Moreover, antibodies were detected
in 13 out of 13 sheep infected with one of four different stocks of Cowdria, and in
sera from calves experimentally infected with six different strains of heartwater. So
far experimental animals immunized against 12 different isolates of Cowdria were
recognized in the competitive ELISA (five isolates from South Africa; Ball 3, Kümm,
Kwanyanga, Zeerust and Welgevonden, Gardel from Guadeloupe, Lutale from Zam-
bia, Kiswani from Kenya, Ifé from Nigeria, Umm Banein from Sudan, Umpala from
Mozambique and Cristal Springs from Zimbabwe).
The results show that in the competitive ELISA serotype-specificity does not play
a role. This may have been expected since Cr32 is a conserved protein present in all
isolates of Cowdria tested so far. Comparison of the competitive ELISA with IFA
test results for goat sera showed 89% agreement. The competitive ELISA detected
antibodies in seven goat sera, which were negative in the IFA test, indicating that the
competitive ELISA is more sensitive. Both tests failed to detect antibodies in 14 sera
which were obtained from goats immunized against different Cowdria stocks. How-
ever, when these sera were tested in Western blots they all appeared to recognize the
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CR32 protein. A possible explanation is that polyclonal goat antisera recognize a
different epitope on the CR32 molecule than the monoclonal antibody. The Western
blot appears to be a more sensitive assay for the detection of antibodies against the
Cowdria-specific protein. However, since Western blotting is not very practical for
large-scale serological testing, the technique is used as an important additional
method of evaluating previous exposure to Cowdria infections.
The advantage of the competitive ELISA is that sera from many animal species
can be tested, but not the mouse. Our preliminary results in Zimbabwe and Mozam-
bique with sera from wild animals indicate that the competition ELISA can also be
used to determine the involvement of wildlife in the epidemiology of heartwater.
Cross-reactions
Ehrlichia
Another important characteristic of an effective serological test is the absence of
cross-reactions with other organisms which may lead to false positive results. It was
shown by Logan et al. (1986) that the specificity of the IFA test based on infected
neutrophil cultures was limited due to cross-reactions between Cowdria and Ehr-
lichia (Camus, 1987; Jongejan et al., 1989). A strong cross-reaction was found
between Cowdria antigens and E. equi antisera and to a lesser extent with E. canis
(Logan et al., 1986). Moreover, two-way cross-reactions between Cowdria and E.
phagocytophila with titres between 1:80 and 1:160 were found when these organisms
were compared in neutrophil cultures by workers in Utrecht (Jongejan et al., 1989).
Similar cross-reactions have been reported using the IFA based on infected
macrophages. Unilateral cross-reactions were found with E. bovis, E. phagocyto-
phila, E. ovina (one only out of two sera tested) and antisera to an Ehrlichia sp.
associated with Jembrana disease in Indonesia (Camus, 1987; du Plessis et al., 1987).
Cross-reactivity between Cowdria and E. phagocytophila is not important in the
epidemiology of heartwater since the infections occur on different continents. More-
over, this cross-reactivity is not linked to cross-immunity between the organisms
(Jongejan and Wassink, 1991). Cross-reactions with other Ehrlichia species, such as
E. bovis or E. ondiri could interfere with the interpretation of sero-epidemiological
surveys of heartwater (du Plessis et al., 1987). Although serological cross-reactions
limit the value of the IFA test based on macrophages in the epidemiology of
heartwater, the test remains a valuable tool to monitor infections in experimental
animals. It remains to be shown if, and to what extent, cross-reaction with Ehrlichia
spp. may play a role in the IFA test based on elementary bodies harvested from
endothelial cell cultures.
Ehrlichia phagocytophila positive sera, shown previously to cross-react in the IFA
test with Cowdria-infected neutrophils, did not cross-react in the competitive ELISA.
Also, in Western blots no epitopes on the Cr32 molecule are recognized by E.
phagocytophila antibodies. Although it seems unlikely that any other ehrlichial agents
will recognize epitopes on this Cowdria-specific protein, further studies on this aspect
of the competitive ELISA are required, especially with E. bovis and E. ondiri which
occur sympatrically with C. ruminantium.
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Chlamydia
The relationship between C. ruminantium and Chlamydia trachomatis has been
studied by immunofluorescence. A monoclonal antibody directed against the
MOMP of Chlamydia trachomatis recognized rickettsial colonies of C. ruminan-
tium in infected goat brain (Jongejan et al., 1991a). No specific fluorescence was
observed in non-infected brain. Also, polyclonal Cowdria antiserum did not recog-
nize Chlamydia trachomatis in cultured HeLa cells, whereas Chlamydia-specific
polyclonal rabbit antiserum did. Western blotting analysis using the Chlamydia
monoclonal antibody on nitrocellulose blots containing Cowdria proteins from
endothelial cell cultures, did not identify proteins with common antigenic determi-
nants. The loss of reactivity of the MAb in Western blots may have been due to
protein denaturation during SDS/PAGE. It was concluded that in addition to the
existing similarities in ultrastructure and developmental cycle, Cowdria and
Chlamydia are to a certain extent antigenically related (Jongejan et al., 1991).
However, further assessment of the relationship between these organisms based on
molecular phylogenetic analysis using 16S ribosomal DNA sequences has revealed
that Cowdria is closest related to several species of Erhlichia (Van Vliet et al.,
1992).
Bovine abortion rickettsia (BAR)
An obligate intracellular rickettsial organism was recently isolated from tissues of
an aborted bovine foetus in the USA (Dilbeck et al., 1990; Kocan et al., 1990). A
high cross-reactivity was found between this newly isolated rickettsia and Cowdria.
In collaboration with Washington State University, Pullman, and the SADCC/
Heartwater Research Project carried out by the University of Florida in Zimbabwe,
the antigenic relationship between this BAR agent and Cowdria was re-examined
using IFA, competitive ELISA and Western blotting. The results obtained did not
confirm the previously claimed cross-reactivity between this new agent and
Cowdria.
Evaluation of competitive ELISA and the IFA test
Mozambique
Heartwater appears to be a major disease problem in improved cattle and goats south
of the River Save in Mozambique; it is much less important in the south of the country.
The vector in the north is A. variegatum and in the south is A. hebraeum. The IFA
test using supernatant from infected endothelial cell culture (from Utrecht) as antigen
was used to test 388 caprine sera and 374 bovine sera collected in six provinces
(Faculdade de Veterinária, Maputo). It was shown that north of the River Save, where
only A. variegatum is present, the percentages of positive sera were low (10% for
goats and 20% for cattle), whereas south of the River Save, where A. hebraeum is
abundant, percentages were much higher (63.5% for goats and 59.5% for cattle). Thus
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the differences in the disease picture in regions with A. hebraeum or A. variegatum
could be confirmed serologically (Asselbergs et al., in press).
Malawi
Cowdria antigen produced at Utrecht in endothelial cell cultures was evaluated in
Malawi (FAO Project GCP/RAF/259/DEN in Lilongwe). It was found that the IFA
test based on elementary bodies of Cowdria was a sensitive indicator of the estab-
lishment of infection after immunization of calves with frozen blood vaccine. Sig-
nificant differences in infectivity were demonstrated between four batches of vaccine.
Seroconversion occurred in between 72 and 100 percent of animals after inoculation
of a reference vaccine of proven viability (J.A. Lawrence, A.P. Whiteland, J. Malika,
P. Kafuwa and F. Jongejan, unpublished data).
Zimbabwe
The competitive ELISA was introduced in Zimbabwe at the Paraclinical Department
of the Faculty of Veterinary Science. Serum samples from 36 free ranging black
rhinoceroses (Diceros bicornis) from the Zambezi Valley in Zimbabwe (obtained
from the Department of National Parks and Wildlife Management) were tested for
exposure to Cowdria using the competitive ELISA. Nineteen (53%) of the animals
were positive, indicating exposure in the natural habitat where there is no contact
with domestic cattle. The findings signify a possible role for the black rhinoceros in
the epidemiology of the disease (N.D. Kock, F. Jongejan, M.D. Kock and R.A. Kock,
unpublished results).
Guadeloupe
The competitive ELISA has been evaluated in the Caribbean region on Guadeloupe
where cattle and goat sera were tested for antibodies directed against the CR32 protein
of Cowdria. All sera obtained from livestock on islands free from A. variegatum were
negative. However, low numbers of sera from cattle on islands other than those where
heartwater has been demonstrated, were found positive by competitive ELISA and
the IFA test and these results have been confirmed using Western blotting analysis at
Utrecht. A serological survey of heartwater in the Caribbean, carried out jointly by
workers in Guadeloupe and Utrecht, will be described elsewhere (Muller-Kobold et
al., 1992).
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INTRODUCTION
Heartwater is an economically important disease of livestock caused by Cowdria
ruminantium and transmitted by ticks of the genus Amblyomma. Current methods for
the diagnosis of heartwater in ticks and animals are either slow or are considered to
have inadequate specificity and sensitivity. Demonstration of C. ruminantium in ticks
and in live animals is difficult and often requires sub-inoculation into susceptible
animals. Definitive diagnosis of heartwater in animals is made by identifying the
organisms in endothelial cells in Giemsa-stained brain smears (Purchase, 1945)
obtained by biopsy or at postmortem. In infected ticks, colonies are found by thick
or thin sections of midgut by light and electron microscopy (Bezuidenhout, 1984;
Kocan and Bezuidenhout, 1987; Yunker et al., 1987). RNA and DNA probes have
been developed to detect rickettsia and other organisms in animal hosts and arthropod
vectors by nucleic acid hybridization (Barker et al., 1986; Goff et al., 1988;
McLaughlin et al., 1987; Shompole et al., 1989) and have been acclaimed to have
high specificity and sensitivity. Bearing this in mind, we have identified a DNA probe
for the diagnosis of heartwater.
IDENTIFICATION OF A DNA PROBE
SPECIFIC FOR COWDRIA RUMINANTIUM
A DNA probe has been identified for the diagnosis of heartwater in ticks and animals.
The probe has been derived from the DNA of the Crystal Springs heartwater isolate
of Zimbabwe (Waghela et al., 1991). This probe has been isolated from a genomic
DNA library prepared by cloning of Sau3A partially digested DNA into the BamH1
site of pUC 19 plasmid vector. Recombinant plasmids from transformed Escherichia
coli were identified by alkaline lysis, followed by digestion with EcoR1 and electro-
phoresis on 0.6% agarose gels. Those plasmids with inserts were digested with Kpn1
and Xba1, Southern blotted and probed with infected and uninfected endothelial cell
DNA. A plasmid carrying a 1306 base pair C. ruminantium DNA fragment was
identified by its hybridization to infected but not uninfected endothelial cell DNA
and was called pCS20 (Waghela et al., 1991).
CHARACTERIZATION OF pCS20 PROBE
The specificity and sensitivity of pCS20 for Crystal Springs DNA was determined
(Waghela et al., 1991). The 32P-labelled pCS20 probe had high specificity for C.
ruminantium DNA as it did not hybridize in a dot blot assay to 400 ng of Anaplasma
marginale, Trypanosoma brucei, Babesia bigemina, B. bovis, Ehrlichia risticii, a new
bovine Chlamydia-like organism, E. coli, Campylobacter jejuni, C. pneumoniae, C.
fetus, Staphylococcus aureus, Pseudomonas aeroginosa, Streptococcus faecalis,
Clostridium perfringens, Actinobaccilus pyogenes, Listeria monocytogenes and goat
and bovine DNA (Waghela et al., 1991). It was determined that the pCS20 probe had
a sensitivity of detection of 1 ng of Crystal Springs genomic DNA which is known
to be contaminated with bovine DNA, as the DNA was prepared from in vitro cultures
of C. ruminantium. The specificity of the pCS20 probe was further characterized by
Southern blotting of Crystal Springs DNA. In this assay it was evident that the pCS20
probe  hybridized  with  four fragments  of  the  Pst1 digested  DNA of the isolate
(Waghela et al., 1991).
SEQUENCE ANALYSIS OF pCS20
The nucleotide sequence of both strands of pCS20 insert revealed a fragment length
of 1306 base pairs containing two open reading frames of 513 and 459 nucleotides
and contained approximately 70% A+T which caused numerous potential prokaryotic
promoter consensus sequences (Waghela et al., 1991).
CROSS REACTION OF pCS20 WITH OTHER HEARTWATER ISOLATES
The reaction of the pCS20 probe was determined against several other isolates of
Cowdria from Zimbabwe, South Africa, Kenya and Nigeria. These analyses
revealed that the probe hybridized to all heartwater isolates tested (Figure 1)
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regardless of their geographical origin, suggesting that it detects conserved DNA
sequences in all the isolates and can be used to detect the parasite in different
endemic regions of Africa.
DETECTION OF COWDRIA RUMINANTIUM
IN AMBLYOMMA VARIEGATUM
The pCS20 probe has been shown to detect C. ruminantium organisms in A. vari-
egatum ticks. The probe detected C. ruminantium DNA in 31 of 70 midgut DNA of
adult ticks fed as nymphs on goats infected with the Kiswani isolate of Kenya, but
not with ticks fed on uninfected goats (Waghela et al., 1991). Ticks fed on infected
goats which were negative with the probe were either uninfected or were infected at
levels that were below the sensitivity of detection of the pCS20 probe.
DETECTION OF COWDRIA RUMINANTIUM IN INFECTED SHEEP
Five sheep inoculated with C. ruminantium Crystal Springs tissue culture organisms
were sampled every other day until day 14 after infection. Cowdria ruminantium
DNA was detectable in elementary body pellets from plasma of all infected sheep,
five days after infection, by hybridization to the pCS20 probe. The maximum
hybridization signal of the pCS20 probe with the pellet DNA from the plasma was
detected on day 10 after infection in all but one animal, and coincided with the peak
of the febrile reaction. The last animal died on day 9 after infection during the febrile
reaction without showing a peak reaction with the pCS20 probe. No hybridization
FIGURE 1. Hybridization of pCS20 DNA probe (32P-labelled) with DNA from cultured
elementary bodies of eight different isolates of Cowdria ruminantium. CS* = Crystal Springs;
Lc* = Lemco T3; Ny* = Nyatsanga; Pr* = Palm River; Ng = Nigeria; Zw* = Zwimba; Ball 3
and Welgevondon (South Africa). (*Zimbabwe isolates)
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signals were detected with plasma from five uninfected control sheep. The probe’s
sensitivity to detect C. ruminantium organisms in recovered or carrier animals is
under investigation.
FURTHER DEVELOPMENTS OF THE pCS20 PROBE
FOR THE DIAGNOSIS OF HEARTWATER
Synthetic oligonucleotides have been prepared from the sequence of the pCS20
probe in order to amplify, by the polymerase chain reaction (PCR), 181 bp and 279
bp products from the two open reading frames of the probe. An evaluation of the
use of such PCR products for the detection of C. ruminantium will be presented.
Such PCR-derived DNA products of pCS20 should reduce the hybridization time
of the probe to test samples. Alternatively, PCR will be used to amplify the products
described above from animal and tick DNA samples, which will be analysed by
agarose gel electrophoresis and/or Southern blotting to confirm Cowdria infection.
This method may be particularly useful for the detection of carrier animals which
may have very low levels of intermittent parasitaemia. To allow routine use of a
DNA-based diagnostic test for Cowdria in the field, a non-radioactive detection
method using chemiluminescence is being developed. Initial results suggest that
this method of detection has a similar sensitivity to the radiolabelled assay.
Application of such a test would facilitate better understanding of the epidemiology
of heartwater and hence allow the development of better control strategies for the
disease.
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INTRODCUTION
Important features of surface protein gene structure of Anaplasma marginale have been
elucidated in the last ten years. The surface protein complex for major surface protein
MSP1 of A. marginale has been shown to induce protection in cattle against homologous
(Palmer et al., 1986) and heterologous (Palmer et al., 1989) challenge. Genes coding for
two antigenically and structurally distinct polypeptides in this complex, MSP1a and
MSP1b, have been cloned, sequenced and expressed (Barbet et al., 1987; Barbet and
Allred, 1991; Allred et al., 1990). From these structures several conclusions can be drawn
concerning surface protein gene organization. For Cowdria ruminantium, the availability
of new culture methods (Bezuidenhout, 1987; Yunker et al., 1988) suggests that similar
advances can now be made. Research on C. ruminantium is at an earlier stage of
development, particularly concerning the nature of protective immune mechanisms.
However, genomic DNA expression libraries have been prepared from C. ruminantium
and colonies expressing fragments of immunodominant proteins identified. This suggests
that previous limitations imposed by lack of purified organisms or of cloned genes
important in generation of immunity can be overcome.
MATERIALS AND METHODS
Cloning and expression of genes coding for polypeptide MSP1a (termed MSP1α genes).
Genomic DNA was purified from the Florida isolate of A. marginale as previously
described (Barbet et al., 1987). DNA libraries were prepared in the plasmid vectors pUC9
and pKK233-2. Recombinant Escherichia coli were screened for expression of MSP1a
by reactivity with neutralizing monoclonal antibody Ana22B1 which was detected by
incubation with rabbit anti-mouse immunoglobulin and 125I-protein A (Barbet et al.,
1987). Individual colonies were isolated that expressed as either fragments of MSP1a or
the complete polypeptide. DNA was also prepared from the Virginia (VA), South Idaho
(ID) and Washington-O (WA) isolates of A. marginale. Different cloning strategies were
used to obtain the MSP1α gene from these isolates: ligation of KpnI (VA) or KpnI/ PstI
(ID and WA) fragments into pGEM4 and screening of transformants by colony hybridi-
zation with probes made from fragments of the FL allele.
Cloning and expression of the gene coding for polypeptide MSP1b (termed
MSP1β gene). DNA libraries were prepared in the plasmid vector pBR322 and
screened for expression as above except that a rabbit antiserum against the MSP1
complex was used. Recombinant colonies were identified that expressed a protein
of identical molecular weight and proteolytic cleavage pattern to MSP1b (Barbet
et al., 1987).
Sequencing of the cloned DNAs. Sequencing was performed on the double-
stranded plasmid DNAs and subclones in pGEM3 and pGEM4 by the dideoxynu-
cleotide method of Sanger et al. (1977). The t7 and SP6 promoter primers were used
to sequence from pGEM into the insert, then new primers were made based on the
newly acquired sequence data. The new primers were used to extend the region
sequenced. By continuing this process of `primer-walking’, both strands of the inserts
were completely sequenced.
Synthetic peptide immunoblots. Nitrocellulose filters were soaked in a solution of
1 mg/ml bovine serum albumin (BSA) for 15 minutes and allowed to air dry. Peptides
were then applied to the BSA coated nitrocellulose in a volume of 1 µl and the spots
also allowed to dry. The nitrocellulose filters were wetted from behind by laying them
for 15 minutes on a piece of 3MM paper that had been soaked in 2.5% glutaraldehyde.
Filters were then washed × 3 rapidly in 0.01 M tris, pH 7.5, 0.17 M NaCl, 0.1 mM
phenyl methyl sulfonyl fluoride and processed for reaction with 2 µg/ml monoclonal
antibody, rabbit anti-mouse immunoglobulin, and 125I-Protein A as described pre-
viously (Barbet et al., 1987).
RESULTS AND DISCUSSION
Sequencing of DNA from recombinant bacteria expressing MSP1a. Subcloning of the
A. marginale insert DNA in different orientations and plasmids, followed by immu-
noscreening, suggested that expression of recombinant MSP1a was occurring under
control of an A. marginale promoter. Sequencing of the complete (Florida) DNA
insert revealed a single long open reading frame potentially coding for a polypeptide
of 767 amino acids (Allred et al., 1990) and calculated molecular weight 77,454. A
prominent feature of the sequence was the presence of eight tandemly repeated
segments containing either 84 or 87 base pairs just 3’ to the initiation codon (Allred
et al., 1990). This long open reading frame is the likely coding sequence because:
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a) plasmid DNA deletion experiments showed that the presence of the tandem
repeats was essential for reaction of recombinant bacteria with monoclonal antibody
22B1;
b) synthetic peptides specified by this open reading frame reacted with neutralizing
monoclonal antibodies (see later);
c) the presumptive coding sequence was transcribed by A. marginale into RNA.
The 5’ end of the transcript was correctly spaced with regard to DNA sequences
homologous to the –10 and –35 consensus promoter sequences of E. coli;
d) recombinant colonies expressing fragments of MSP1a contained the 5’ region
of this sequence including promoter, initiation codon and repeats, but were missing
the 3’ end; and
e) the N-terminal sequence of isolated native MSP1a agreed with that specified by
the open reading frame.
The molecular weight of the complete polypeptide predicted from the sequence is
less than its apparent molecular weight on SDS gels. This is a common finding with
polypeptides containing tandem repeats (Kemp et al., 1987) and agrees with our
observation that a recombinant fragment of the MSP1a polypeptide containing only
the repeat region also migrated anomalously.
Mapping of the epitope recognized by neutralizing monoclonal antibodies. A
series of overlapping peptides were synthesized that were specified by different
regions within the 87 base pair repeats of the Florida MSP1α gene. Each peptide
was tested for reaction with monoclonal antibodies 22B1 and 15D2 in immunoblots
and ELISA. Their reactivity in each assay and with both antibodies was compa-
rable. The minimal epitope required for binding was the 6 amino acid sequence,
QASTSS, which is present in seven of the peptide repeats. An alternative form of
this sequence EASTSS (a conservative substitution of glutamic acid for glutamine
in the N-terminal amino acid) exists in one repeat and also bound antibody.
Shorter peptides missing either the N- or C-terminal amino acids of QASTSS and
negative peptide controls did not bind. The 29 amino acid peptide representing
one complete repeat, DSSSAGGQQQESSVSSQSDQASTSSQLGA, clearly
bound more antibody than either of the 6 amino acid peptides. This suggests
that although the epitope can be represented by QASTSS or EASTSS, the
surrounding amino acids are important in maintaining an optimal conformation
for binding.
Antisera which had been prepared previously in rabbits and cattle against
non-recombinant MSP1 complex isolated from A. marginale infected erythrocytes
(Palmer et al., 1986) reacted well with the synthetic 29 amino acid peptide in the
ELISA, demonstrating that this is an immunodominant part of the molecule. No
reaction was obtained between these antisera and shorter peptides.
Comparison of the MSP1α gene in different Anaplasma marginale isolates. Restriction
maps developed from chromosomal DNAs by Southern blot analysis revealed that the
MSP1α gene was contained in a KpnI fragment that varied considerably in length (e.g.
from 6.1 Kbp in the VA isolate to 6.6 Kbp in FL). This restriction fragment length
polymorphism correlated  with the variability in the apparent sizes  of the MSP1a
polypeptides from the different isolates (Figure 1). Because of the regions of the
chromosome contained in the various plasmids and the fact that the plasmids each
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directed the synthesis of full-sized, immunoreactive polypeptides, we determined that
the entire MSP1α gene was contained in the variable KpnI to PstI fragment and not in
the constant surrounding regions.
The most unusual feature of the MSP1a polypeptide immediately follows the
N-terminal domain: a region of tandemly repeated amino acids in which repeat units
of 29 or 28 amino acids are repeated two (VA), four (WA), six (ID) or eight (FL)
times. Five different repeat forms exist in the four isolates; of these, 25 of the amino
acids are completely conserved in all forms. The variability in the numbers of repeats
can completely account for the observed variations (Oberle et al., 1988) in the size
of this polypeptide.
Sequencing of DNA from recombinant bacteria expressing MSP1b. The cloned Florida
MSP1β gene was mapped to a single long open reading frame coding for a protein of
756 amino acids and a calculated molecular weight of 80,350. As with the MSP1α gene,
A. marginale RNA was sequenced to identify the transcription start site and the N-ter-
minal sequence of native MSP1b was obtained to confirm location of the initiation codon.
A typical E. coli –10 consensus sequence was observed in the expected location with
respect to the transcription start. A domain containing four tandem repeats of a degenerate
7 amino acid sequence was observed. A second unusual feature was the presence of a
run of four or five glutamine residues 6 amino acids in from the N- and C-termini (Barbet
and Allred, 1991). There appeared to be three to four partially homologous copies of the
MSP1β gene in genomic DNA, of which at least two occur in tandem.
Implications for vaccine development. Availability of complete gene sequences for
MSP1a and b allows several possibilities for construction and testing of recombinant
and synthetic products. Similar work on expression of recombinant immunodominant
C. ruminantium proteins is in progress. These proteins and the cloned genes will be
used in delineation of protective immune mechanisms and vaccine development.
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FIGURE 1: Restriction map of the MSP1α gene and region 3’ to the gene, from four allelic
variants. The region of the chromosome containing the coding sequence of each MSP1α allele
is indicated by bolding and delineated by slashes. The strings of A, B, C, D and E at the left
end of each refer to the form and number of each repeat unit found in each allele. K= KpnI;
H= HindIII; B= BamHI; Sm= SmaI; P= PstI; S= SstI; Hp= HpaI.
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RESISTANCE TO COWDRIOSIS
Reports that populations rather than breeds of domestic animals could be resistant to
cowdriosis were first mentioned by Uilenberg (1983). Although the observation that
indigenous populations can survive in endemic areas while imported, exotic animals
are fully susceptible to the disease is of importance, interpretations on the status of
resistance can be biased due to the fact that very young animals are naturally resistant
to cowdriosis. If not infected within a few weeks after birth, these animals become
fully susceptible. Therefore, investigations of genetic resistance as opposed to immu-
nity need to be performed in areas where the epidemiology of cowdriosis is well
understood. Since cowdriosis was diagnosed in Guadeloupe (Perreau et al., 1980), a
complete epidemiological study has been performed on this and neighbouring is-
lands. This has allowed the identification of areas free of ticks and therefore of the
disease, areas in which the number of infected ticks has been assessed and livestock
populations which have been in contact or not with the causal organism, Cowdria
ruminantium. Furthermore, because importation and movement of livestock is well
controlled and the C. ruminantium strain isolated in Guadeloupe is highly pathogenic,
all conditions necessary for the study of genetic resistance to cowdriosis are fulfilled
(Camus, 1989).
Currently, 95% of the livestock in Guadeloupe consists of Creole breeds which
have been adapted to the environment. This population, mainly cattle and goats, was
imported from West Africa in the 19th century. Importation from Africa stopped with
the end of the slave trade. Goats first populated Basse Terre and Grande Terre, the
two main islands of Guadeloupe, and were exported to the nearby island of Les
Saintes, which is free of ticks.
Resistance of cattle to cowdriosis
In the absence of tick control, mortality due to cowdriosis is only 1% for the Creole
breed while it increases to 10% for European breeds and 5% for cross-breds. Since
only 1% of ticks are infected by C. ruminantium, it has been estimated that less than
half of the cattle population is challenged each year. This observation implies that
few newborn animals are challenged during the period of natural age-related immu-
nity, which lasts three to six weeks after birth. As a result, many animals are not
naturally immune to the disease and differences in mortality between breeds are
significant in terms of resistance to cowdriosis (Camus 1989). However, before
stating that Creole cattle are resistant to cowdriosis, experimental infections need to
be performed on animals born in tick-free areas.
Resistance of goats to cowdriosis
The most devastating effects of cowdriosis in Guadeloupe are in goats. In the absence
of tick control, the mortality due to C ruminantium infection is 20% (Camus 1989).
Therefore, goats are more susceptible to cowdriosis than cattle. For economical and
practical reasons Creole goats were first used as experimental animals to study the
transmission of the parasite. It was noticed that the susceptibility to cowdriosis varied
from animal to animal within a herd and from herd to herd within the Creole
population. In order to further investigate whether this variation in susceptibility or
resistance was genetically controlled, population and family studies were performed.
Three herds from three different locations were studied. Creole goats from Les
Saintes have been evolving in a cowdriosis-free environment for the last 100 years
while the population from the Duclos farm (Basse Terre) has been free from the
disease for the last ten years. This population was derived from the Gardel farm
(Grande Terre) which is an endemic area for cowdriosis. The numbers of animals
subjected to experimental infection were 85, 90 and 36 from the Les Saintes, Duclos
and Gardel populations, respectively. None of the animals were treated and the
survival rates were 25, 54 and 78% respectively. A correction factor was introduced
to the data obtained from the Gardel farm in order to account for a possible effect
due to animals already immune. Also, a parallel experiment using the same C.
ruminantium strain was carried out in Holland on 12 Dutch goats and none survived
(Matheron et al., 1987).
Of the 90 goats from the Duclos farm tested, 77 had identified parents and were
the descendents of 19 sires. Seven sires had more than four offspring whose survival
rate varied from 20 to 83%. The population comprised ten full-sib pairs of which nine
reacted similarly, either both died or both survived. From these observations, it was
concluded that, most likely, cowdriosis resistance was genetically controlled and a
recessive sex-linked gene may have been involved. However, definite conclusions
could not be drawn because of the small numbers studied (Matheron et al., 1987).
METHODS AND STRATEGIES TO FURTHER
INVESTIGATE RESISTANCE TO COWDRIOSIS
Establishment of Creole goat families
It is clear from the results described above that some Creole goats are resistant to
cowdriosis. Techniques of artificial insemination and embryo splitting  are well
established and will be applied to obtain goat families with large numbers of full- and
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half-sibs. These families will be valuable in the exploration of paternal effects on
resistance and to study the heritability of characters conferring resistance to cow-
driosis. Sperm from susceptible animals will be kept in order to establish susceptible
families, and embryos from suspected susceptible females inseminated by susceptible
males split. One half of the embryo will be used to test for susceptibility, the other
half to procreate. This strategy will insure the status of progenitors for further
breeding experiments and the crossing of susceptible or resistant males to susceptible
females will provide information on the contribution of the paternal genes to cow-
driosis resistance and for the estimation of the heritability of characters linked to the
resistance.
Breeding programs in cowdriosis-free areas in Guadeloupe have already been
started. Since the Creole breed is very prolific, three generations per two years,
results on the segregation of characters of resistance should be obtained in the near
future.
DNA polymorphism and resistance to cowdriosis
Detection of very polymorphic regions in the genomes of the goats should provide
an efficient tool to localize genes responsible for resistance to diseases. It is generally
accepted that the location of 200 polymorphic markers equally spaced through the
genome will provide a linkage map for any genome. Polymorphic markers could be
genes such as the major histocompatibility complex or microsatellites (simple repeats
spread throughout the genome whose length can vary). The establishment of linkage
maps in several species, including sheep, has already been started and studies in this
area will certainly help the research on genetic resistance to cowdriosis. The ultimate
goal will be to correlate certain polymorphisms with resistance. The study of the
segregation of polymorphisms in families from resistant and susceptible animal
crosses should greatly assist in ascertaining whether a given region of the genome is
linked to a gene involved in resistance to cowdriosis. Unfortunately, many polymor-
phisms detected by microsatellites in one species cannot be extrapolated to another
species. However, it is possible that many microsatellite-associated polymorphisms
will be conserved between goats and sheep.
Definition of the Creole goat genome is under way. Polymorphic regions such as
the  caprine major  histocompatibility complex are  currently being studied using
oligonucleotides combined with polymerase chain reaction technology and genomic
libraries targeting random sequences in the genome containing microsatellites will
be performed.
The pathology of cowdriosis
Understanding the pathology of cowdriosis may help to explain the mechanisms of
resistance in this disease. The pathology of this disease is very poorly understood but
analysis of clinical symptoms between resistant and susceptible animals could direct
research towards a more systematic investigation of what causes disease or death.
The first observation is that resistant and susceptible animals are equally susceptible
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to infection by C. ruminantium; the rickettsia is found inside neutrophils or brain
capillary endothelial cells in both categories of animals. Most of the resistant animals
undergo a brief febrile reaction while fever persists in susceptible animals. The
second observation is that there is no correlation between rickettsaemia and death.
Thus, mechanisms of growth control of the organism are not likely to be primarily
involved in resistance. This would imply that Cowdria does not kill the animal but
rather induces a severe metabolic change which results in the appearance of hydrop-
ericardium and hydrothorax which are more likely to be lethal. Also, the nervous
symptoms are indicative of disorders affecting the permeability of the endothelial
brain barrier. In the light of these observations, several metabolic pathways involved
with the progression of the disease can be explored. The first question to be answered
is what alterations does C. ruminantium induce in the host cell.
Bovine brain endothelial capillary cells can be cultured in vitro (Gospodarowski
et al., 1986) and passaged many times without alteration of their original phenotype.
These cells can be readily infected with C. ruminantium (D. Martinez, unpublished
data). Thus this system can be used to study the effect of infection on endothelial
cells. Cytokine production can be monitored and compared between infected and
non-infected cells. Endothelial cells produce interleukin 1 (IL1). This molecule has
the capacity to activate T cells and, when over-produced, it is involved in causing
fever and intestinal disturbances leading to diarrhoea. T-cell activation and hypersen-
sitivity reactions resulting in inflammatory reactions are linked and could account for
the pathology of cowdriosis. Other candidate molecules which can trigger inflamma-
tory reactions are prostaglandins. Thus, it is possible that resistant and susceptible
animals may differ in their ability to regulate cytokine and/or prostaglandin produc-
tion. Therefore, the development of an in vitro system involving the culture of
capillary endothelial cells from resistant and susceptible animals will be attempted
in order to quantify cytokines, permeation factors and prostaglandins following
infection with Cowdria. If differences are obtained, they should be confirmed in the
animal itself.
A similar approach can be followed for neutrophils, although these cells are more
difficult to maintain in culture for long periods. Unravelling the cascade of events
which leads to the death of animals should therefore provide indications on the genes
to target for detailed analysis in the families mentioned above.
CELL-MEDIATED IMMUNITY AND ITS POSSIBLE
ROLE IN CONTROLLING COWDRIOSIS
In studies of the immunity against cowdriosis, it has been shown that antibodies are
not protective and it has been suggested that cellular immunity is the most likely
mechanism of protection (du Plessis, 1970, 1984). The mouse model, developed by
du Plessis (1982, 1991), has shown that cell-mediated mechanisms play a key role in
protection against cowdriosis and it is likely that this mechanism also provides
protection in ruminants. Studies on the nature of immunity will lead towards better
control of the disease through the development of safe vaccines.
The investigation of the cell-mediated immune responses against C. ruminan-
tium will require breeding of goats and/or cattle to derive histocompatible animals
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in which transfer of immunocompetent cell populations can be done. The CD8+
T-cell population, which comprises mainly cytotoxic cells, has been shown to
provide protection against cowdriosis in the mouse (du Plessis et al., 1991) and
these cell populations will be studied in ruminants. Purification of ruminant CD8+
T cells could be achieved by lysing all other cells obtained from immune animals
with monoclonal antibodies specific for the non-CD8+ cells (Howard et al., 1991)
and complement. These purified CD8+ cells will be transferred to histocompatible,
naive animals previously infected with C. ruminantium. If the recipient animals
survive infection, then a search for protective antigens, using the effector cell
population, could be undertaken. Rickettsial genomes are relatively small (3.106
base pairs) and a systematic screening for antigens recognized by T cells is
technically feasible. To be recognized by CD8+ T cells, antigens have to be
synthesized inside the host cell and presented on the surface of the cell in conjunc-
tion with the major histocompatibility complex antigen. To achieve this, random
genomic libraries will be constructed in appropriate vectors which should allow
expression of foreign DNA in mammalian cells after transfection. Some vectors
have the capacity to replicate in the cytoplasm of the host cell. Therefore on
recognition of the specific antigen, CD8+ T cells will lyse the transfected cells
liberating the plasmid in which genes of interest are inserted into the culture media.
Development of such techniques will help in the identification of antigens which
could be candidates for synthetic vaccines.
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INTRODUCTION
Control of anaplasmosis can be achieved by vaccination with live and attenuated
Anaplasma organisms (Henry et al., 1983; Legg, 1936; Palmer, 1989; Theiler, 1912;
Vizcaino et al., 1980). Vaccines using killed Anaplasma organisms also induce
adequate protective immune responses for disease control (Brock et al., 1965;
Montenegro-James et al., 1990). The problem with the existing vaccines is that they
are derived from the blood of infected calves. As a result, the most used attenuated
vaccine is based on A. centrale organisms. However, only a few countries use this
vaccine in control programs. Induction of a protective immune response in cattle with
live, attenuated and killed Anaplasma organisms suggests that antigenically defined
subunit vaccines can be developed. Subunit vaccines could be made by recombinant
DNA or synthetic methods, possibly allowing widespread use.
PROTECTIVE IMMUNITY WITH NATIVE SURFACE PROTEINS
Our  research on  subunit vaccines  for anaplasmosis  was initiated  by pursuing the
hypothesis that isolated initial body surface proteins would induce a protective immune
response against challenge with A. marginale organisms. This hypothesis was tested by
identifying at least five initial body surface proteins (Palmer and McGuire, 1984),
isolating three different surface proteins by monoclonal antibody affinity chromatogra-
phy (Palmer et al., 1986a, 1988b), immunizing calves with these proteins and challenging
the calves with A. marginale organisms (Palmer et al., 1985, 1986a, 1988a).
Surface proteins were identified using a strain of A. marginale isolated from cattle
in Florida in 1955 (Ristic and Carson, 1977). Identification was by immunoprecipi-
tation of proteins radioiodinated with a reaction catalyzed by lactoperoxidase (Palmer
and McGuire, 1984). The primary antibody in the immunoprecipitation reactions was
from immune sera that neutralized A. marginale initial body infectivity for cattle.
Five of the Florida isolate surface proteins were designated by apparent molecular
weights and included proteins of 105, 86, 61, 36 and 31 kilodaltons (Palmer and
McGuire, 1984).
Following identification, the 105-kDa surface protein was shown to be a complex
and designated major surface protein 1 (MSP1) complex (Allred et al., 1990;
Barbet et al., 1983; Oberle et al., 1988). The MSP1 complex was composed of
protein heterodimers designated MSP1a and MSP1b. Monoclonal antibodies react-
ing with MSP1a were identified and designated ANA 22B1 or ANA 15D2 (McGuire
et al., 1984; Palmer et al., 1986a). These monoclonal antibodies recognized a
neutralization sensitive epitope on MSP1a that mapped to six amino acids of a
tandem repeat of 29 amino acids in the MSP1a protein (Allred et al., 1990).
Variation in the size of the MSP1a protein in different A. marginale strains (Oberle
et al., 1988) was explained by the number of tandem repeats encoded in the 5 end
of the MSP1a gene of the strains (Allred et al. 1990). However, all strains
examined, including nine from the United States, two from Kenya, two from Israel
and one from Zimbabwe, express conserved epitopes which react with monoclonal
antibodies 22B1 and 15D2 (McGuire et al., 1984; Palmer et al., 1988b; Tebele et
al., 1991). Also, these monoclonal antibodies bound to an epitope expressed on A.
centrale organisms (Palmer et al., 1988b). Therefore, the rationale for determining
if the MSP1a complex could induce a protective immune response was based on
the observation that MSP1a had a neutralization sensitive epitope conserved among
all strains tested.
The native MSP1 complex was isolated from purified initial bodies of the Florida
strain and disrupted with detergent (Palmer et al., 1989, 1986a). Isolation was done
with affinity columns containing either monoclonal antibody 22B1 or 15D2. In two
different trials (Palmer et al., 1989, 1986a), immunization of calves with MSP1
complex induced a significant protective immune response to challenge with the
homologous strain of A. marginale when compared to calves immunized with a
control antigen. Calf groups were immunized with either 50 or 100 µg of isolated
MSP1 complex per injection mixed with Freund’s complete adjuvant for the first
injection and incomplete adjuvant for three subsequent injections. In each trial using
five calves per group, two calves did not have microscopically detectable rickettsae-
mia or anaemia while the remaining calves had significantly lower rickettsaemias
than two control groups immunized in the same way with ovalbumin and adjuvants
(Palmer et al., 1989, 1986a).
Immunization of calves with native MSP1 complex isolated from the Florida
isolate of A. marginale also induced a protective immune response to challenge with
heterologous Washington-O strain (Palmer et al., 1989). In this case, none of five
MSP1 complex immunized calves had detectable rickettsaemia or anaemia following
Washington-O strain challenge while all five calves immunized with ovalbumin
developed rickettsaemia. Rickettsaemias in the ovalbumin immunized and challenged
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calves ranged from 3.6 to 5.5%. Packed cell volumes in these calves ranged from 25
to 28% compared to a range of 33 to 36% in the MSP1 complex immunized and
challenged calves. The complete protection observed in the MSP1 complex immu-
nized calves, evidenced by a lack of microscopically detectable rickettsaemia and
anaemia following heterologous strain challenge, demonstrates that cross-protec-
tion against strains can be induced with isolated MSP1 complex (Palmer et al., 1989).
MSP2, another surface protein of A. marginale, also induced a protective im-
mune response in calves against both homologous and heterologous strain chal-
lenge (Palmer et al., 1988b). The rationale for testing MSP2 was based on the
presence of conserved epitopes among all strains tested from the United States,
Kenya and Israel (McGuire et al., 1984; Palmer et al., 1988b) and on the positive
results obtained with MSP1 complex. MSP2, originally described as a 36-kDa
surface protein on initial bodies of the Florida strain (Palmer and McGuire, 1984),
was isolated by affinity chromatography with monoclonal antibody ANAO 58A2
(Palmer et al., 1988b). Surface exposed peptides of MSP2 from United States
strains were conserved and the apparent molecular weights varied from 33 to 36
kDa. Groups of calves were immunized with either isolated MSP2 or ovalbumin
using procedures similar to those described above for the MSP1 complex. Follow-
ing immunization, calves were challenged with either Florida or Washington-O
strains of A.  marginale. Two of  five MSP2-immunized  calves  did  not have a
detectable rickettsaemia following homologous challenge, two had a significantly
delayed rickettsaemia, and one was not protected. Among five calves immunized
with MSP2 and given a heterologous challenge, two did not have detectable
rickettsaemia and the remaining three had very low rickettsaemias compared to the
control group (Palmer et al., 1988b).
A third surface protein, MSP3, is target for a subunit diagnostic test (McGuire et
al., 1991; Palmer et al., 1986b) and was tested for its ability to induce a protective
immune response against homologous challenge (T.C. McGuire, D. Knowles and
G.H. Palmer, unpublished data). Initial designation of MSP3 as AmF86 (Palmer et
al., 1986b; Palmer and McGuire, 1984) was based on its apparent molecular weight
of 86 kDa. MSP3 was isolated from the Florida strain by affinity chromatography
using monoclonal antibody AMG 75C2 (McGuire et al., 1991) and used to immunize
calves. Five calves  immunized  with  four injections  of  MSP3  in  saponin had a
significantly lower rickettsaemia when challenged than five calves given injections
of saponin alone.
In conclusion, native MSP1a complex and MSP2 induce a protective immune
response in calves against both homologous and heterologous challenge with A.
marginale. These antigens are clearly candidates for subunit vaccine development.
PROTECTIVE IMMUNITY WITH MEMBRANE FRACTIONS
In addition to experiments on isolated surface proteins, tests of the hypothesis that
an outer membrane fraction of A. marginale will induce protective immunity were
done (Tebele et al., 1991). Membrane fractions of isolated and sonicated initial bodies
from the Norton Zimbabwe strain (Tebele and Palmer, 1991) were separated by
sucrose density gradient centrifugation. A fraction banding at 1.22 g/cm3 shared
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epitopes with surface proteins of the Florida strain and contained outer membranes
of A. marginale (Tebele et al., 1991). Another membrane fraction that was distinct
immunologically and by electron microscopy, banded at 1.15 g/cm3. Immunization
of cattle with either band suspended in saponin induced a protective immune response
against homologous challenge with the Norton Zimbabwe isolate. When compared
to control groups either not injected or injected with saponin alone, immunized
groups had significantly less anaemia and significantly lower rickettsaemias. Four of
five cattle immunized with the outer membrane fraction did not have microscopically
detectable rickettsaemias, and protection in cattle immunized with both membrane
preparations correlated with, and could be predicted with, antibody titre (Tebele et
al., 1991).
Identification of membrane proteins inducing a protective immune response may
facilitate development of subunit vaccines either by being a component in a multiple
subunit vaccine or being an effective single subunit vaccine.
RECOMBINANT AND SYNTHETIC REPLICAS OF PROTEIN SUBUNITS
Isolation of surface or other proteins from initial bodies derived from A. marginale-
infected cattle blood is not a viable option for vaccine production. Therefore, we are
now testing the hypothesis that recombinant and synthetic replicas of either the MSP1
complex or MSP2 will induce a protective immune response similar to that obtained
with isolated native proteins. Genes from the Florida strain encoding the complete
MSP1a and MSP1b proteins were cloned and sequenced (Allred et al., 1990; Barbet
et al., 1983). Expression plasmids containing these genes were used to transform
Escherichia coli and the individual expressed proteins were isolated by monoclonal
antibody affinity chromatography (T.C. McGuire, G.H. Palmer and A.F. Barbet,
unpublished data). Isolated recombinant proteins were mixed with saponin and used
to immunize groups of calves. Even though calves developed high serum antibody
titres to the respective native proteins, neither group had significant protection against
challenge with the Florida strain when compared to a control group given saponin
alone.
CURRENT RESEARCH
Several experiments are in progress and include those to evaluate complexes of
recombinant MSP1a and  MSP1b  in  order to more  closely  mimic  native MSP1
complex, to make and test recombinant MSP2, and to further test synthetic peptides
including the 29 amino acid tandem repeat of MSP1a.
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INTRODUCTION AND STRATEGY
The ability to induce immunity in cattle against experimental and field challenge with
virulent Babesia bigemina is well established (Callow, 1977; Dalgliesh et al., 1981).
The most effective method of vaccination has been the inoculation of susceptible
animals with live blood stage parasites that have been attenuated by passage in
splenectomized calves (Callow, 1977; Dalgliesh et al., 1981). Strong co-infectious
immunity (premunition) induced in this way protects against both homologous and
heterologous challenge (Callow, 1977; Dalgliesh et al., 1981; de Vos et al., 1982),
although extensive testing of heterologous strain immunity under controlled condi-
tions has not been performed. Equivalent induction of protective immunity has not
been achieved with a crude killed antigen preparation (Callow, 1977; Kuttler and
Johnson, 1980; Lohr, 1978; Young, 1988). Nevertheless, the ability of live blood stage
parasites to induce homologous and heterologous protective immunity is an important
observation, indicating that (i) antigens capable of inducing protection are expressed
by blood stage parasites, (ii) cattle can respond to these antigens, (iii) conserved
epitopes are present among geographically and antigenically distinct strains, and (iv)
antigens expressed by blood stage parasites are capable of inducing protection against
challenge with tick stages.
Despite the availability of an effective live vaccine, premunition has not been a
widely adopted practice in areas where B. bigemina is prevalent. Drawbacks of this
procedure include reversion to virulence, contamination of the vaccine with other
blood-borne parasites, cumbersome production  and  quality  control  procedures
involving live animals, necessity of maintaining a cold chain, and unavoidable
contamination of the vaccine with bovine erythrocyte antigens (Callow, 1977). The
history of vaccination against bovine babesiosis, current control procedures and
epidemiology have been reviewed (Barbet 1989; Callow, 1977; Irvin, 1987; Taylor,
1989; Montenegro-James et al., 1989; Goodger, 1989; Young, 1988; Wright and
Goodger, 1988; Ristic and Montenegro-James, 1988; Young et al., 1988; Zwart and
Brocklesby, 1979). The mechanism of immune protection in premunition is un-
known. Passive transfer of immune serum confers significant protection against
homologous challenge (Dwivedi and Gautam, 1980; Mahoney, 1967; Mahoney et
al., 1979). Non-B cell mediated mechanisms of immunity to babesial parasites have
largely been unexplored. CD4 bearing T cells are important in generating T-cell
help and amplification of the immune response and may, in conjunction with
macrophages, elaborate soluble mediators such as gamma-interferon and tumour
necrosis factor that have a direct effect on parasites. A role for cytotoxic T cells
seems unlikely since the bovine erythrocyte does not appear to bear MHC class I
molecules. Gamma-delta T cells may however be important in parasite elimination.
The general approach towards developing an improved method of immunopro-
phylaxis against B. bigemina has been to define the antigens responsible for the
induction of protective immunity by blood stages. Based on accessibility to anti-
body and some subsets of T cells, antigens located on the surface of the merozoite
and  infected erythrocyte  are  likely targets of the protective  response. Soluble
parasite-derived mediators that have been described in B. bovis infection (Young,
1988) have not yet been characterized in B. bigemina-infected animals. However,
since the destruction of erythrocytes in B. bigemina-induced clinical disease
invariably exceeds the number of parasitized cells, and the osmotic fragility of
uninfected cells from B. bigemina-infected animals is increased (Wright, 1973), it
seems plausible that parasite derived or induced factors play a significant role in
the pathophysiology of B. bigemina infection. These soluble antigens may also be
targets of the protective response. Lastly, the unique apical organelles that define
members of the Apicomplexa, including rhoptries and micronemes, by virtue of
their putative role in invasion, may be a blockable step in the parasite’s life cycle.
Initial studies have focused on merozoite surface antigens. The strategy for
characterizing merozoite antigens with surface exposed epitopes was to identify
monoclonal antibodies (MAb) that bound to the surface of intact, viable and
infectious merozoites. These antibodies could then be used to identify, characterize
and isolate merozoite polypeptides bearing surface exposed epitopes. The efficacy
of individual antigens as protective immunogens could then be tested directly in an
immunization trial, and the genes encoding surface proteins with neutralization-
sensitive epitopes cloned and expressed. Recombinant genes expressing neutrali-
zation-sensitive  epitopes  would  then  be  tested in  different vaccine constructs,
including vector-expressed antigens (such as vaccinia or related pox viruses,
Salmonella, and others) with storage and administration properties amenable to use
in tropical and subtropical areas of the world.
RESULTS
All studies have been performed with both uncloned and biologically cloned
Mexican strains of B. bigemina. Infectious merozoites with intact cell membranes
have  been gradient separated in Percoll (McElwain et al., 1987). Monoclonal
antibodies (MAbs) that bound to the surface of these viable merozoites immuno-
precipitate one of five apparently different 35S-methionine-radiolabelled parasite
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polypeptides or polypeptide complexes, with the major protein immunoprecipitated
by different MAbs migrating in SDS-PAGE with apparent molecular weights of 72,
58, 55, 45, and 36 kDa. A MAb against the 58-kDa antigen also reacts with
acetone-fixed infected cells in a patchy punctate pattern similar to MAbs against
malarial rhoptry antigens in indirect immunofluorescent antibody assay (Clark et
al., 1987; Howard et al., 1984; Perrin et al., 1985; Peterson et al., 1989; Roger et
al., 1988; Schofield et al., 1986). Surface reactive MAbs identified by other
investigators react with antigen complexes ranging in molecular weight from 68 to
36 kDa (Figueroa et al., 1990), including the same 58-kDa antigen complex
described above (unpublished data). Several of these MAbs are inhibitory to
merozoite growth in vitro (Figueroa and Buening, 1991). Two additional MAbs
have been identified that bind to the infected erythrocyte in acetone-fixed but not
unfixed IFA assays. These MAbs immunoprecipitated an 35S-methionine-labelled
polypeptide of >200 kDa (McElwain et al., 1989). All of these polypeptides appear
to be recognized by antibodies in sera of cattle that are immune to challenge with
B. bigemina (Figueroa et al., 1990; McElwain et al., 1987).
In vitro radiolabelling and immunoprecipitation studies indicate that post-transla-
tional modification of B. bigemina surface proteins is common (McElwain et al.,
1991). At least 10 parasite proteins are post-translationally modified by incorporation
of glucosamine, while seven are myristilated. Five of the myristilated and glycosy-
lated polypeptides can be immunoprecipitated by surface reactive MAbs. The 58-kDa
antigen complex is not modified by the incorporation of glucosamine or myristic acid.
It is interesting that most of the glycosylated and myristilated polypeptides of B.
bigemina are known to be surface proteins. This does not appear to be the case with
B. bovis, in which only one known surface polypeptide will incorporate glucosamine
or myristic acid (Hines et al., 1989).
Initial studies of cross-reactivity of MAbs with geographically different strains
of B. bigemina in immunofluorescence assays indicated that MAb epitopes on
gp55, gp45, and gp36 were variant. More extensive immunoblot studies using
monospecific rabbit and bovine antisera prepared against purified antigens con-
firmed that epitopes on gp45, gp55, and gp36 were not well conserved among
geographic isolates. When cross-reactivity was present, most isolates expressed
polypeptides of approximately the same molecular weight. The exception was that
MAb against a Mexican isolate gp45 and gp55 polypeptides identified high mo-
lecular weight polypeptides in a Kenya isolate of B. bigemina. In contrast to these
results, the p58 surface polypeptide/rhoptry antigen was conserved in all isolates
tested, and always migrated with the same or nearly the same molecular weight in
polyacrylamide gels. Additional MAbs identified by other investigators have been
widely cross-reactive. All these results have been previously published or are in
press (Figueroa et al., 1990; Hines et al., 1989; McElwain et al., 1987, 1988, 1991),
and are summarized in Table 1.
To test the efficacy of these merozoite surface proteins as immunogens, groups of
five cattle were immunized with immunoaffinity chromatography purified 58, 55, 45
or 36 kDa antigens, or a control protein (ovalbumin) in Freund’s adjuvant. The purity
and specificity of the antigen preparations were confirmed by silver-stained SDS-
PAGE and Western immunoblots, respectively. All cattle were challenged with 3 ×
109 uncloned, Mexican strain-infected erythrocytes from a splenectomized donor
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calf. Animals immunized with p58, gp55 and gp45 were able to neutralize the
infectivity of merozoites as judged by a statistically significant reduction in the peak
parasitaemia as compared to controls. The severity of clinical disease in these groups
was also reduced, as 4/5 controls but 0/5 gp45 immunized cattle and 1/5 p58 and gp55
immunized cattle had haemoglobinemia and haemoglobinuria. Percentage reductions
in PCV and rises in rectal temperature were reduced in the gp45, gp55 and p58
immunized groups in comparison to controls, but these changes were not statistically
significant on a group basis due to an outlier effect. These results are summarized in
Table 2 (McElwain et al., 1991).
The gene encoding the merozoite surface and putative rhoptry protein, p58, has been
cloned, expressed, sequenced and characterized. Recombinant protein expressed by
the cDNA copy induces antibodies in rabbits that immunoprecipitate native p58, and
bind to the surface of live merozoites from all strains tested. A minimum of four gene
copies are detected in Southern blots of genomic DNA from a cloned Mexican strain
of B. bigemina. Four different copies of the gene encoding p58 have been cloned from
polymerase chain reaction (PCR)-amplified DNA using primers flanking the long open
reading frame. All four copies have been completely sequenced and compared. There
are substantial blocks of sequence divergence located in both the 5’ and 3’ halves of
the protein. In comparison to the gene copy encoding the cDNA expressed polypeptide,
one of the four genes contains a divergent 3’ region, one has a divergent 5’ region, and
one has both a 3’ and a 5’ divergent regions that are present in the other two divergent
gene copies. Using gene specific probes on PCR-amplified DNA reverse transcribed
from mRNA, it can be shown that three of the four gene copies are simultaneously
expressed in the cloned strain. Further characterization of the p58 gene copies and the
significance of the sequence divergence to function are being investigated. A partial
copy of the gene encoding gp55 has also been cloned and expressed, but has not been
further characterized (Mishra et al., 1991).
TABLE 1. Babesia bigemina surface-exposed epitopes.*
Polypeptide
(kDa) Epitope location Isolate conservation Comments
36 merozoite surface Mexico, Texcoco, glycosylated/
St. Croix myristylated
45 merozoite surface Mexico, Kenya glycosylated/
myristylated
55 merozoite surface Mexico, Texcoco, glycosylated/
Kenya only myristylated
58 merozoite surface All tested to date putative rhoptry
72 merozoite surface N/A
200 parasitized rbc N/A
*Isolates tested to date include the American isolates (Mexico, Texcoco, Puerto Rico, St.
Croix), Israel isolate and an African isolate (Kenya). Correlation with monoclonal antibodies
binding to Costa Rica, Texas and Tecocutla isolates is pending.
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CONCLUSIONS
While our results indicate that an immune response directed against individual
surface exposed merozoite antigens can neutralize their infectivity, it is clear that
isolated native merozoite surface proteins do not induce sufficient protection
against clinical babesiosis. In our trial, only a small portion of the antibody
response was against the surface of the merozoite (Table 2). Directing the response
towards specific surface exposed epitopes may enhance the efficacy of these
antigens. However, induction of immunity against clinical babesiosis may require
a combination of antigens that target the response towards all surfaces or molecules
TABLE 2. Immunization of cattle with purified Babesia bigemina merozoite surface
proteins
Surface Peak % Group Peak
Immunogen Animal ELISA titre IFA titre parasitemia % parasitemia*
B258 — — 2.5
B257 — — 1.7
Ovalbumin B263 — — 2.4 1.8 +/–0.7
B262 — — 0.8
B235 — — 1.4
B264 5×104 102 0.6
B260 104 102 0.6
gp45 B265 104 102 0.9 0.7 +/–0.1†
B256 104 102 0.7
B261 5×104 102 0.6
B279 104 102 0.3
B277 104 102 0.9
p58 B274 104 102 1.2 0.8 +/–0.4†
B273 5×104 102 0.9
B272 5×104 102 0.5
B271 104 101 0.6
B275 103 101 0.6
gp55 B276 104 102 0.5 0.8 +/–0.6†
B278 104 102 0.6
B238 104 102 1.9
B266 104 101 1.8
B267 104 101 1.7
gp36 B268 103 101 2.0 1.4 +/–0.6
B269 104 101 0.4
B270 104 101 1.2
*
mean +/–standard deviation†
significantly different from ovalbumin controls, p < 0.05
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for which a protective response may be effective or a pathophysiologic effect
neutralized. In addition, the method of antigen presentation may be important, and
antigenic diversity or variation may limit the usefulness of some otherwise effective
antigens. Thus, we are directing our research towards (i) testing of the conserved
merozoite surface protein p58 and the high molecular weight erythrocyte mem-
brane protein as immunogens alone and in combination, (ii) defining the polypep-
tides present on the infected erythrocyte surface and in the apical complex
organelles, and (iii) testing the efficacy of expression vectors for presentation of
antigens.
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INTRODUCTION
The tick-transmitted haemoprotozoan parasite Babesia bovis is the causative agent
of the most severe form of bovine babesiosis (tick fever) and is responsible for major
economic losses in the tropical and sub-tropical cattle industries of Africa, Latin
America, Australia and South East Asia. After infection with B. bovis, recovered
animals remain sub-clinically infected and immune for life. In Babesia-endemic areas
calves receive maternal antibody from immune mothers which confers protection
against B. bovis challenge in early life (Hall, 1960, 1963). Babesia bovis mortality in
young, immunologically naive animals is far lower than in adult cattle. Greatest
mortality occurs in areas where tick-transmission of B. bovis is highly unstable; those
areas bordering endemic regions or in instances where animals are moved from
tick-free to tick-infested areas.
Current strategies for the control of B. bovis include the extensive use of
acaricides to control ticks and the use of a live attenuated vaccine developed and
produced commercially in Australia (Callow et al., 1979). Vaccination against B.
bovis using a culture-derived antigen preparation (Smith et al., 1981; Montenegro-
James et al., 1989) has been extensively tested in Venezuela, although the efficacy
of this vaccine, particularly with regard to cross-strain protection, is questionable
(Timms et al., 1983). Although preimmunization using the live attenuated vaccine
confers a high degree of protection, a number of disadvantages are inherent with
its production and use. The vaccine is produced in splenectomized calves and
contamination with other pathogens may occur (Wright and Riddles, 1989). A
proportion (approximately 5%) of vaccinated animals react severely to infection
with the attenuated parasite and require drug treatment to prevent mortality. All
animals show a significant haematocrit fall (mean value approximately 30%) upon
vaccination and retain the potential to transmit the parasite (which may revert to
virulence) to other animals. Some problems with strain variation in the field and
subsequent breakthrough of infection have been observed (A.J. de Vos, personal
communication).
The involvement of the CSIRO in research on babesiosis dates back to the work
of Mahoney in 1962 which demonstrated that immunization using killed whole
parasite antigen induced a high level of protective immunity (Mahoney, 1967;
Mahoney and Wright, 1976) and that serum from immune animals conferred protec-
tion against B. bovis infection when transferred into susceptible, infected animals
(Mahoney et al., 1979). The humoral immune response plays an important part in
immunity to B. bovis and vaccination with exogenous antigen is a feasible approach
to vaccine production. More recent work has implicated immune effector cells in
addition to antibody as an important mechanism of immunity to B. bovis (James,
1988; Jacobson et al., 1991).
FRACTIONATION AND TESTING OF BABESIA BOVIS
ANTIGENS IN VACCINATION TRIALS
The approach taken by our group has been to systematically fractionate the material
obtained by disruption of B. bovis-infected erythrocytes using a variety of techniques
including centrifugation, precipitation, electrophoresis and various types of chroma-
tography. At every stage of purification, each fraction was tested in a vaccina-
tion/challenge experiment to assay for the potential to induce protective immunity.
Protective antigen fractions were used to raise monoclonal antibodies (MAbs), which
were then tested for reactivity with babesial antigen by Western blotting and indirect
immunofluorescence test (IFAT) against B. bovis-infected erythrocytes. Monoclonal
antibodies were then used to select babesial antigens which were purified by affinity
chromatography and the purified antigens tested in vaccination experiments. Single
antigens which induced protective immunity were then produced using recombinant
DNA technology.
THE W11C5 ANTIGEN
Of eight B. bovis antigens that were purified from the `β‘ protective fraction (Goodger
et al., 1985) by MAb affinity chromatography, one was found to induce protective
immunity in vaccinated animals challenged with virulent B. bovis parasites of strains
both homologous and heterologous to the strain used for antigen purification. This
antigen was designated W11C5 after the nomenclature of the MAb reactive with it.
The W11C5 MAb reacted predominantly with  the B. bovis-infected erythrocyte
membrane in IFAT and produced a stepladder of bands on Western transfers of `β‘
antigen from approximately 70 to > 200 kDa. The W11C5 MAb was used to screen a
cDNA expression library constructed in the vector λgt11 (Huynh et al., 1985). Of ten
positive clones examined, one was found to express a large beta-galactosidase fusion
protein of approximately 280 kDa (β-gal = 120 kDa). The W11C5 fusion protein was
reactive with the W11C5 MAb on Western transfers and produced a stepladder of
discrete break-down products similar to that evident on Western transfers of `β‘ antigen
probed using the MAb. The W11C5 fusion protein, which comprised 1–2% of total
soluble Escherichia coli protein, was tested in vaccination experiments as SDS-PAGE
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gel-band purified material and as unpurified soluble E. coli lysate at a dose of 10 µg
per animal per vaccination in a standard two-shot, four-week interval vaccination
regime using Freund’s complete adjuvant (FCA). Sera from the vaccinated cattle were
shown to react in IFAT with the B. bovis-infected erythrocyte membrane and produced
a stepladder of bands on Western transfers of β fraction antigen and W11C5 fusion
protein characteristic of W11C5 MAb reactivity. Upon challenge with heterologous
strain B. bovis-infected erythrocytes, animals vaccinated with the W11C5 fusion
protein, either SDS-PAGE purified or as crude E. coli lysate, developed significantly
lower parasitaemias (mean maximum 74 ± 27/µl and 479 ± 424/µl respectively) and
exhibited increased survival rates (5/6 and 6/6 respectively) relative to two groups of
control animals vaccinated with the corresponding beta-galactosidase only materials
(mean maximum 3609 ± 2509/µl, 1/6 survival and 6725 ± 3327/µl, 0/6 survival,
respectively). Expression and purification of the W11C5 recombinant antigen was
enhanced by cloning into the plasmid vector pGEX-1 (Smith and Johnson, 1988). This
yielded an expression greater than 30% of total E. coli protein of a soluble W11C5-
glutathione S-transferase (GST) fusion protein which was purified in a single step by
affinity chromatography using glutathione-agarose. The purified W11C5-GST fusion
protein was found to induce levels of immunity to B. bovis similar to that obtained
using the beta-galactosidase fusion protein without the pyrogenic effect of contami-
nating E. coli lipopolysaccharide (LPS). In addition, the W11C5 antigen was found to
be as effective when used with the commercially acceptable adjuvants Quillaja saponin
of Quil A as with FCA.
ORGANIZATION AND STRUCTURE OF THE W11C5 GENE
Analysis of the expression and organization of the W11C5 gene using the W11C5
cDNA as a hybridization probe demonstrated that the full length transcript of the
W11C5 gene is approximately 10.0 kb (hence encoding a complete protein of
approximately 350 kDa) and that the W11C5 gene is present as a single copy in all
strains examined including several Australian and one African isolate. The W11C5
gene homologues have not been detected in B. bigemina or B. canis or in Theileria
species, although  immunological cross-reactivity  of  the  W11C5 MAb has  been
reported with B. ovis and B. divergens (I.G. Wright, personal communication).
DNA sequence analysis has shown that the W11C5 cDNA (3.1 kb) is composed of
two distinct regions—a 5’ repetitive region consisting of 19 copies of a 90 base pair (bp)
sequence and a 3’ unique sequence region. The repetitive and unique regions were
separately subcloned and expressed as GST fusion proteins for testing in vaccination
experiments. The purified W11C5 repetitive region fusion protein was found to induce
no protection to B. bovis challenge whereas the W11C5 unique region fusion protein was
protective. The failure of the repetitive region to induce protection provides evidence to
support the hypothesis that the highly immunogenic repetitive antigens commonly found
in parasites exposed to the host immune system (Kemp et al., 1987) have evolved to act
as immunological smoke-screens (Anders, 1986) or are immunosuppressive (Liew et al.,
1990). The repetitive region of the W11C5 antigen may represent a built-in smoke-screen
or immunosuppressive domain which functions to decrease the immune response of the
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host to the unique region of the antigen which may be a functionally important protein
domain. The observation that immunodominant antigens do not generally induce a
protective immune response has been confirmed by our group with regard to a purified
B. bovis antigen (Goodger et al., 1986) and in fact these antigens may abolish the
protective potential of other antigens used concurrently in a mixture of immunogens (I.G.
Wright and K.R. Gale, unpublished results).
THE 12D3 ANTIGEN
The MAb 12D3 is a more stable IgG1 subclass antibody producing clone reactive with
the 15B1 protective antigen (Wright et al., 1983), originally isolated from a protamine
sulphate precipitated antigen fraction. The 12D3 MAb was shown to react by IFAT
with the B. bovis parasite and the infected erythrocyte cytoplasm and on Western
transfers of B. bovis antigen with a 38-kDa soluble antigen. A cDNA clone containing
the entire coding sequence of the 12D3 antigen was isolated from a λgt10 cDNA library
(Huynh et al., 1985) using a DNA probe designed using the N-terminal amino acid
sequence of the purified 12D3 protein. Recombinant 12D3 was expressed in E. coli
as highly insoluble inclusion bodies which required the addition of SDS and 2-mer-
captoethanol to achieve solublization. Vaccination of cattle using renatured 12D3
recombinant antigen resulted in a significant reduction in parasitaemia upon B. bovis
challenge relative to control animals, although the level of protection was not as high
as was obtained using the native B. bovis expressed protein (Riddles et al., 1990). DNA
sequence analysis of the 12D3 gene revealed a very high cysteine residue content
(approximately 10%), a signal peptide, indicating that the protein is transferred across
a membrane, and the potential to form epidermal growth factor-like domains (Riddles
et al., 1991). No repetitive sequences have been identified within the 12D3 gene. Due
to the high cysteine content it is probable that the conformation of the 12D3 protein
as produced in E. coli and after denaturation and renaturation in vitro is not repre-
sentative of the native 12D3 protein. Further work to enhance the protective potential
of this antigen by expression in a eukaryote system (baculovirus) is currently under
way. DNA hybridization studies have revealed that the 12D3 gene is conserved across
a range of different species of Babesia. Homologues of the gene have been detected
in B. bigemina, B. canis, B. bovis and B. divergens. The 12D3 homologue from B.
bigemina has now been cloned and sequenced and is approximately 60% similar to
the B. bovis gene at the amino acid sequence level (P.W. Riddles, in preparation).
VACCINATION TRIALS USING RECOMBINANT ANTIGEN COCKTAILS
To investigate the effect of combining recombinant protective antigens, the W11C5
and 12D3 antigens were used in combination in a vaccination trial. Together, the
antigens induced a 99% suppression of parasitaemia in the vaccinates relative to the
control animals. Both parasite suppression and the suppression of fall in haematocrit
value were superior to the results obtained using the antigens singly. When this
antigen combination was  tested under field trial conditions, 10% of vaccinated
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animals required treatment compared to 40% of the control animals. Mean maximum
parasitaemias were 232 ± 345/µl in the vaccinates and 2154 ± 3065/µl in the controls.
Mean maximum haematocrit falls were 30.11 ± 14.74% and 45.50 ± 10.61% for the
vaccinates and controls respectively.
Although the W11C5/12D3 antigen cocktail induced 90% protection under field
trial conditions, it was decided to add a third recombinant antigen to the cocktail in an
attempt to further improve vaccine efficacy. The antigen selected, designated T21B4,
was recently cloned using the MAb of the same designation (R.E. Casu, unpublished
results) which was raised against the `protease’ protective antigen fraction (Commins
et al., 1985) and shown to induce protection in a preliminary vaccination trial. The
W11C5/12D3/T21B4 antigen cocktail was tested in a field trial in direct comparison
with the Queensland Department of Primary Industries (QDPI) live attenuated vaccine.
Under conditions of heavy tick infestation and coincidental B. bigemina challenge, the
trivalent antigen vaccinates (n = 18) underwent a mean maximum fall in haematocrit
value of 16.02 ± 3.30%, a mean maximum parasitaemia of 824 ± 34.8/µl and a 0/18
treatment rate compared with the naive controls (n = 19) which showed a mean
haematocrit fall of 35.95 ± 2.95%, a mean maximum detected parasitaemia of 6962 ±
152.5/µl and a treatment rate of 13/19. Upon vaccination, the QDPI group (n = 40)
showed a mean  maximum fall in haematocrit value of 25.82 ± 3.13%, a mean
maximum detected parasitaemia of 1206 ± 3939.58/µl and 2/40 animals required drug
treatment. Upon challenge with B. bovis, the QDPI vaccinates showed a mean maxi-
mum fall in haematocrit value of 19.91 ± 1.72%, a mean maximum detected parasi-
taemia of 141 ± 27.0 and a treatment rate of 1/38. Further vaccination trials are
currently under way to test the efficacy of the trivalent vaccine under a range of field
challenge conditions. The feasibility of developing vaccines against other species of
Babesia using the existing protective antigens or their homologue clones from different
species is currently being investigated. The natural diversity observed in protozoan
parasite species (Kemp and Cowman, 1990) and the ability of most species to rapidly
generate genetic diversity by either somatic mutation/recombination or recombination
during sexual reproduction (Walliker, 1989) poses a serious threat to the success of
any vaccination strategy. This problem is likely to be enhanced if a recombinant
vaccine containing a single antigen is used. For this reason it is proposed to pursue the
development of a vaccine based on several distinct protective antigens, each of which
induces significant protection in the vaccinated host. The analysis of strain variation
by analysis of restriction fragment length polymorphisms (RFLP) in all Australian
strains used during the work of this group has been reported (Dalrymple et al., 1992).
Investigation of future changes in Australian B. bovis population composition in
response to vaccine use is considered by our group to be essential to ensure long-term
success of a recombinant vaccine. The polymerase chain reaction (PCR) (Saiki et al.,
1988) will provide a powerful tool with which to determine directly the extent of
sequence polymorphism in the vaccine antigen genes of field isolates, thus enabling
appropriate changes in vaccine composition to be made if necessary.
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SUMMARY
We have found that B. bovis immunodominant antigens, which are preferentially
cloned when expression libraries are screened using immune sera from previously
infected animals, do not induce a protective immune response in the host. The
approach we have used of systematic fractionation of parasite antigen, testing of each
fraction in vaccination trials and progressive purification to yield single components
with the ability to induce protective immunity in cattle, although painstaking, has
proven successful. To achieve protection comparable with that obtained using a live
B. bovis vaccine or killed antigen preparations, several distinct recombinant antigens
are probably required. A recombinant vaccine against B. bovis should provide a safer,
more commercially acceptable alternative to the live attenuated vaccine currently
used in, and exported from, Australia.
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INTRODUCTION
Babesia divergens, a tick-transmitted haemoprotozoa, is the main agent of bovine
babesiosis in Europe (Kuttler, 1988) and is responsible for important economic losses
in cattle. Unlike other Babesia species, B. divergens infects not only cattle but other
mammalian species such as man (Gorenflot and Brasseur, 1991) and gerbils. In
Europe, several human infections have been recorded especially in splenectomized
patients, and a high mortality rate has been reported. In attempts to protect cattle from
clinical disease, different vaccination strategies have been investigated using live
vaccines (Dalgliesh et al., 1990; Wright et al., 1982) or inactivated vaccines (Goodger
et al,. 1984; Montenegro-James et al., 1987; Moreau et al., 1988; Ristic and Monte-
negro-James, 1988; Winger et al., 1987). Live vaccines, attenuated parasites or
irradiated parasites provide good protection but have several restricting features: a
short shelf life, a possible reversion to virulence, the risk of transmission of other
pathogenic agents and the maintenance of healthy carriers. Identification and charac-
terization of protective antigens make it possible to avoid some of these shortcomings,
although the development of an industrial vaccine requires a safe, potent and well
characterized product which is easy to produce and standardize. The development of
methods for in vitro propagation of Babesia provides a useful technique to obtain and
characterize antigens involved in protective immunity.
IN VITRO CULTURE
A major breakthrough in babesiosis research was achieved by the development of the
microaerophilus stationary phase (MASP) method for in vitro propagation of B. bovis
(Levy and Ristic, 1980). When applied to B. divergens, this method was reported to
give parasitaemia levels lower than 15 percent. In contrast, our long-term in vitro
culture (Gorenflot et al., 1991) of more than 305 subpassages of B. divergens in human
red blood cells routinely exhibited parasitaemia levels of about 30 to 40 percent. This
high parasitaemia was not a feature of only the original isolate but all European isolates
tested could infect human erythrocytes and produce high parasitaemia with only slight
differences in the growth rates. Furthermore cultures could be initiated from human,
bovine or gerbil erythrocytes without any marked differences and, after a few passages,
the original erythrocytes disappeared and the isolate was stabilized. The optimal
conditions of our culture required a serum concentration lower than those used in
previous studies and after more than two years of continuous in vitro culture, there is
no apparent modification of the virulence when tested in gerbils.
EXPERIMENTAL TRIALS ON GERBILS
In order to evaluate immunogenicity of in vitro culture-derived antigens, we prepared
a vaccine for evaluation in gerbils, a convenient laboratory model for B. divergens
infection (Gorenflot et al., 1990). One hundred gerbils were randomly divided into
five equivalent groups and immunized with different doses of parasitized culture
supernatant equivalent (PCSE) emulsified with 0.2 mg of Quil A. Control groups
received 1.5 ml of unparasitized culture supernatant equivalent (UPCSE) plus Quil
A or saline solution alone. After homologous challenge, the gerbil mortality rate in
control groups varied from 70 to 90 percent. In contrast, all gerbils vaccinated with
two or three injections of 1.5 ml or 0.3 ml of PCSE survived, except one animal
vaccinated twice with 0.3 ml of PCSE. In the group receiving 0.06 ml of PCSE, the
mortality rate was similar to the control groups.
Antibodies in gerbils vaccinated with the full vaccine (1.5 ml of PCSE) or a 1:5
diluted vaccine dose (0.3 ml PCSE) were measured using an immunofluorescence
assay. In gerbils vaccinated with a full vaccine dose, antibodies were observed 14
days after the first injection. A second or third injection of vaccine did not strongly
enhance the antibody titres. Comparatively, only the third injection of the 0.3 ml
PCSE vaccine dose was able to induce antibody titres as high as those obtained with
only one injection of a full vaccine dose. On day 17 after challenge, the antibodies
reached similar levels in all gerbils.
Analysis of the antigenic specificities of the antibody responses was performed
by immunoprecipitation. Babesia divergens antigens radiolabelled with 35S-
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methionine were immunoprecipitated with sera from gerbils vaccinated with one,
two or three injections of 1.5 ml of PCSE before and after challenge. The first
injection of 1.5 ml of PCSE induced a strong humoral response against several B.
divergens antigens. In contrast with results obtained by the immunofluorescence
assay, some differences were observed after the second and third injections: two
bands of molecular weight of about 40 kDa after the second injection and two new
bands after the third injection, one of high molecular weight, the other of low
molecular weight. Virulent challenge did not significantly modify the antibody
pattern obtained with vaccination.
In the second trial, a vaccination protocol was designed to assess the protection
provided by B. divergens in vitro culture supernatant against heterologous challenge
with different geographical isolates (Precigout et al., 1991). Gerbils were vaccinated
twice with 1.5 ml of PCSE mixed with 0.2 mg of Quil A on days 0 and 21. Controls
received 1.5 ml of UPCSE plus Quil A. Three weeks after the last injection, vaccinated
animals and controls were divided into four groups. Each group was challenged with
different isolates: French homologous isolate, French heterologous isolate, German
isolate and UK isolate. On challenge, the gerbils were fully protected against the two
French isolates and partially protected against the UK (80 percent) and the German
isolates (60 percent). The differences observed could be due to the variable virulence
of the isolates. Indeed, the UK and the German isolate were significantly more
virulent (100 percent mortality in control groups) than the French isolates (80 to 90
percent of mortality rate in control groups). In addition the mortality was more rapid
with the UK and German isolates than with the French isolates.
BOVINE IMMUNIZATION
To confirm the validity of the gerbil model for vaccine assessment, we have conducted
a limited trial in cattle. The first step was to define the optimal conditions for this
animal model to be able to induce sufficient disease to discriminate between the
protected and unprotected animals. After several experimental infections, we con-
cluded it was very difficult to induce a severe and reproducible infection in intact
animals, so splenectomized cattle were used.
Four  18-month-old  cattle,  bred  in a tick-free  area,  were  splenectomized  and
divided into two groups of two animals each. The first group received 15 ml of PCSE
emulsified with 1.5 mg of Quil A. The immunogens were injected on days 0, 21 and
42. The second group received 15 ml of UPCSE plus Quil A. Three weeks after the
last injection all the animals were challenged with 3 × 1010 fresh parasitized bovine
erytrocytes intravenously. Protection was assessed on the basis in the level of
parasitaemia and reduction in packed cell volume (PCV).
Parasites were detected in the two controls on day 2 after challenge. In contrast
one of the vaccinated calves had detectable parasites on day 2 and the second on day
4. Parasites were observed in all animals, but a significant difference was seen
between the daily parasitaemia of vaccinates and controls. In one of the controls,
parasitaemia increased very rapidly to reach 30 percent on the seventh day after
challenge. In the other control the parasitaemia reached 2.2 percent. In contrast, the
parasitaemia in the vaccinates did not exceed 0.7 percent. The clearance of the
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parasites was also faster in the vaccinates than in the controls. All cattle had a
reduction in PCV but the maximum percentage reduction was significantly lower in
vaccinates than in controls. Maximum PCV reduction in one control was 71 percent
on day 6 after challenge and 44 percent on day 11 in the other. In the vaccinated calves
the maximum PCV reductions were 19 and 24 percent, respectively. In addition the
return to normal PCV was rapid in vaccinates (day 14 and 20). The PCV did not return
to normal for seven weeks after challenge in the controls.
In an attempt to combine the PCV reduction and the time to return to normal PCV
as a single parameter, we developed a new criterion: the cumulative PCV reduction.
This was calculated using the area delimited by the line of the 0 percent reduction
and the curve of the daily relative PCV until the return to normal value. With this
criterion, the  difference  between controls  and vaccinates  was very marked: the
cumulative PCV reduction in the controls was four times greater than that for the
vaccinates.
The serological response after vaccination was estimated using an IFA test. The
antibody titre was 1/400 after the first vaccine injection and 1/1200 after the second
injection. The third injection did not increase the IFAT antibody and at the time of
challenge the two vaccinate animals had antibody titres of between 1/1200 and
1/1600.
In conclusion, the experiment in cattle confirmed that a crude B. divergens in vitro
culture supernatant could induce good protection in splenectomized cattle. This crude
supernatant appeared to be a good source of material from which to identify and
purify antigens involved in protection. In addition the gerbil seemed to be a good
laboratory model for screening antigens involved in protection.
CHARACTERIZATION OF PROTECTIVE ANTIGENS
In order to facilitate identification and purification of the antigens involved in the
protection, we developed a semi-defined medium which supported the growth of B.
divergens without serum. The multiplication rates and the levels of parasitaemia
obtained with this medium were similar to those observed with the classical medium.
Exoantigens obtained using this new culture method were concentrated and emul-
sified with saponin and conferred complete protection in gerbil to homologous
challenge.
Several defined fractions from this aseric culture supernatant were purified by
chromatography. These fractions were mixed with saponin and administered subcu-
taneously in three doses on days 1, 21 and 42. After challenge with the homologous
isolate, one of these fractions conferred a very strong immunity with no mortality in
vaccinated  animals. The  immunity  induced by this  fraction was similar to that
observed with total supernatant.
A protein bearing an epitope in this defined protective fraction recognized by
monoclonal antibody (MAb) DG7 was identified (E. Precigout, A. Valentin, B. Carcy,
A. Gorenflot, K.I. Nakamura, M. Aikawa and J. Schrevel, unpublished data). The
monoclonal antibody labelled the whole parasite membrane in different stages but,
in merozoites, an intracellular and linear structure was clearly recognized. After
disruption of purified merozoites, the MAb DG7 staining was detected not only on
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the merozoite membrane but also on a released tubular structure, indicating a possible
organelle location. Similar staining was observed with different B. divergens isolates
and with B. canis in acetone fixed smears. As the immunofluorescence localization
of the protein bearing the DG7 epitope seemed to be restricted predominantly to B.
divergens membranes, a Triton X 114 phase separation was performed followed by
an immunoprecipitation by MAb DG7. The protein bearing epitope DG7 was evi-
denced only in the aqueous phase and never in the detergent phase or in the detergent
insoluble pellet. Immunogold labelling of B. divergens-parasitized erythrocytes was
localized along the peripheral cytoplasm just beneath the membrane of the merozoite.
The sub-membrane localization observed with immunogold, and the hydrophilic
character of this protein demonstrated by Triton X 114 phase separation, could
indicate that the protein bearing the MAb DG7 epitope is an extrinsic protein present
on the cytosol side of the membrane. Purified MAb DG7 specifically inhibited the
growth of B. divergens in vitro at very low concentrations. The inhibitory concentra-
tion 50 percent (IC50) was estimated to be 26 µg/ml after 17 hours, 18 µg/ml after
26 and 16 µg/ml after 42.
CONCLUSIONS
The inhibitory effect of the MAb DG7 on the growth of B. divergens in vitro, the
demonstration that the protein bearing the epitope is a major constituent of a
chromatographically defined fraction of B. divergens in vitro culture supernatant
which confer complete homologous protection in gerbils, the distribution of this
antigen in different geographic isolates of B. divergens and other Babesia species
indicate that this protein could be a good vaccine candidate against the asexual blood
stage of B. divergens.
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IN VITRO CULTIVATION
Cultivation of Babesia
M. Pudney
Department of Molecular Sciences
Wellcome Research Laboratories
Langley Court, Beckenham, Kent BR3 3BS, UK
Babesiosis is a tick-borne intra-erythrocytic protozoan parasite which causes a
disease of  domestic and some wild animals characterized by fever, haemolytic
anaemia, haemoglobinuria  and death. From  an economic  point of view, bovine
babesiosis is a serious problem as it is widely distributed and threatens the health and
safety of some 500 million cattle in tropical and semi-tropical regions of the world.
Eighteen of the many species of Babesia cause disease in domestic mammals, man
and laboratory animals, the four economically important bovine species being B.
bovis, B. bigemina, B. divergens and B. major. The tropical species B. bovis and B.
bigemina often occur together and in association with Anaplasma marginale and are
transmitted by the same tick species.
Initially the culture of Babesia spp. was seen as a source of antigens for immu-
nological studies and for improved vaccine. However, the continuous growth of
Plasmodium falciparum in vitro (Trager and Jensen, 1976) has clearly demonstrated
the wide range of experimental uses for such cultures in addition to the primary
interest in vaccines. These include basic biological/biochemical investigations, inva-
sion mechanisms, host and strain specificity, cloning of parasites, virulence factors,
interaction with the immune system and chemotherapy assays.
The feasibility of adapting the method for culturing P. falciparum in vitro (Trager
and Jensen, 1976) to Babesia was first shown by Erp et al. (1978). Short-term in vitro
multiplication of B. bovis was obtained using suspensions of bovine erythrocytes
incubated at 38 °C in medium-199 with 50% bovine serum, and a gas phase of 5%
CO2 in air. The erythrocytes were maintained in suspension by slow stirring (100
rpm) in spinner flasks and the medium was replaced at 24-hour intervals. Parasite
multiplication did not continue beyond three days, but this system was used to
determine the most important parameters for long-term growth. With minor adapta-
tions, continuous growth was eventually obtained (Erp et al., 1980a) and further
shown that parasites cultured for up to 85 days were still able to infect a splenecto-
mized calf. The important culture parameters were identified as the use of freshly
collected erythrocytes at a packed cell volume (PCV) of 20–30%, anticoagulation of
blood by defibrination, complex tissue culture media such as medium-199, NCTC-
135 or RPMI-1640, stringent control of the pH of the medium (pH 7.0) for which 25
mM HEPES buffer was found to be acceptable, a gas phase of 5% CO2 in air, at least
25% adult bovine serum in the medium, avoiding storing for longer than a week at 4
°C, and subculture every one to three days.
A further modification of this method, the microaerophilus stationary phase culture
(MASP), using small volumes in a stationary phase, produced rapid growth and high
parasitaemias (Levy and Ristic, 1980) and has become the method most widely used
for Babesia cultivation. This method, using 60% medium-199 and 40% normal
bovine serum with 15 mM HEPES and 100 mcg/ml streptomycin and 100 units/ml
penicillin, depends on a critical depth of medium and the metabolism of the parasite
to produce the reduced O2 conditions required for optimal growth and re-invasion of
the erythrocytes. Medium is changed daily and subcultures carried out at two- to
three-day intervals. Cultures were initiated using defibrinated donor blood with a
parasitaemia of 0.1–2%, to give a final PCV of 5–10%. The medium was titrated to
pH 7.0 with 1N HCl and seeded into 25 cm2 flasks or microtitre plates at a volume
of 0.62 ml/cm2. The column of medium above the parasitized cells acts as a barrier
to O2 exchange and its depth is crucial to successful cultivation. The settled cells
become dark red to black due to the deoxygenation of the erythrocytes. This method
requires a minimum seeding density, as the parasites modify the culture conditions,
although there does not appear to be a period of adaptation to culture. Incubation was
at 37–38 °C in 5% CO2 in air. Subcultures were carried out after 48–72 hours with
addition of fresh erythrocytes and reduction of the parasitaemia to 0.5–1% at each
passage. Parasitaemias of 38% were obtained in this way. After five months in culture,
babesiosis was induced in a splenectomized calf using parasites maintained in this
way.
The importance of the gas phase was confirmed when it was shown that, by
reducing the O2 level to 2%, a wide range of fluid levels could be used, and cultures
could be initiated with low percentage parasitized erythrocytes (PPE), below 0.1%
(Rodriguez et al., 1983). Using a gas phase of 5% CO2, 2% O2, 93% N2, and by
gradually reducing the PPE to initiate subcultures, Rodriguez et al. (1983) were able
to clone B. bovis by limiting dilution. These culture conditions also allowed the
isolation of parasites from carrier animals in which the parasites were undetectable
on blood smears. Other effects on growth, as measured by PPE or by [3H]-hypoxan-
thine incorporation, due to changes in culture conditions have also been reported,
including serum supplements (Levy et al., 1980) collection, preparation and storage
of erythrocytes (Palmer et al., 1982), pH and buffer of medium (Goff and Yunker,
1988) and the effect on varying initial PPE (Goff and Yunker, 1986). This has led to
the continuous cultivation of several strains of B. bovis as well as other species of
Babesia (Table  1). Microaerophilus stationary phase cultures are asynchronous,
containing both trophozoite and paired merozoites at any one time. Under specific
culture conditions, a threshold number of infected erythrocytes will be obtained, after
which exponential growth ceases. However, at this level individual parasite develop-
ment will continue, eventually resulting in a higher proportion of mature merozoite-
infected erythrocytes (Goff and Yunker, 1986).
Babesia bovis-infected erythrocytes could be stored for up to 30 days at 4 °C (Erp
et al., 1980b) and B. divergens and B. major for up to eight weeks with a once weekly
subculture (Konrad et al., 1985), which would then resume growth when returned to
38 °C. The most efficient method for the cryopreservation of B. bovis was found to
be the freezing of extracellular parasites in a solution of 10% wt/vol polyvinyl
pyrrolidone (PVP –40) in Pucks saline G (PSG) containing 20 g glucose, using a
cooling rate of 20 °C/min (Palmer et al., 1982). Although cultures could be reestab-
lished from thawed, infected erythrocytes, the plating efficiency was relatively low.
A similar method has been used successfully for B. bigemina (Vega et al., 1985b)
except that VegayMartinez (VYM) solution replaced PSG, and a low O2 gas phase
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was necessary for resuscitation. Babesia divergens growing in human erythrocytes
was cryopreserved using a standard P. falciparum method (Pudney, 1984), with 10%
dimethyl sulphoxide (DMSO) in complete growth medium and plunging into liquid
N2; human erythrocytes are less susceptible to haemolysis on thawing than bovine
red cells.
A modification of both the culture system and the cryopreservation technique for
B. bovis permitted continuous growth of large volumes of this species in vitro and
enabled cultures to be established directly from liquid N2 stabilates (J.S. Crowe,
personal communication). The stabilates contained infected erythrocytes frozen in
medium-199 with Earles salts and 40% v/v fresh bovine serum buffered with 22.5
mM HEPES at a haematocrit of 20% with the addition of 2% DMSO. Freezing was
performed at approximately 10 °C/min before storage in liquid N2. Stabilates were
thawed at 37 °C followed by one wash in 15 vols of medium-199 with 40% bovine
serum, and centrifuged at 3,000 g for 10 min. The pellet was resuspended in 7 ml
medium with 10% v/v erythrocytes in a 25 cm2 flask. Flasks were gassed with 4%
O2, 5% CO2, 91% N2 and incubated lying flat on an orbital shaking incubator at 37
°C and 50 rpm. The doubling time of the parasites was approximately 24 hours and
parasitaemias of 25% were routinely obtained. Medium was replaced at 24-hour
intervals, 25 ml of medium was used in 75 cm2 flasks for larger-scale cultures.
TABLE 1. Cultivation of Babesia species.
Host Species Culture Reference
Bovine B. bovis short term Erp et al., 1978; Timms, 1980
continuous Erp et al., 1980a; Levy and Ristic, 1980;
Palmer et al., 1982; Rodriguez et al., 1983
Goff and Yunker, 1986, 1988
bulk Timms and Stewart 1989; Crowe, 1991
tick stages Droleskey et al., 1983; Bhat et al., 1979
B. divergens continuous Vayrynen and Tuomi, 1982; Pudney, 1984;
Donelly et al., 1984; Konrad et al., 1984, 1985;
Gorenflot et al., 1991
bulk Pudney, 1984
B. bigemina short term Timms, 1980
continuous Vega et al., 1985a; Montenegro-James et al., 1987
B. major continuous Donelly et al., 1984; Konrad et al., 1985
Equine B. equi lymphocytes Schein et al., 1981; Moltmann et al., 1982;
Zweygarth et al., 1984; Rehbein et al., 1982
B. caballi tick stages Kurtii et al., 1983
Canine B. canis short term Levy and Ristic, 1980
Murine B. rodhaini short term Jack and Ward, 1980; Barry, 1982a, 1982b
B. microti short term Bautista and Kreier, 1979
Deer B. odocoilei continuous Holman et al., 1988
Pudney, CULTIVATION OF BABESIA
131
Babesia divergens, like B. bovis, is a small Babesia of bovids, which can also cause
fatal disease in splenectomized humans and in intact gerbils. It can also be maintained
in culture (Vayrynen and Tuomi, 1982). The ability to grow B. divergens in a small
laboratory animal, together with in vitro culture of isolates from either cattle
(Vayrynen and Tuomi, 1982; Konrad et al., 1984; Gorenflot et al., 1991), a human
isolate maintained in gerbils, `J’ strain (Pudney, 1984), or directly from human
isolates (Gorenflot et al., 1991), combined with equally good in vitro growth in either
bovine or human erythrocytes (Pudney, 1984; Flory et al., 1990), has proved particu-
larly useful.
A more detailed review on Babesia vaccines is given elsewhere in these proceed-
ings, so I will only briefly outline the type of work which has resulted from the
establishment of continuous Babesia cultures. This can be divided into two areas, the
use of soluble antigens secreted into culture media for vaccination, and the use of
live, attenuated parasites or parasite antigens produced in culture as a source of
parasite antigen for vaccination, or for the production of monoclonal antibodies for
the further examination of specific antigens. Immunization of cattle with cell free
soluble antigens prepared from suspension culture supernates (Erp et al., 1978,
1980a) was shown to provide protection against a homologous tick-borne challenge
exposure with virulent B. bovis organisms (Smith et al., 1979, 1981). Similarly,
soluble antigens from the MASP method (Levy and Ristic, 1980) are effective in
inducing protective immunity to bovine babesiosis (Kuttler et al., 1982). Immuno-
chemical analysis of B. bovis supernates has demonstrated that at least three parasite
exoantigens are released in vitro, and these have been characterized as proteins with
Mr of 30–40 kDa (James, 1984). However, although trials conducted with B. canis
and B. bovis have shown that soluble exoantigens found in culture supernates are
highly immunogenic after homologous challenge (Molinare et al., 1982; Kuttler et
al. 1983); after heterologous challenge these antigens have only conferred partial
protection (Timms et al., 1983). The soluble antigens of cultured B. canis have also
been characterized (Azzar et al., 1990), and a vaccine produced from short-term in
vitro culture by Merieux.
Exoantigens from B. divergens in vitro used in vaccination trials in gerbils dem-
onstrated protection against virulent homologous and heterologous challenge (Goren-
flot et al., 1990). Immunoprecipitated soluble antigens from B. divergens of human
and bovine origin showed similarities in the immunodominant polypeptides produced
using serum  from man, gerbil and ox, the  three potential hosts of this species
(Gorenflot et al., 1991). A monoclonal antibody (MAb 13.4) (Flory et al., 1990)
raised against the Weybridge (bovine) strain of B. divergens has been shown to react
with a 24-kDa antigen present on the surface of B. bovis and B. bigemina merozoites,
as well as on B. divergens merozoites from bovine cultures. This MAb inhibits
invasion in vitro and the affinity purified antigen is partially protective against
subsequent challenge with B. divergens. MAb 13.4 will bind to `J’ and Weybridge
merozoites which have been cultured in bovine erythrocytes, but not after their culture
in human erythrocytes, showing potentially different erythrocyte receptors for inva-
sion. Both strains can cause fatal infections in gerbils and return to bovine culture,
showing transient antigenic alterations (Flory et al., 1990). A high degree of antigenic
cross-reactivity between P. falciparum and B. bovis parasites and the sharing of
common antigenic epitopes has also been observed using monoclonal antibodies
IN VITRO CULTIVATION
132
produced against individual culture-derived parasite polypeptides. Animals vacci-
nated with a merozoite vaccine prepared from spinner flask cultures of B. bovis were
protected from death following challenge (Smith et al., 1979). Both a B. bovis clone,
selected on its rapid growth rate in vitro, and an attenuated strain produced in vitro
by continuous propagation in bovine erythrocytes in cultures in which bovine serum
was gradually replaced by equine serum have been successful in immunizing sple-
nectomized calves (Yunker et al., 1987), yearling heifers and two-year-old steers
(Kuttler et al., 1988), indicating the potential use of these culture-derived parasites
as live immunogens. Using a different approach, the vaccine strain of B. bovis, Ka,
could be maintained in vitro using MASP cultures for 174 days without a change in
virulence. A combination of MASP cultures and a short period of batch culture or
flow through cultures were able to produce titre quantities of heavily parasitized
erythrocytes for vaccine use (Timms and Stewart, 1989).
Current knowledge of the behaviour of Babesia within the tick is incomplete. In
vitro systems offer a means to study some of these host cell-parasite interactions
under controlled conditions. Hoffmann (1972) studied the cyclical multiplication of
B. bigemina in cultures of infected Boophilus annulatus organs. Various stages of the
parasite were seen for 5–12 days, but there was no conclusive evidence that the
parasites multiplied. There was no mention of whether these parasites were capable
of invading organs from uninfected ticks. To investigate the pathological effect caused
by B. cabalii in the vector tick, Anocentor nitens, cell lines were initiated from
transovarially  infected embryos. In culture the parasites were detected by light
microscopy for three to five days but did not transform into other tick-associated
stages, and were not seen after one week. There was no evidence of replication, and
only limited development was seen in both primary cultures and young cell lines
isolated from embryos of various tick species, including the vector (Kurtii et al.,
1983). Ronald and Cruz (1981) obtained similar results when they infected two
Boophilus microplus cell lines with B. bovis kinetes from haemolymph and eggs.
Attempts to infect cultured tick cells with the erythrocytic stages of B. bovis have
also not resulted in the development of tick-associated stages of Babesia (Bhat et al.,
1979), although electron microscopic examination was able to show that when B.
microplus cell cultures were inoculated with high concentrations of erythrocytic
stages of B. bovis, the erythrocytic stage of the parasite apparently developed to a
stage with many of the ultrastructural characteristics of the sexual stages of B.
bigemina and B. canis; indicating that these parasites may have represented the sexual
forms (Droleskey et al., 1983).
The complete vertebrate life cycle of B. equi has been demonstrated in vitro, and
the corresponding stages identified in the horse (Schein et al., 1981). The exoerythro-
cytic stages observed were similar to those found in Theileria species with typical
schizont stages. Equine lymphoblastoid cell lines were also infected and transformed
by B. equi sporozoites as described for T. annulata and T. parva cell lines (Rehbein
et al., 1982). The first schizonts were detected on days 2–5, and, on days 8–10 after
inoculation of the sporozoites, schizonts began to undergo merogony. The merozoites
thus formed were able to infect horse erythrocytes in vitro and in vivo. The lym-
phoblastoid cells were subcultured after 10–14 days, and, on Giemsa staining, the
percentage of infected cells reached 90–95%. The mode of replication of the parasit-
ized lymphoid cells appears to be identical to the process in T. parva and T. annulata
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cell cultures, with the division of the schizonts and their host cells being interdepend-
ent. After a period of five months (20 passages), the cell culture of B. equi contained
only schizonts. Sporozoites did not invade horse erythrocytes in culture. Cultured
schizonts, inoculated into a clean donor, induced piroplasms in the peripheral eryth-
rocytes two days later. The ultrastructure of the exoerythrocytic stages of B. equi also
shows striking similarities to the schizogony stages of the Theileria life cycle
(Moltmann et al., 1983).
The presence of exoerythrocytic schizonts, with possibly different drug sensitivi-
ties, could be  an explanation for the fact that B. equi is difficult to treat with
babesicidal drugs. The B. equi-infected continuous lymphoblastoid cell line BE10
(Rehbein et al., 1982) was used to test the efficacy of halofuginone, parvaquone
(Clexon) and oxytetracycline, all of which have been shown to have a schizonticidal
effect in the treatment of bovine theileriosis, and the babesicidal drug diminazene
aceturate which, although effective against B. caballi, is ineffective against B. equi.
Parasite growth was determined by measuring DNA synthesis in drug-treated and
control cells. Cells were incubated in the presence of drug for 72 hours in microtitre
plates at 37 °C in 5% CO2 in air, and then pulsed for six hours with [3H]-thymidine.
Both halofuginone and parvaquone caused over 80% inhibition of [3H]-thymidine
incorporation at either 0.02 or 5.0 ug/ml respectively, indicating that both compounds
act on the schizont stages. Inhibition of over 60% was observed at a level of 50 ug/ml
oxytetracycline, and only 40% for diminazene aceturate, indicating a far greater
response to the schizonticidal drugs than the babesicidal drug, diminazene, and thus
the possible potential for its use in the treatment of B. equi (Zweygarth et al., 1984).
Other large-scale systems for B. bovis erythrocytic stages, apart from the spinner
culture of Erp et al. (1980b) and the batch culture of Timms and Stewart (1989)
include the use of rotated 75 cm2 flasks (J.S. Crowe, personal communication).
Babesia divergens was also grown in batch cultures by Pudney (1984) using the
human `J’ strain grown with human erythrocytes in 200 ml volumes in a Techne
microcarrier stirrer. Greater than 20% parasitaemias were also routinely produced by
the use of 50 ml volumes in 100 ml Erlenmeyer flasks on an orbital shaker, using the
same method as for small cultures, i.e. 10% haematocrit in a gas phase of 5% CO2,
2% O2 and 93% N2, with daily medium changes of RPMI 1640, with added glucose,
hypoxanthine and 10% human serum and subcultured every three to four days. Up to
4 × 1012 parasites (Erp et al., 1980b) were produced weekly and used for the isolation
and study of mitochondria (M. Fry, personal communication).
Isolation of intracellular parasites, whilst retaining both parasite integrity and
viability, is a constant source of concern for parasite biochemists and others
requiring pure, viable material. However, the observation by Levy and Ristic
(1980) that large numbers of merozoites of B. bovis accumulate in the medium
following CO2 deprivation has provided a simple method for producing free
parasites. In the case of B. bovis the parasites can be further concentrated using
differential lysis. Winger et al. (1987) prepared isolated B. divergens merozoites
by incubating cultures in a desiccator over soda lime for six to eight hours at 38
°C. Merozoites were further concentrated by a modification of the method of Levy
and Ristic (1980) and the material containing merozoites and red cell ghosts was
used for the production of monoclonal antibodies. Inhibition of merozoite invasion
by these antibodies was later shown using the merozoite neutralization assay. Large
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numbers of isolated B. divergens parasites were obtained for studies on O2 uptake,
by leaving cultures open to air for 24 hours and removing any remaining infected
or uninfected red cells by centrifugation (M. Pudney and M. Fry, unpublished data).
Centrifugation in a Percoll gradient has also been used to completely separate
parasites (B. bovis) from red blood cells and stroma (Rodriguez et al., 1986) as
well as to concentrate infected erythrocytes. Isolation of B. bigemina from eryth-
rocytes prior to concentration and purification was obtained by the use of glycerol-
enhanced osmotic shock (Figueroa et al., 1990).
Erythrocytes and intraerythrocytic Babesia parasites, like Plasmodium, are unable
to  synthesize  purine  nucleotides de  novo and therefore  rely on obtaining these
metabolites from the extracellular medium (Irvin and Young, 1979; Conrad, 1986).
In accordance with this obligate requirement, nucleoside transport has been found to
be induced in bovine erythrocytes upon infection with B. bovis (Gero, 1989). Bovine
erythrocytes, which are virtually impermeable to glucose, were also shown to display
a dramatic increase in glucose permeability following infection with B. bovis (Upston
and Gero, 1990). Evidence has also been obtained for the insertion of a parasite
specific nucleoside/nucleobase transporter into the membranes of the bovine (host)
red cell. Thus, whereas normal (non-parasitized) bovine red cells are essentially
incapable of transporting nucleosides across their membranes, the invasion of these
cells by B. bovis introduces a transporter that can be inhibited by classic nucleoside
transport inhibitors (Matias et al., 1990).
The continuous cultivation of P. falciparum and the [3H]-hypoxanthine assay
described by Desjardins et al. (1979) has become a standard tool in antimalarial
research, with widespread applications and modifications. This system has now
been applied to both B. divergens (Pudney and Matthews, 1985) and B. bovis (Nott
et al., 1990) with growth in continuous culture. Using a  human isolate  of B.
divergens maintained by serial passage in gerbils, cultures have been initiated and
maintained continuously in parallel strains in bovine and human erythrocytes
(Pudney, 1984). Culture material readily infects splenectomized calves and intact
gerbils, and parasites from the bovine strain grow well in human erythrocytes and
vice versa. Tests were carried out using microtitre plates in a total volume of 150
ul/well and an initial parasitaemia of 2%. Trays were incubated at 37 °C for 24
hours in a humidified chamber in the Babesia gas mixture, following which
[3H]-hypoxanthine was added and the trays incubated for a further 24 hours. Cells
were harvested using a cell harvester which lyses the cells and deposits washed
particulate material onto filter papers. These discs, placed individually into scin-
tillation vials, are counted to calculate the [3H]-hypoxanthine incorporated (Pud-
ney and Matthews, 1985). Variations on this assay described by Nott et al. (1990)
included the use of sterile water in the peripheral wells to ensure adequate humidity,
a total volume of 200 ul/well and an initial parasitaemia of 1%, and pulsing with
hypoxanthine for 18 hours instead of 24 hours. Large numbers of compounds can
be screened for activity with this system and then IC50 levels obtained for active
drugs for comparison with other compounds.
Incorporation of [3H]-hypoxanthine was found to be a reliable indicator of
parasite growth, closely paralleling the increase in percentage of parasitized cells.
The activity of the standard antibabesial compounds for B. divergens gave the
following IC50s: quinuronium sulphate, 3.4 × 10–8M; ethidium bromide 4.7 ×
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10–8M; imidocarb dipropionate 1 × 10–7M; pentamidine isethionate 3.6 × 10–7M;
diminazene aceturate 3.7 × 10–7M and amicarbalide isethionate 4.6 × 10–7M.
Comparable results for B. bovis were 1.27 × 10–7M; 9 × 10–7M; 5.8 × 10–7M; 5.8
× 10–7M; not done, and 1.25 × 10–6M, respectively. There is considerable interspe-
cies variation in drug response within Babesia, and although B. divergens was used
in a primary screen as a representative of the small Babesia spp., all active
compounds were then screened against B. bovis (Pudney, 1984). The level of
activity is similar, although consistently lower in B. bovis. This may in part be due
to the test system which has been optimized for B. divergens. Further confirmation
of the usefulness of this test system was the indication of the activity of a series of
hydroxynaphthoquinones (HNQ) which had been inactive in the B. rodhaini model.
The most active of these HNQs, 720C (buparvaquone) was subsequently shown to
have activity against B. divergens in both gerbils and cattle (unpublished data).
Another advantage of this system is the unique opportunity to investigate drug
effects in different host cells. In the majority of cases the compounds were less
effective in the human cells. Evaluation of some standard antimalarial drugs
showed antibabesial activity, which was however very low compared to their
corresponding antimalarial activity; it can be seen why such drugs are ineffective
against human cases of babesiosis. One of the HNQs shown to have antibabesial
activity in both human and bovine erythrocytes, 566C, is currently in clinical trials
for treatment of malaria, and in Pneumocystis carinii and Toxoplasma gondii in
AIDS patients; the in vitro assay would indicate that this compound would be
suitable for the treatment of human cases of babesiosis.
This assay has also been used as a more general research tool. The HNQ series
of drugs are known to act on the electron transport chain of the mitochondria. In
vitro effects of standard electron transport inhibitors has indicated the presence of
a functional, mitochondrial electron transport pathway in B. divergens. Approxi-
mately 50% of the O2 uptake by intact cells is inhibited by classical electron
transport inhibitors. Cytochemical staining has also indicated the presence of
cytochrome oxidase activity contained within a large, cristate and probably single
mitochondrion per parasite (M. Fry, unpublished information). Nott et al. (1990)
found imidocarb and amicarbalide to be active against B. bovis in the 10–40 nM
range. They also demonstrated the activity of tubercidin and other nucleoside
analogues, as well as the antibiotic tetracycline, the HNQ menoctone, and pyrazo-
furin, an inhibitor of pyrimidine biosynthesis. Both phloretin and phlorizin inhib-
ited babesial growth indicating that active transport rather than simple diffusion
mechanisms operate across the membrane of the parasitized host cell or that of the
intracellular parasite. Also shown was the activity of a series of  antimalarial
diMannich bases. Such results illustrated the usefulness of this in vitro assay
system, both for assessing inhibitors of a specific biochemical function, and for
testing compounds of known activity and novel structures. It is difficult to deter-
mine the reason for the difference in efficacy of the antibabesial standards as
reported by Pudney and Matthews (1985) and Nott et al. (1990), but may be due to
the difference in species and/or strain of species used, or to the technical differences
in the assay, which would be expected to produce minor differences. However, the
efficacy of the compounds in two independent laboratories has been confirmed.
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Cultivation of Babesia, especially of bovine origin, has now developed to the stage
where several species and strains are culture adapted and can be reliably maintained
in continuous culture and stored in liquid N2. Unfortunately the necessity for daily
medium changes has not yet been overcome, although some strains can be left over
a weekend period without attention. Automation of this process would greatly
increase the usability of the system. The in vitro cultures have lived up to their
potential in several areas and have been used to make significant advances, particu-
larly in the area of soluble exoantigens for vaccine use,  the traditional  use of
producing attenuated parasites, the provision of antigens for the production of
monoclonal antibodies, for investigations on immunological response, on parasite
entry into the red cell, and certain aspects of host specificity. The culture method has
enabled biochemical investigations to be carried out on viable material, even if over
short time periods. The determination of the exoerythrocytic stage of B. equi was
confirmed by the use of the culture system which has clearly shown this aspect of the
developmental cycle. This has brought into doubt the classification of this species as
a true Babesia, but it has also highlighted possible reasons for the lack of success in
the treatment of B. equi.
As yet, little success has been achieved in comparable cultures of the developmental
stages in the tick. The wider use of the [3H]-hypoxanthine uptake assay for the
identification of new drugs, and the investigation of their site(s) of action will build
on the success already achieved in this area. The establishment of drug efficacy in
the treatment of babesiosis is complicated by the wide variety of hosts and Babesia
species which have differing degrees of drug tolerance and susceptibility. The devel-
opment of culture systems for other species of Babesia would assist in characterizing
the biochemical, as well as antigenic differences, that exist between them.
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Progress with the cultivation of Cowdria
ruminantium in endothelial cells
J.D. Bezuidenhout and S. Brett
Veterinary Research Institute
Department of Agricultural Development
Onderstepoort, 0110, South Africa
The in vitro cultivation of Cowdria ruminantium remains a fragile system despite
considerable progress made since its initial development. A minimum of 13 stocks of
C. ruminantium have been cultivated successfully in vitro in endothelial cells. Organ-
isms are cultured on bovine or ovine endothelial cells in the Glasgow modification of
Eagles minimal essential medium (Gibco: GMEM) or Leibovitz L-15, both with
additives. Cultured organisms have been used as antigen in immunofluorescent tests,
in biochemical studies in which immuno-dominant proteins were isolated, for the
isolation of Cowdria DNA and in studies on the development of a tissue culture
inoculum against heartwater. The morphology and life-cycle of the organism have been
studied and attenuation of the Senegal stock of C. ruminantium has been reported.
INTRODUCTION
The successful in vitro cultivation of Cowdria ruminantium, which took place rela-
tively recently, has stimulated renewed interest in the disease (Bezuidenhout, 1987,
1988). In vitro-cultured organisms or infected cells have been used as antigen in
serological tests such as in the direct and indirect fluorescent antibody test (Bezuid-
enhout et al., 1985; Yunker et al., 1988; Martinez et al., 1990) in an enzyme-linked
immunosorbent assay (ELISA) (Viljoen, 1985) and during the development of mono-
clonal antibodies used in the competitive ELISA (Jongejan et al., 1990a). Furthermore,
infected tissue cultures have been used for the isolation of Cowdria DNA in studies
aimed at establishing DNA libraries and DNA probes (Ambrosio et al., 1987; Wilkins
and Ambrosio, 1989; Jongejan, 1990; Yunker, 1991). Biochemical studies have also
been conducted on the organisms in culture and immuno-dominant proteins isolated
(Jongejan and Tielemans, 1989; Rossouw et al., 1990). At the Veterinary Research
Institute (VRI), Onderstepoort, a study has also been made into the possible replace-
ment of the present blood vaccine with a live tissue culture inoculum. During studies
on the in vitro cultivation of C. ruminantium, the Senegal stock was attenuated through
continuous cultivation in endothelial cells (Jongejan, 1991).
CELL LINES SUITABLE FOR IN VITRO CULTIVATION OF COWDRIA
The first successful in vitro cultivation of the organism was in bovine umbilical cord
endothelial cells (E5) (Bezuidenhout et al., 1985). The cells were isolated according
to the method of Maruyama (1963) (B.J. Erasmus, personal communication). Sub-
sequently, Yunker et al. (1988) tested 11 cell lines, other than E5, for their suscepti-
bility to Cowdria. They found that three of these cell lines, all established from bovine
arterial endothelium according to a modification of the method described by Hirumi
and Hirumi (1984), supported the growth of the organisms on a continual basis, while
a fourth, established from foetal bovine heart endothelium (American type culture
collection CRL-1395), supported the multiplication of the organism in some in-
stances. Bovine umbilical endothelial cells (BUE), isolated according to a modifica-
tion of the method of van de Wiel et al. (1989), were used by the group in Utrecht
during their studies on the organism in culture (Jongejan et al., 1990b; Jongejan,
1990). An ovine endothelial cell line (SBE189) was recently established at the VRI,
Onderstepoort, according to a modification of the method described by Phillips et al.
(1979) (S. Brett, unpublished data). This cell has supported the growth of Cowdria
since its fourth passage and is presently at passage 50. Another ovine cell, isolated
from pulmonary artery endothelium, was found to be susceptible to Cowdria (Byrom
et al., 1991).
CULTURE MEDIA
The Glasgow modification of Eagle’s minimum essential medium (GMEM, Gibco
version containing L-Glutamine 292 ug/ml), locally produced at the VRI, Onderste-
poort, with the addition of tryptose phosphate broth (TPB), bovine serum and
antibiotics, was used during the first successful Cowdria cultivation experiments.
This medium is still in use with excellent results in the yielding of highly infected
Cowdria cultures (Bezuidenhout et al., 1985; Bezuidenhout, 1987; S. Brett, unpub-
lished results). The GMEM (commercially available), supplemented with TPB,
L-Glutamine, foetal calf serum (FCS) at 10% (sometimes even as low as 3%) and
antibiotics, is used widely (Yunker et al., 1988; Jongejan et al., 1990b; Martinez et
al., 1990). Byrom and Yunker (1990) obtained better results by using Leibovitz L-15
medium supplemented with 0.45% glucose, 5% foetal bovine serum, 292 ug/ml
L-glutamine and antibiotics. The pH of the GMEM culture medium is adjusted to
6.0–6.5 by gassing with CO2 and the L-15 by adding HCL.
CULTURE METHODS AND CONDITIONS
Irradiation and cyclohexamide were used in early culture studies to inhibit the growth
of cells in order to facilitate initial infection with Cowdria (Bezuidenhout et al., 1985;
Yunker et al., 1988). It is now generally accepted that the irradiation of cells is not a
prerequisite for successful initial infection of cultures (Bezuidenhout, 1987, 1988;
Byrom and Yunker, 1990; Jongejan et al., 1990b). Very little or no success has been
reported after treatment of cultures with cyclohexamide (Bezuidenhout, 1987; Yunker
et al., 1988). A very simple and practical method to facilitate closer contact between
the cells and inoculum, now widely incorporated in the cultivation of Cowdria, is to
place the cultures on a slow-rocking platform (2–4 rocks/min), or, for mass produc-
tion, to use a roller bottle system (S. Brett, unpublished results). Cultures are
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incubated at 37 °C. No conclusive information has been published on the effect of
temperature on the growth of Cowdria in cultures.
The storage of Cowdria at low temperatures remains a problem due to the loss of
infectivity during the freezing/thawing process. However, it was found that the
freezing of organisms in liquid nitrogen while still intra-cellular as small colonies
(two days after infection) gives excellent results when such cultures are revived (S.
Brett, unpublished results).
INOCULATION OF CULTURES
Sheep or goat blood collected in heparin (50 units/ml) with or without sucrose
phosphate buffer during the febrile reaction is mostly used for the inoculation of
cultures (Bezuidenhout et al., 1985; Yunker et al., 1988; Jongejan et al., 1990b;
Martinez et al., 1990). It appears that fresh blood gives better results than frozen
blood. A variety of blood components such as leucocytes, neutrophils and macro-
phages have been used as inocula without success (Byrom and Yunker, 1990; Byrom
et al., 1991) but blood plasma gives better results.
In the case of mice infected with murinotropic stocks, pooled samples of infected
organs such as spleen, liver, heart, kidney and blood have been used successfully as
inocula and, more recently, the lungs alone have been used (S. Brett, unpublished
results). Inocula of tick stabilates prepared from C. ruminantium-infected ticks have
also been successfully cultivated in vitro (Bezuidenhout et al., 1985; Bezuidenhout,
1987). Due to their toxicity to the cultured cells and the fact that they often contain
bacterial contamination, tick stabilates are, however, not regarded as a very effective
inoculum.
STOCKS OF COWDRIA RUMINANTIUM CULTURED
The successful in vitro cultivation of a great number of Cowdria stocks have been
reported (Table 1). The Kumm stock appears to be the only one to yield constantly
negative results (Bezuidenhout, 1987) even on the ovine endothelial cell line
(SBE189) which gives excellent support to other stocks (S. Brett, unpublished data).
At this stage it would be unwise to lay too much emphasis on any differences reported
between the growth potential of different stocks, especially as they were not always
subjected to the same culture conditions.
OBSERVATIONS OF COWDRIA IN CULTURE
After C. ruminantium is taken up by endothelial cells in culture, it divides by binary
fission within intracytoplasmic vacuoles, forming colonies of reticulate bodies. After
three to four days in culture, the reticulate bodies develop into smaller intermediate
bodies characterized by an electron-dense core. The intermediate bodies condense
further into electron-dense elementary bodies which rupture from the cells and are
released into the culture medium. From here they invade other endothelial cells thus
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initiating a new infectious cycle which lasts between four and six days (Jongejan et
al., 1990b). Earlier reports of the detection of Cowdria colonies only 11–14 days after
inoculation (Bezuidenhout, 1987; Yunker et al., 1988) were probably due to a low
initial infection rate allowing detection only after the organisms had multiplied
through one or more cycles. After gaining more experience and information on the
in vitro cultivation of Cowdria, colonies are now detected as early as two days after
inoculation (S. Brett, unpublished observation; Byrom et al., 1990; Jongejan et al.,
1990b).
Depending on the level of infection of cultures, a cytopathic effect (CPE) is
observed usually from day 5 after infection, but sometimes only after 11–14 days or
TABLE 1. Stocks of Cowdria ruminantium cultivated in endothelial cells.
Stock* Cell line† Reference
Ball 3 E5 Bezuidenhout et al., 1985;
Bezuidenhout, 1987;
Byrom and Yunker, 1990
Crystal Springs BA886; BA987; FBHE Yunker et al., 1988;
Byrom and Yunker, 1990
Gardel E5 Martinez et al., 1990
Highway BA987; BPA689; Byrom and Yunker, 1990
OPA Byrom et al., 1991
Kwanyanga E5 Bezuidenhout, 1988
SBE189 Brett, unpublished data
Lemco T3 BA987; BPA689 Byrom and Yunker, 1990
Mali E5 Bezuidenhout, 1988
Mbizi BVE Byrom et al., 1991
Nonile E5 Bezuidenhout, 1988
Nyatsanga BVE Byrom et al., 1991
Palm River BA987 Yunker et al., 1988
Senegal BUE Jongejan et al., 1990b
E5 Martinez et al., 1990
Welgevonden E5 Bezuidenhout, 1987
Martinez et al., 1990
SBE189 Brett, unpublished data
BA886 Yunker et al., 1988;
Bezuidenhout, 1988
BUE Jongejan, 1990
BA897; FBHE; BPA987 Yunker et al., 1988;
Byrom and Yunker, 1990
*Two additional stocks viz. Nigeria and Zwimba have also been cultivated in vitro in
Harare, Zimbabwe (C.E. Yunker, personal communication).
†All the cells are of bovine origin except the SBE189 and OPA which are from ovine
origin.
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even later. Cytopathic effect is especially noticeable if the cultures are kept in constant
movement as on a rocker or in roller bottles. Under such conditions CPE is seen as
clear streaks in the monolayer where affected cells are in the process of detaching or
already detached (S. Brett, unpublished observation; Yunker et al., 1988; Byrom et
al., 1991).
DISCUSSION
Apart from the usual hazards associated with culture work, such as sporadic contami-
nation of cultures and poor performance of cells or inocula in culture, techniques for
the in vitro cultivation of Cowdria are now fairly standardized and reasonable to
excellent yields are obtained. It is possible to produce the organism in bulk in roller
bottles, but only with great care, which includes monitoring of cultures in order to
ensure correct timing of the optimal release of elementary bodies.
Most bovine endothelial cells presently in use for the cultivation of Cowdria seem
to be suitable for this purpose provided they are kept healthy. They grow well under
most laboratory conditions but their division rate is rather slow compared to most other
cells used for vaccine production. The ovine endothelial cell line (SBE189) recently
established at the VRI, Onderstepoort, supports the growth of Cowdria very well and
is, in most cases, more suited to a high rate of initial infection than the E5 cell line.
However, as in the case of the E5 cell line, it also does not support the growth of the
Kumm stock, for which a murine endothelial cell line might have to be developed.
There does not seem to be an urgent need to identify any other cell for the cultivation
of Cowdria, unless such a cell could facilitate the process of attenuation.
Some of the objectives identified earlier with regard to the in vitro cultivation of
Cowdria have been achieved. These include aspects such as the use of cultured
organisms as antigen in serological tests and biochemical and DNA studies. Infected
cell cultures were also studied in detail to clarify the life cycle of Cowdria and the
principle of attenuation of organisms in culture has also been established (Jongejan
et al., 1990b; Jongejan, 1991). Perhaps the most important objective is the use of cell
cultures for the development of a safe and effective vaccine against heartwater. The
main reasons for this are the lack of cross-protection between the different stocks,
the labile nature of the organism, the inability of inactivated organisms to stimulate
a protective immunity (S. Brett and J.D. Bezuidenhout, unpublished data) and the
impracticality of using the intravenous route for effective inoculation. Of course it is
realized that with the latest techniques in molecular biology, it is, at least in theory,
possible to overcome most of these problems. If protective proteins can be identified
and the genes coding for them incorporated into vectors that will stimulate cellular
immunity, together with the latest adjuvants, it could turn out to be a very effective
and safe vaccine. However, judging from the slow progress made with research on
other, similar or even more simple organisms, this could take a long time.
It is, therefore, important that, if we wish to exploit the developments made so far
towards improving practical measures of disease control, aspects such as stability of
the organism in infected culture material and the potential of blood as an infective
inoculum should receive more attention. It has been established that enough organ-
isms can be cultured in a roller bottle (800 cm2) to vaccinate 20,000 sheep (S. Brett,
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unpublished data). However, more studies need to be done on preserving the final
product in order to maintain a high level of infectivity after freezing and thawing.
Freeze-drying could play an important role in this regard (du Plessis et al., 1990).
Attenuation of organisms in vitro, as already established for the Senegal stock
(Jongejan, 1991), should also be studied in other stocks. If attenuated stocks are stable
and the protection that they offer against other important stocks reliable, they would
hold great promise in the development of future live vaccines. Other aspects also
identified as objectives (Bigalke, 1987) that still need attention are the cloning of
endothelial cells and, perhaps even more urgently, the cloning of the different stocks
of C. ruminantium. The development of a plaque assay for this purpose and also for
the quantification of infective material is, therefore, of utmost importance.
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INTRODUCTION AND HISTORICAL PERSPECTIVE
An in vitro culture system for Anaplasma marginale is an important objective of
anaplasmosis research. The logistics and expense of working with cattle places
constraints on many aspects of research on this disease, particularly in areas like
chemotherapeutic and vaccine trials. Although there is no continuous culture system
presently in use, previous attempts have provided valuable information on the
behaviour of the organism and suggest that a continuous culture system is possible.
As research into the biology of Anaplasma continues, it is becoming clear that this
organism is unusually complex among rickettsiae. It is important for anyone working
in the area of in vitro propagation to understand the historical progression of culture
attempts to appreciate the fastidious nature of this organism outside of its natural
environment.
The first reported attempt at culturing A. marginale was in 1915 (Veglia, 1915) in
South Africa. There have been numerous attempts since then, primarily involving
propagation of infected erythrocytes in various liquid medium preparations. Many
attempts have gone unreported. Following the techniques of Trager and Jensen (1976)
for cultivation of the erythrocytic stages of Plasmodium, a number of short-term
culture systems for A. marginale have been reported (Davis et al., 1978; Kessler et
al., 1979; Kessler and Ristic, 1979; Mazzola and Kuttler, 1980; McHolland and
Trueblood, 1981). More elaborate systems such as continuous flow culture have also
been attempted (Erp and Fahrey, 1975). Most of these systems have resulted in
increased parasitaemia over one to three days followed by a gradual decrease or stasis.
While the initial increase in parasitaemia observed may be attributed in part to
development of mature inclusion bodies from initial bodies, it has been demonstrated
that infection of uninfected bovine erythrocytes by stages in ovine erythrocytes did
occur during the first 48 hours in culture (Kessler and Ristic, 1979). Viability of A.
marginale, as determined by animal inoculation, has been maintained for 33 days
(Kessler et al., 1979). Parasites are also capable of maintaining protein and DNA
synthesis by incorporating precursors for up to five days in culture although replica-
tion appears to cease after one or two days (Davis et al., 1978). Short-term culture
systems have been useful in studying aspects of the basic biology of the organism in
an artificial system and may eventually be applied to successful long-term systems.
There have been several attempts to cultivate Anaplasma in nucleated cells. The
most interesting report is by Marble and Hanks (1972), who inoculated cultured rabbit
bone marrow cells with bovine erythrocytes infected with A. marginale. Cultures
were passaged weekly and animals were periodically inoculated with culture mate-
rial. Their results indicated that cultures remained infective to cattle for 140 days.
Organisms could not, however, be  identified in  cultures  using  Romanowsky  or
acridine orange staining techniques. The results were encouraging but they have not
been duplicated. Swann et al. (1981) reported that, in a similar attempt, increasing
numbers of organisms could be identified in rabbit bone marrow cells using im-
munofluorescence for 6–12 days but began declining after 20 days. Hidalgo (1973)
reviewed several attempts to infect bovine bone marrow cells with the erythrocytic
stage of A. marginale but none were successful. In an eight-year progress report,
McHolland and Trueblood (1981) detailed attempts to infect bovine marrow, lymph
node, embryonic kidney, turbinate and spleen cells, and mouse fibroblasts and chick
embryo fibroblasts with the erythrocytic stage. They reported that all these cells took
in organisms and survived for varying periods of time but no replication was
observed. Infection of lymph node organ cultures with stored, infected erythrocytes
has also been attempted (Trueblood and Bear, 1973). Organisms were identified in
smears of lymphoid cells with fluorescent antibody and Giemsa staining techniques
but replication was not apparent. Supernatant from these cultures was, however,
infective for cattle up to 40 days after initiation.
Attempts to infect vertebrate nucleated cells with the erythrocytic stage of A.
marginale have thus far produced inconclusive results. This stage is infective when
mechanically transmitted between cattle but there is no evidence that the organism
replicates in cells other than erythrocytes in vivo. While it has been known for many
years that A. marginale can be transmitted mechanically or biologically by blood
feeding arthropods (Dikmans, 1950), it has now been demonstrated that this organism
can undergo a complex development within different cells of ixodid ticks (Kocan et
al., 1980, 1988, 1990a, 1991; Stiller et al., 1989). The infective form for the tick cells
is likely to be the erythrocytic stage. The first attempts to infect arthropod cell lines
involved inoculation onto cells derived from Aedes albopictus (Mazzola et al., 1976,
1979). These cells were shown to phagocytize infected erythrocytes and organisms
were observed intracellularly for up to 60 days but without apparent replication.
Infectivity was maintained for 21 days as determined by calf inoculation. Samish et
al. (1988) inoculated a cell line derived from Dermacentor variabilis embryos with
infected erythrocytes. It was reported that phagocytized Anaplasma-like particles,
identified with fluorescent microscopy, increased in number over 20 days and two
passages, but no corroborating evidence of replication was provided. Hidalgo et al.
(1989a) used a tick gut stage of A. marginale as inoculum for a cell line derived from
embryonic D. variabilis. Using a fluorescent monoclonal antibody to the erythrocytic
stage, the authors reported a generalized fluorescence in infected cultures that was
not found in control cultures inoculated with uninfected tick material. Electron
microscopy revealed intracellular inclusions which appeared to contain rickettsial-
like organisms. Cultures were maintained for 22 passages over 11 months. Inocula-
tion of culture material into susceptible animals did not induce infection and animals
were susceptible to challenge although some pre-challenge sera did react at a 1:10
dilution in an ELISA test (Hidalgo et al., 1989b).
In examining the relatively short list of reports on attempts to cultivate A. margi-
nale there appears to be a consistent theme which might serve to encourage further
IN VITRO CULTIVATION
150
work. In both erythrocytic and a number of nucleated cell cultures the organism
appears to survive intercellularly for an extended period of time. Replication has not
been demonstrated but survival after extended passages might allude to this. The
potential benefits of a successful continuous culture system would warrant its further
investigation.
CURRENT RESEARCH
In light of previous unequivocal findings and the continued need for an in vitro system
to study A. marginale, research was recently initiated at the Oklahoma State Univer-
sity Anaplasmosis Research Laboratory to further investigate possible culture sys-
tems. Initial efforts have focused on uses of short-term erythrocytic cultures and
measures to increase the longevity of these culture systems. Efforts are currently
under way to evaluate potential continuous culture systems using tick-derived stages
on A. marginale.
Short-term erythrocyte cultures
The first culture attempts of A. marginale by our group were based on the Trager and
Jensen (1976) model for the cultivation of Plasmodium with different variables of
this system being manipulated. Initiation of cultures with blood at different levels of
parasitaemia were attempted. Cultures initiated with low level parasitaemic blood
(1% or less) resulted in no noticeable increase. Cultures initiated with infected blood
during log phase growth generally resulted in varying degrees of increase over a
48-hour period. Cultures initiated with  10–20%  infected erythrocytes  increased
approximately 5% above the initial parasitaemia but those initiated with 50% or more
infected erythrocytes increased by 30–40%. After six to seven days the number of
infected erythrocytes decreased in all cultures. The following variables were also
investigated in our short-term cultures: adjustment of pH between 7.0 and 7.4, varying
serum content between 10% and 40%, using calf serum instead of foetal calf serum,
increasing incubator temperature to 40 °C, increasing CO2 levels from 5 to 10%,
varying the size of incubation flasks and increasing glucose levels in medium from
2 to 4 g/L and glutamic acid levels from 20 mg/L to 40 mg/L. We have also attempted
to use a modification of a suspension culture method for Babesia bovis (Erp et al.,
1978) in which cultures were kept in suspension using a cell rocker or rotator. None
of the modifications employed here resulted in a significant departure from previous
findings.
Cultures were initiated based on the microaerophilus stationary phase (MASP)
system of Levy and Ristic (1983) for the cultivation of B. bovis. In this system the
depth of the column of medium above stationary cells was critical in maintaining
the low oxygen environment necessary for continued development of Babesia. It
was also found that parasite multiplication did not persist beyond three to four days
after subculturing and reducing parasitaemias to 0.5–1% resulted in maximum
growth. In using this system with A. marginale-infected erythrocytes, we seeded
cultures at parasitaemias of 1, 5 and 10% and subcultured every two days at a ratio
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of 1:3. This resulted in a rapid dilution of parasitaemia over several subcultures.
Cultures were next seeded at 5% and subcultured at a 1:1 ration every four to five
days. Inclusion bodies could still be identified after five subcultures but at a very
low level. These trials are continuing to determine if a persistent low level
infection can be maintained.
Development and infectivity of new cells
One of the aspects of the developmental cycle of A. marginale that is not fully
understood is the mechanism by which the organism infects new cells. This has
become particularly important in regard to attempts to stimulate increased growth
and development of the organism in vitro. It has been accepted that infection of
erythrocytes is initiated by a single initial body. It has been demonstrated with
immunofluorescence that infection may occur between erythrocytes in vitro
(Kessler and Ristic, 1979) but morphological evidence of transfer has not been
shown. During log phase increases in parasitaemia at levels as high as 70% we have
not been able to identify the exit of parasites from infected erythrocytes in samples
collected directly from reacting animals or in short-term cultures. In these samples
it is not uncommon to find single initial bodies which have just entered a cell and
very rarely an initial body outside of a cell. The actual infection of organisms may
not occur in general circulation but in the close confines of the microcirculation.
It has been a consistent observation that organisms free from host cells appear to
lose morphological integrity rapidly. Closer contact between cells would be en-
hanced in areas such as capillary beds and transfer might be facilitated. Another
observation in short-term cultures initiated with cells in log phase parasitaemic
growth was an apparent disassociation of intracellular inclusion bodies. Inclusions
in various stages of breaking apart from the inclusion body membrane have been
consistently observed in samples cultured for 24–48 hours and from samples
collected directly from reacting animals. Exit of individual initial bodies, free of
the inclusion membrane, might be accomplished with less damage to the erythro-
cyte membrane than if the entire inclusion body functioned in the exit process. This
mechanism is still being investigated.
Manipulation of intercellular movement
The observation that infection of uninfected erythrocytes ceases after 24–48 hours in
the various culture systems investigated suggests that one or more factors present in
the vertebrate host are not present in vitro or are used up rapidly. Factors which might
enhance the entry or exit of A. marginale are being investigated. Calcium has been
shown to play an important role in the long-term maintenance of other intraerythro-
cytic parasites in vitro, particularly during invasion and early growth (Tanabe et al.,
1989; Krishna and Squire-Pollard, 1990; Ray et al., 1989). The adhesion of chlamy-
dial organisms to host cell membranes and enhanced infection rates of these cells
have been associated with a flux of calcium across the cell membrane (Murray and
Ward, 1984).
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In our studies a calcium influx into cultured erythrocytes infected with A. margi-
nale was induced using the ionophore A23187. Cultured erythrocytes from two
animals with rising parasitaemias were treated with 10 uM of A23187 in the initial
trial. After 24 hours, there was a decrease in the percentage of infected erythrocytes
(PEI) in both the treated cultures (from 19 to 12% and 13 to 7.7%). The untreated
control cultures increased slightly over 48 hours. In the second trial, infected eryth-
rocyte (19%) cultures were treated with ionophore at 1 uM and 5 uM on three
consecutive days. Two  controls were used—untreated infected erythrocytes and
infected erythrocytes treated with the same volume of dimethylsulphoxide (diluent
for the ionophore). Infection levels were monitored and haemoglobin samples were
taken 24 hours after each treatment. Intracellular calcium levels were found to
increase following addition of ionophore but there was no significant difference
between the 1 uM and 5 uM samples. There was a slight increase in PEI from 19 to
22.6% over 48 hours in untreated cultures, a slight drop from 19 to 18% after 24 hours
in cultures treated with 1 uM and a significant decrease from 19 to 13.8% after 24
hours in cultures treated with 5 uM of A23187. Cultures treated with the diluent
(DMSO) only increased slightly from 19 to 20.75% after 24 hours. Haemoglobin
levels were considered low in all samples but slightly higher levels were found in
treated culture supernates. Levels were not sufficient, however, to incriminate lysis
of the more fragile infected cells as the cause of the significant drop in PEI in cultures
treated with 5 uM of ionophore.
Electron micrographs of culture samples revealed what appeared to be the
expulsion of entire inclusion bodies as well as individual initial bodies from the
periphery of erythrocytes during the first 24 hours in ionophore-treated cultures
and may have been responsible for the decrease in PEI. In most of these observa-
tions erythrocyte membranes appeared to remain intact following the release of
organisms. While infection of erythrocytes did not appear to be enhanced, release
of organisms was facilitated. Further studies  will utilize intracellular  calcium
chelators to determine if release was due to action of the ionophore or a calcium-
dependent mechanism.
Culture systems using tick-derived stages of Anaplasma marginale
The developmental cycle of A. marginale in ixodid ticks has proven to be extremely
complex. Research using male D. andersoni transferred from infected to susceptible
cattle has demonstrated a sequence of development in which the organism first
undergoes growth in midgut epithelial cells (Kocan et al., 1980, 1988, 1990a, 1991).
This is followed by an intermediate site of development in gut muscle cells (Kocan
et al., 1990a) with the final stage of development in salivary gland cells (Kocan et
al., 1988, 1991; Stiller et al., 1989). It was also shown that different morphological
forms occur in the tick tissues and that not all of these forms are infective for cattle
(Kocan, 1986). Long-term studies on the co-ordinated development of this organism
in D. andersoni ticks (Kocan, 1986; Kocan et al., 1990b) have resulted in feeding
regimes in which consistently high levels of organisms can be obtained from each
tick tissue. This ability forms the basis for present efforts at initiating continuous
culture systems.
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Initiation of erythrocyte cultures with tick stages of Anaplasma marginale
A hypothetical life cycle for A. marginale involves a tick-derived stage entering
erythrocytes of the vertebrate host by endocytosis and subsequently undergoing
binary fission (Ristic and Watrach, 1963). The infection of bovine erythrocytes by a
tick-derived stage of the organism has not been demonstrated previously. In an
attempt to initiate an in vitro infection with a tick stage and show direct infection of
bovine erythrocytes, cultured erythrocytes were inoculated with the salivary gland
stage of A. marginale. Uninfected male D. andersoni were fed on a clean calf to serve
as controls. After holding ticks for five days, each set was fed on separate susceptible
animals for 14 days. Ticks were dissected, salivary glands were removed and homoge-
nized. Inoculum prepared from 10 ticks was added to each 35 × 10 mm culture dish
containing erythrocytes in medium supplemented with 20% foetal calf serum. Sam-
ples were collected after 30, 60 and 120 minutes for electron microscopy (EM). After
24 hours, samples were collected daily for EM, Giemsa and FITC staining. Salivary
glands of ticks fed on the infected animal were found to contain A. marginale colonies
and the animal subsequently developed anaplasmosis. Colonies and individual rick-
ettsiae were found in EM samples of the inocula from these ticks. No rickettsiae were
found in control ticks and the calf on which they were fed did not become infected
with Anaplasma. In EM samples from the first day, rickettsiae were observed entering
erythrocytes by an endocytosis-like process. Individual organisms were observed
intercellularly throughout the observation period but no replication was observed. No
rickettsiae were observed in control samples. Due to the size of individual rickettsial
bodies identification with light microscopic staining is difficult to interpret. Although
replication did not appear to occur, infection of cells can be achieved. Present efforts
are concentrating on increasing infection levels in the system and if sufficient levels
can be achieved it may have application in in vitro neutralization studies.
Infection of nucleated cells with tick stages of Anaplasma marginale
Hidalgo et al. (1989a) first used tick gut stages of A. marginale to infect an embryonic
tick cell line and indicated that replication may have occurred over an 11-month
culture period. It has been suggested that this organism may require actively growing
cells and that initial development is associated with the host cell nucleus (Hidalgo et
al., 1989c). Investigations are presently under way to infect different nucleated cell
lines of arthropod and vertebrate origin with the different tick-derived stages of A.
marginale. Initial attempts to infect bovine endothelial cell lines with gut stages have
been inconclusive. Similar cell lines inoculated with salivary gland-derived stages
have been found to be positive using the polymerase chain reaction after six weeks
post inoculation after several passages. Anaplasma-like inclusions similar to those
reported by Hidalgo (1989c) were also observed with light and electron microscopy.
Infectivity of cultured material is being investigated. In preparing viable inocula
from tick tissues two consistent observations have been made. It is difficult to
separate individual organisms from colony membranes and associated tick cell
material and, once free of inclusion membranes, organisms appear to lose viability
quickly. Techniques to prepare cleaner inoculum and facilitate contact between host
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cells are being evaluated. Of particular interest are events which occur just after
inoculation. If survival of organisms occurs, the intracellular events need to be
determined and these are under investigation.
CONCLUSIONS
The precise requirements for growth of A. marginale have not been fully defined. The
parasite appears to survive in several in vitro situations but replication has not been
confirmed. Use of short-term erythrocyte cultures has proven useful in studying
certain aspects of the behaviour of A. marginale. If the infection of erythrocytes with
salivary gland stages can be optimized, this system would be beneficial in studying
neutralization of infection. Emphasis is presently being given to the use of tick-de-
rived stages of A. marginale in various nucleated cell lines. Based on results to date
this appears to be the most promising area to pursue.
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SUMMARY OF DISCUSSIONS
Summary of discussions
Disease distribution, economic
importance and control
Chairman: Dr. R. Dalgliesh
Rapporteurs: Dr. B.D. Perry, Dr. A.W. Mukhebi
BABESIOSIS AND ANAPLASMOSIS
The discussion centred on three areas: the effects of endemically stable states on
livestock production; the effects of different strains and intensity of Anaplasma
marginale challenge on the efficacy of A. centrale immunization; and the changing
incidence  of  vaccinal  failures  in the  face  of  live Babesia bovis vaccine use  in
Australia.
Unpublished studies from Uruguay suggest considerable losses in live-weight gain
in apparently healthy but carrier animals, but this work has not been substantiated
elsewhere. Evidence of differences in weight gain between vaccinated and control
cattle in endemically stable areas was also reported. However, animals immunized
with A. centrale in Australia experienced some decrease in live-weight gain, but this
was followed by compensatory growth over the subsequent two to three months. In
immunization trials in Malawi, there were no differences in live-weight gain, body
score and packed cell volume between vaccinated and control animals six months to
three years old two months after trivalent (A. centrale, B. bigemina and B. bovis)
immunization.
The variation in clinical response to A. centrale immunization was emphasized.
Anaplasma centrale has a behavioural difference from A. marginale, and a transmis-
sion difference, being transmitted by Rhipicephalus appendiculatus simus and not by
Boophilus spp. It was noted that in some Asian countries Anaplasma had a more
central position within the erythrocyte, although they were called A. marginale. They
were reported from areas in which A. centrale vaccination may have been used. Some
regional differences to immunization with A. centrale were noted. Some alarming
reactions were reported from Australia. The role of differing A. marginale challenge
was discussed. DNA probes had shown a homogeneity in Australian A. marginale
isolates, whereas a heterogeneity in North American isolates was reported. It was
suggested that with only one recorded introduction of A. centrale to Australia, there
was no heterogeneity in isolates in that country, and the clinical disease also showed
marked homogeneity.
Vaccinal failures with B. bovis vaccine in Australia were originally blamed on
the strain used. Although after 1978, a frozen stabilate from an early passage was
used, failures still persisted. Failures seemed to spread from one property to
another and tended to be associated with frequent vaccine use. However, when
breakthrough strains were isolated in the laboratory and tested against the
vaccine strain, it was shown that the protective effect had not changed. This
indicates changes in the field populations of B. bovis rather than the vaccine
strain.
It was evident from the discussions that there are inadequate data to make
comprehensive and practical estimates of the economic losses attributable to these
diseases and the benefits from their improved control.
COWDRIOSIS
The economic importance of heartwater in comparison with other tick-borne diseases
and the difficulty associated with quantifying this was discussed at length. It was
stressed that there are considerable differences throughout Africa in disease occur-
rence depending on cattle types and acaricide use. These differences influence the
prevalence of endemic instability. It was suggested that in South Africa, Zimbabwe
and West Africa, the disease was considerably more important than other tick-borne
diseases. It was also identified as a major problem in Kenya where other tick-borne
diseases were controlled by immunization under field-trial conditions. It was empha-
sized that heartwater has been considerably under-diagnosed due to the lack of a
diagnostic test for use in the live animal.
The outstanding questions arising from the discussions on anaplasmosis, babe-
siosis and heartwater were:
In general
• Are there better ways to define the effects of babesiosis and anaplasmosis on
livestock production? Are control measures justified? If so, what control
measures are economically feasible?
• How variable is A. marginale? What are the reasons for difference in virulence
among countries and where can A. centrale be useful, and where not?
• Does repetitive vaccination in a particular situation lead to selection for an
emergence of antigenetically different, virulent parasite strains? If so, what are
the mechanisms and what are the solutions?
In South America
• Why is the American A. marginale apparently so much more virulent than the
same parasite in other countries? Why does A. centrale not protect?
• What can be done to stop the spread of A. marginale by mechanical transmission
in vaccination programs for other diseases such as foot-and-mouth disease?
• Is the inactivated culture vaccine sufficient for control of babesiosis in
Venezuela and  other South  American  countries? Should live  vaccines be
prevented?
• Why is B. bigemina a particular problem in Brazil?
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In West Africa
• Is the introduction and use of Anaplasma and Babesia vaccination justified in
Nigeria and other countries in the West African region?
• Is it possible that Boophilus decoloratus is the vector of B. bovis in some parts
of Nigeria? If not, what is the reason for the epidemiological evidence that
suggests that this is so?
In Southeast Asia
• Can we develop an internationally coordinated approach to ensure all suscepti-
ble  cattle  imported into tropical/subtropical areas are adequately protected
against babesiosis and anaplasmosis?
• Why was the Sri Lankan strain of B. bovis not amenable to a reduction in
virulence by passage whereas it has been successful on at least 10 strains in
Australia, South Africa and South America? What are the implications for other
countries?
On cowdriosis
• Are there better ways to define the effects of heartwater on livestock production?
Are control measures justified? If so, what approach is economically feasible?
The importance of defining the effects of heartwater on production cannot be
over-emphasized. Ranking of the economic importance of the disease must be
an integral part of research programs. Heartwater is apparently top priority in
many countries and it is, therefore, wrong to push programs on other diseases
ahead of heartwater.
• How great is the threat of spread of heartwater in other parts of the world where
it is a relatively new disease, and how best can this threat be met?
• What is the potential of the tick-decoy approach in the control of heartwater? If
it is extremely effective for vector control, it may have commendable economic
advantages over other control methods.
Diagnosis
Chairman: Prof. G. Uilenberg
Rapporteurs: Dr. P.A.O. Majiwa, Dr. O.K. ole-MoiYoi
The discussants agreed that infectious organisms needed to be accurately identified.
This called for the use of reagents which achieve the objective precisely and quickly.
It is extremely important to convince farmers of the simplicity and reliability of a
particular test because they are the ones who must pay for the services of a veterinar-
ian to treat their animals. They therefore need to be convinced that the test really
works. The farmer and the veterinary clinician need tests that are quick and reliable
and which will thus identify infected animals that need treatment before their
condition worsens. A point that was emphasized is that it would be desirable to have
a diagnostic test to detect a parasite before the onset of disease, before it is too late
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to successfully treat the animal so that it regains full productivity. The reagents used
should help identify infected animals, the strain or substrain (species or subspecies)
of the infectious organism, and should also identify those organisms which do not
respond to treatment, the so-called `breakthrough’ strains.
It was clear that microscopic examination of blood smears might be insufficient
in many situations. Although a microscopic examination can be done routinely and
quickly, it can also be subjective. This emphasized the need for reagents upon which
standard and objective tests can be based. Recombinant antigens which can be
standardized for use in ELISA, other antigen capture assays and DNA hybridization
probes could meet these requirements. Indeed, for some of the organisms, such as
Anaplasma, both reagents are available and what needs to be done is to use the
reagents to answer specific epidemiological questions.
It was pointed out that Anaplasma infections can be sterilized; however, animals
usually remain carriers after treatment. It is therefore important to have assay systems
which will discriminate between acutely infected, subacutely infected and carrier
animals. It is apparent from the above that a combination of diagnostic tests will have
to be employed in many situations, particularly since in these infections, antibody
titres may bear little, if any, relationship to the degree of immune protection of the
animals. None of the reagents available, recombinant DNA probes or serological
reagents, has been critically evaluated as to specificity. To do this, one would need to
perform expensive experiments that involve the use of many animals and/or appro-
priate vectors of the infectious organism. Questions also arose as to the necessity of
identifying infectious organisms present either in the vectors or in the hosts at such
low levels that they would not cause disease or be transmitted. This important issue
was not resolved in the discussion.
New vaccines
Chairman: Dr. A.J. Musoke
Rapporteurs: Dr. L.L. Logan-Henfrey, Dr. D.J.L. Williams
The discussion focussed on three topics—the nature of the immune response, the role
of the carrier state and the importance of innate resistance in local breeds.
ANAPLASMA MARGINALE
The relevance of the multiple copies of the 29 amino acid tandem repeat was
questioned. So far all isolates have shown multiple copies of this sequence repeat
although the number of repeats varied between isolates. All isolates tested reacted
with a MAb raised against this amino acid sequence, suggesting that the motif is
conserved. The major surface proteins (MSPs) were found to be protective in
preliminary trials in Zimbabwe. A point was made that challenges should be made
with sporozoites to evaluate the level of protection against tick challenge in the
field.
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A general question about vaccine delivery systems was raised. Vaccinia virus is
currently being evaluated as a vector in the US. This allows for 2 conformational changes
in expressed proteins but stimulates a cell-mediated immunity rather than an antibody
response. Other adjuvants such as biodegradable plastics are being developed.
COWDRIA RUMINANTIUM
A question was raised concerning the CR32-kDa antigen’s ability to elicit a protective
immune response. In vitro neutralization assays are being carried out and preliminary
experiments showed that mice immunized with affinity-purified CR32 in Freud’s
complete adjuvant were not protected. It was postulated that if this antigen were
protective,  selective pressure would  have  resulted in polymorphisms  within the
protein. This does not appear to be the case. The group working on this protein agreed
that its protective capacity was in doubt but suggested that it could be a very useful
diagnostic tool.
One discussant thought that the nature of resistance in local livestock populations
to a variety of diseases should be studied in depth. Questions were raised regarding
the level and seasonality of tick challenge in endemic areas and its role in maintaining
resistance. Similarly the question of whether resistance was related to an animal’s
carrier status was discussed. No data are available to answer these questions.
Finally the discussion returned to the type of immune responses which were
generated by infection or vaccination. It was agreed that the type of protective
immune response generated by infection should be characterized since the epitopes
involved in cytotoxic lymphocyte responses would be very different to those which
elicit antibody responses. In addition the antibody response generated by single-shot
vaccines should be characterized to determine not just the titre but the avidity and the
rapidity of the response. In other words, can it outstrip parasite multiplication?
Natural immunity may be different from that which can be induced artificially (for
example, in malaria, sporozoite antigens contain no T-cell epitopes). By adding T-cell
epitopes, effective antibody responses can be generated. With the isolation of genes
for the protective antigens of Babesia, Anaplasma and Cowdria, elegant manipula-
tions are being carried out, allowing the design of effective subunit vaccines.
In vitro cultivation
Chairman: Dr. H. Hirumi
Rapporteurs: Dr. R. Kaminsky, Dr. P.R. Spooner
It was emphasized that the Babesia culture system is well established and suitable for
the in vitro isolation of field strains. Areas for further improvement were considered
to be the development of (1) an automated system to reduce laborious medium changes,
(2) large-scale culture systems and (3) methods to cultivate the parasite stages in the
tick. Due to lack of knowledge of the development of Babesia in ticks, only limited
emphasis has been placed on the culture of the arthropod life cycle stages.
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COWDRIA RUMINANTIUM
Improvement of the culture system for Cowdria is still desirable, in particular with
respect to the growth rate of endothelial cells. The source (tissue origin) of
endothelial cells may have an influence on the growth of the organisms. Problems
in the cryopreservation of Cowdria may be overcome by the use of sucrose-gluta-
mate-phosphate buffer and by using culture material two days after infection. It
was suggested that inconsistent DNA recovery was due to the difficulty in disrupt-
ing elementary bodies which may be improved by using reducing agents such as
2-mercaptoethanol or dithiothreitol. The success rate for initiation of cultures using
plasma was considered to depend on the state of infection in the animal. Problems
in the propagation of the arthropod life stages were not discussed.
ANAPLASMA MARGINALE
The precise requirements for growth of A. marginale have not been fully defined for
either bovine or tick stages. The parasites can be maintained in culture but the present
systems have not been shown to  maintain  infectivity  or  to support replication.
Short-term cultures can be used for studies only on certain aspects of the biology of
Anaplasma. Long-term cultures are obviously needed for chemotherapeutic and
immunological studies.
Commercialization
Chairman: Dr. T.T. Dolan
Rapporteurs: Dr. J.A. Lawrence, Dr. N. McHardy, Dr. G. Bissuel
A separate discussion was held on the likely contribution of the pharmaceutical
industry to the control of tick-borne diseases.
THERAPEUTICS
Drugs exist for control by therapy and prophylaxis of babesiosis, anaplasmosis and
cowdriosis, but they are few and some previously useful products are no longer
available. The drugs available for the treatment of babesiosis are diminazene acetu-
rate (Berenil, Ganaseg) and imidocarb dipropionate (Imizol). In addition, tetracycli-
nes are increasingly used for specific roles such as the control of vaccine reactions.
The drugs that have been withdrawn are amicarbalide, phenamidine and pentamidine.
Quinuronium sulphate (Acaprin) is not available in most markets but is a mainstay,
particularly for ovine babesiosis, in the Middle East. Two drugs are available for
anaplasmosis—tetracyclines and imidocarb. Users appear reasonably satisfied with
their efficiency. The only available drugs for cowdriosis are oxytetracycline and
its near relative doxycycline, which shows promise as a sustained-action product.
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Two active leads, rifampins and thiosemicarbazones are not expected to become
availableforregulatory/safetyreasons.
No new therapeutics for these three diseases are believed to be in development.
This is a cause for concern since, although drug resistance among these diseases is
not a significant problem, in the long term it is inevitable and new products will be
required. The withdrawal of drugs has been due to declining markets, presumably
because currently available products are superior, and not because of the development
of resistance. Nonetheless, some would still find niche uses if they were available.
If new therapeutics are to be developed, this can only be done by industry. The cost
of developing new therapeutics solely for tick-borne diseases is regarded by industry
as prohibitive. Apart from the difficulty of identifying new active compounds, the
need to establish human safety in the face of increasingly stringent regulations is the
principal cost constraint.
While no specific need for new therapeutics was identified, the possibility of
developing sustained action products such as doxycycline for control of cowdriosis
would be attractive. The problem of human safety from persistent residues could,
however, pose insuperable regulatory problems.
Any new product would inevitably be relatively expensive because of the need to
recoup the cost of its development (perhaps £50 million over 10 years) and to give a
return on investment.
DIAGNOSTICS
A number of improved diagnostic tests have been developed by research organiza-
tions to a level at which they could be of value for epidemiological surveys or
clinical diagnosis. There is little, if any, interest from commerce in further devel-
opment and production of these tests for field use because of the limited perceived
market. Diagnostics will almost certainly require public funding for development.
FAO/IAEA and OIE have already initiated development and production of a number
of tests. It was the general opinion that these organizations were the most appro-
priate for this and for monitoring quality, and were in the best position to seek
funding from donors and commerce to support the work. Commerce should be
encouraged to sponsor development of diagnostics to improve the utilization of
vaccines and chemotherapeutics in the field.
VACCINES
There is an urgent need to increase the efficiency of cattle production in Africa. The
population is increasing at a rate of three percent, and it is predicted that by the year
2025 the requirement for red meat will increase three to four times. One of the major
constraints to improved production is tick-borne diseases, and vaccines are the most
desirable way of controlling them. Great progress is being made in the development
of subunit vaccines but it is unlikely that any will be on the market within the next
five to seven years. In the meantime, every effort should be made to promote the use
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of conventional vaccines, despite their limitations. This will require some input from
public funds and the involvement of commerce.
Cattle owners in Africa are generally accustomed to paying for acaricides and
chemotherapeutics, but in the past vaccines have often been provided free. There is
therefore a reluctance to pay for vaccines for tick-borne diseases, which must be
overcome. Widespread use of vaccines will require a concerted extension approach
and good marketing organization. Commerce should be encouraged to develop
packages incorporating vaccines, acaricides and chemotherapeutics, which can be
marketed effectively to improve productivity. Farmers should be given better access
to credit to encourage them to purchase such packages to initiate an economic
approach to production which is essential for livestock improvement.
If significant improvement in livestock production is to be achieved, it is essential
to develop strategies for integrated tick and tick-borne disease control and to promote
them by intensive extension programs. If successful, this will have the effect of
improving the quality and value of cattle in Africa, which in turn will increase the
market for vaccines and other products and therefore increase the motivation for
commerce.
Concluding discussion
Chairman: J.J. Doyle
Rapporteur: T.T. Dolan
The discussion on babesiosis returned to the development of resistance to the B.
bovis blood vaccine in Australia and the selection for parasite populations in the
field which differed from the vaccine strain.  There was  no evidence (yet) of
problems in other countries where the Australian vaccine had been used, but this
may simply be because repeated vaccination has not been applied. Should resis-
tance develop, it will be necessary to change the vaccine strain as was done in
Australia. In the case of vaccination against A. marginale, it was apparent that A.
centrale worked inconsistently and the use of A. marginale needed to be explored
more widely to provide comparative data and perhaps a better vaccine alternative
in problem areas.
In South America there is a large market for the current anaplasmosis and babe-
siosis vaccines but their availability is a problem. A culture supernatant vaccine for
babesiosis is being tested in a large number of cattle and while the results are generally
positive, there are difficulties in interpreting them. Babesia bigemina is most impor-
tant in Brazil while B. bovis is the more important pathogen in most other countries.
It is important to be able to determine the relative importance of the two species and
to study the factors influencing virulence.
The vast majority (90%) of cattle in West Africa are owned by pastoralists and
hand de-ticking and acaricides are the most widely used control measures. Studies
on the vectors for B. bovis were required and integrated control measures, which
might include the cautious introduction of vaccination, should be considered.
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In regard to Southeast Asia, the point made on an internationally coordinated
effort to ensure that susceptible high-grade cattle being introduced into tropical and
subtropical countries were protected against anaplasmosis and  babesiosis was
repeated. Organizations such as OIE could be responsible for ensuring that this is
done as the high losses encountered in these introduced cattle totally undermined
this method of livestock improvement. The failure to attenuate Sri Lankan B. bovis
strains could indicate that similar problems will be encountered elsewhere. This
strengthens the case for importing well-characterized, safety-tested vaccines rather
than attempting to develop vaccine strains in a multitude of countries.
There is good evidence for the spread of Amblyomma species in a number of
countries and, depending on the region of Africa, this has important implications for
cowdriosis and/or dermatophilosis. The potential of the tick decoy method of control
of this species based upon a pheromone elaborated by the attached male tick and
insecticide was considerable. The possibility of using this ingenious approach in a
plastic tag slow release (pheromone and insecticide) form could be an important
practical control measure.
Much greater emphasis is needed to determine the economic importance of
tick-borne diseases. The costs of acaricides, dip construction, maintenance and use
have been estimated for many countries but particular attention must be directed
towards an accurate assessment of mortality and of the production losses to subclini-
cal disease. Having accurate estimates of these losses could induce pharmaceutical
companies to re-appraise the potential for investment in tick-borne disease chemo-
therapy, diagnostics or vaccines. A start should be made and methodologies devel-
oped which would be applicable in many situations. The use of existing models or
the development of new models for studies of disease, economics or control would
contribute to faster and more accurate assembly of these data. The availability of hard
data on the economic impact of these diseases would also strengthen the case for
national and donor investment in their control.
The development of high-quality standardized diagnostic tests is critically needed
for epidemiological studies. The development of tests for immunity, for presence of
infection (carrier state), for discrimination between field and vaccine exposure, for
identification of strains and for detection and quantification of infection in vectors is
desirable. Such tests would greatly improve epidemiological studies and contribute
to the assessment of economic impact, particularly in assessing the effects of sub-
clinical infections. It was agreed that a group representing the institutes attending the
workshop would meet to establish collaboration for the development of improved
diagnostics, particularly antibody- and antigen-detection ELISAs for anaplasmosis
and babesiosis.
The potential for subunit vaccines for the tick-borne diseases was very promis-
ing. In the case of Anaplasma, partial protection was provided against parasitaemia,
but not anaemia, using recombinant antigens of MSPs. For B. bigemina, polypep-
tide complexes from the surface of merozoites isolated by affinity chromatography
have been shown to provide up to 70% protection. Recombinant antigens of B. bovis
based upon fractionated lysates also provided protection, which was improved
when they were combined. Culture supernatant vaccines being explored for a
number of Babesia species also promise well. However,  these novel Babesia
vaccines all perform less efficiently than the live vaccines available and therefore
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will require considerable improvement before they can replace them. In the case
of Cowdria, it was generally believed that the important immune responses were
cell-mediated. The identification and isolation of the expressed peptides may be
difficult and ILRAD’s immunological expertise could contribute to the search for
protective antigens. Although vaccines based upon infection and treatment or tissue
culture are effective, they are compromised. The development of subunit vaccines
is a high priority research need so that live vaccines with the attendant risks of
transmission of other pathogens, the introduction of vaccine parasite strains, the
possibility of reversion to virulence, and the complications of delivery in many
tropical countries may be replaced.
The questions of challenge dose and the nature of challenge were also raised in
the testing of protection provided by novel vaccines; what parasites (homologous or
heterologous) should be used and should blood, tissue culture, stabilates or ticks be
used and what dose? Finally, when subunit vaccines are produced, what international
approval/ regulations will be required prior to their release, especially if live delivery
systems are used.
The major points  regarding in  vitro culture and  commercialization  had  been
discussed thoroughly in the sessions immediately prior to this concluding discussion
and there was no further discussion.
Concluding remarks
Dr. Gray thanked the participants for the quality of their papers and for the openness
of the discussion. They had provided ILRAD with a comprehensive update on the
research and control of the three diseases. This information will greatly assist ILRAD
in developing research strategies for the next ten years. Dr. Gray strongly supported
the setting up of collaboration for development of standardized diagnostic assays. He
thought  that  ILRAD’s future  involvement in other tick-borne or tick-associated
diseases, if approved by the Technical Advisory Committee of the CGIAR, would be
in the form of collaboration, exploiting ILRAD’s advantages in bovine immunology,
vaccine development, location in Africa and its excellent laboratory and cattle
production facilities. He thanked the organizers, chairmen and rapporteurs and hoped
that the publication of the proceedings would be timely and useful.
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CONCLUSIONS
AND RECOMMENDATIONS
Conclusions and recommendations
• The epidemiology of tick-borne diseases is poorly understood in most countries
of the world. It is recommended that detailed structured studies be conducted
within national and regional programs that would monitor vector distribution and
dynamics, the interplay of the different parasites and their virulence, and carrier
states so that the epidemiology is understood and appropriate control measures can
be applied.
• The variation in quality and frequent unavailability of diagnostic tests for tick-
borne diseases seriously compromise epidemiological studies and disease surveil-
lance. It is recommended that reproducible and simple-to-use tests should be
developed and that the groups attending this Workshop should meet to establish a
collaboration to address the development, production and distribution of these
tests.
• The effects of tick-borne diseases on the productivity of cattle are widely recog-
nized but poorly quantified. It is recommended that studies on the productivity of
cattle should be incorporated from the planning stages of future epidemiological
and control programs for tick-borne diseases at both national and donor level.
• Short-interval acaricide application as a control measure for ticks and tick-borne
diseases is not being employed effectively in many countries and alternative
control measures are required. It is recommended that integrated control, which
might include strategic acaricide use, exposure of young cattle to natural chal-
lenge, immunization with available vaccines and chemotherapy, be adopted. The
use of the tick hormone/insecticide decoy method for Amblyomma control should
be tested more exhaustively as a potential component within these integrated
measures.
• Live vaccines for tick-borne diseases have well-known limitations but for many
countries they represent the only available means of disease control. It is recom-
mended that where vaccines are used, strict attention be paid to quality control and
safety testing and if this cannot be guaranteed, adequately tested vaccines should
be obtained from established laboratories.
• The distribution of Amblyomma ticks, vectors of Cowdria ruminantium, is
expanding in a number of countries in Africa and in the Caribbean. It is
recommended that strict monitoring of the changing distribution of these ticks
be undertaken and the possible spread of heartwater into susceptible populations
of livestock be assessed.
• The available chemotherapeutics for tick-borne diseases are effective and resis-
tance has not been recorded. However, important effective drugs have been
withdrawn from the market and the high cost of developing new veterinary drugs
inhibits further investment by industry. It is recommended that drugs be adminis-
tered at the correct dose rates and that resistance be regularly monitored.
• The benefits of the introduction of high-producing cattle into many tropical
countries is seriously undermined by mortality and morbidity due to tick-borne
diseases. It is recommended that where possible such cattle be immunized against
Anaplasma and Babesia before introduction. Organizations such as OIE should
inform recipient countries of the high susceptibility of these cattle to tick-borne
diseases and of the vaccination options available.
• The current research on subunit vaccines for Anaplasma and Babesia shows
considerable promise of success. It is recommended that further investment be
made in attempting to identify and characterize potentially protective antigens for
future vaccines and that ILRAD’s experience in cell-mediated immunity be drawn
upon in the search for antigens of Cowdria.
• In vitro cultivation of tick-borne pathogens is an important technique that has
contributed to identification of anti-parasitic drugs, understanding of the basic
biology of parasites, provision of DNA for molecular studies and antigens for
diagnosis or immunization. It is recommended that studies be continued towards
the production of automated, bulk culture systems for Babesia, the identification
of more rapidly growing endothelial host cells for Cowdria, the development of
long-term culture systems for Anaplasma and the development of arthropod cell
culture  systems for the production of livestock-infective  stages  of all three
parasites.
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